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Summary 
The ureters are integral components of the urinary system that serve the transport of urine from 
the renal pelvis to the bladder. They are composed of an inner epithelial lining with layers of 
basal, intermediate, and superficial cells, and an outer mesenchymal coat with peristaltically 
active smooth muscle cells and surrounding fibrocytes of the tunica adventitia and the lamina 
propria. How these cell types arise in embryonic development from two multipotent progenitor 
populations in the intermediate mesoderm, the epithelial ureteric bud and its surrounding mes-
enchyme, has remained poorly understood. 
In an attempt to delineate sub-pools of progenitor cells in the anlage of the urogenital system, 
comparative expression analysis was used to demarcate the expression domain of the T-Box 
transcription factor gene Tbx18 with respect to know markers. It was shown that Tbx18 was not 
only expressed in mesenchymal progenitors of the ureter but was also transiently expressed in 
the adrenogonadal primordium. Genetic fate mapping and lineage tracing approaches revealed 
that cells from these expression domains significantly contributed to the mesenchymal wall of 
the ureter and to the renal stroma as well as to cells of the gonads and adrenal glands. Tbx18 
was functionally required only in the ureteric mesenchymal lineage to restrict a renal stromal 
fate and to allow smooth muscle differentiation by rendering cells competent for inductive sig-
nals from the ureteric epithelium.  
Using cell type specific markers and genetic lineage tracing experiments the time course of 
differentiation, and the lineage relations and restrictions of the mesenchymal and epithelial cell 
types of the ureter were further defined. An early subdivision of the ureteric mesenchyme sep-
arated adventitial fibrocytes from smooth muscle and lamina propria progenitors. While adven-
titial fibrocytes started to differentiate at embryonic day (E) 13.5, smooth muscle progenitors 
diversified into subepithelial fibrocytes of the lamina propria and differentiated smooth muscle 
cells from E16.5 onwards. The uncommitted epithelium of the distal ureteric bud gave rise to 
intermediate cells at E14.5 and began to stratify. Intermediate cells subsequently differentiated 
into superficial and basal cells at E15.5 and E16.5, respectively, to form the three layered 
urothelium at E18.5. In homeostasis, intermediate cells continued to give rise to basal cells and 
superficial cells, whereas basal cells were terminally differentiated. 
Growth and differentiation of the epithelial and mesenchymal components of the ureter need to 
be precisely coordinated within and between the two tissue compartments. Previous work im-
plied paracrine sonic hedgehog (SHH) signaling from the ureteric epithelium in the control of 
proliferation and differentiation of the mesenchyme. Here, a combination of genetic loss- and 
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gain-of-function approaches was employed to study the cellular and molecular mechanisms that 
underlie SHH function in the developing ureter in more depth. Genetic deletion or activation of 
the SHH signal transducer smoothened in the ureteric mesenchyme confirmed the involvement 
of the pathway in mesenchymal growth and differentiation and revealed its requirement for 
mesenchymal survival and urothelial differentiation. The forkhead transcription factor gene 
Foxf1 was identified as a target of SHH signaling in the ureteric mesenchyme and misexpres-
sion of a dominant negative allele recapitulated the proliferation and differentiation defects ob-
served under hedgehog loss-of-function conditions. Genetic and pharmacological rescue exper-
iments uncovered a SHH-FOXF1-BMP4 regulatory module that couples growth and differen-
tiation of the mesenchymal and epithelial tissues in the ureter. 
Expression analysis of components and target genes of retinoic acid (RA) signaling indicated 
that this pathway was specifically active in the mesenchymal and epithelial progenitor popula-
tions of the ureter. In order to address a potential function of RA, pharmacological loss- and 
gain-of-function experiments in ureter explant cultures were performed. Inhibition of RA sig-
naling prior to the onset of differentiation resulted in an expansion of smooth muscle cells at 
the expense of lamina propria cells in the mesenchymal wall of the ureter and an expansion of 
superficial cells at the expense of intermediate cells in the urothelium, while activation experi-
ments gave complementary results. A depletion of the mesenchymal and epithelial progenitor 
pools by precocious differentiation was identified as the cellular cause for the observed pheno-
types. Potential effector genes of the pathway were identified that may explain a function of 
RA in the maintenance of ureteric progenitors. A human genetics research group identified a 
kindred with an autosomal dominant form of congenital anomalies of the kidney and the urinary 
tract. Heterozygous truncating mutation in the NRIP1 gene were identified as a cause for the 
disease. Biochemical analysis revealed that NRIP1 protein negatively regulates RA mediated 
transcriptional activity by a physical interaction with RA receptors. I contributed to the analysis 
and was able to show that developmental Nrip1 expression in the mouse nephric duct and ure-
teric bud was strongly RA dependent. 
Taken together, this thesis provided novel insight into the multipotent progenitor populations 
and into the temporal and spatial profile of lineage diversification and differentiation in the 
developing ureter. A SHH-FOXF1-BMP4 signaling axis was identified as a crucial regulatory 
module that coordinates growth and differentiation of the epithelial and mesenchymal tissue 
compartments of the ureter while RA signaling was implicated in the maintenance of ureteric 
progenitor cells. 
Keywords: ureter development, lineage tracing, hedgehog signaling, retinoic acid signaling 
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Zusammenfassung 
Die Ureteren sind wichtige Komponenten des Harnsystems und dienen dem Transport von Urin 
aus dem Nierenbecken zur Harnblase. Sie bestehen aus einer inneren epithelialen Auskleidung 
mit Schichten von Basal-, Intermediär- und Superfizialzellen und einem äußeren mesenchyma-
len Mantel mit peristaltisch aktiven Glattmuskelzellen und sie umgebenden Fibrozyten der Tu-
nica adventitia und der Lamina propria. Wie diese Zelltypen im Verlaufe der Embryonalent-
wicklung aus zwei multipotenten Vorläuferpopulationen, der epithelialen Ureterknospe und 
dem sie umgebenden Mesenchym, entstehen, ist nur unzureichend verstanden. 
In einem Versuch, unterschiedliche Gruppen von Vorläuferzellen in der Anlage des Urogeni-
talsystems darzustellen, wurden vergleichende Expressionsstudien durchgeführt, um die Ex-
pressionsdomänen des T-Box Transkriptionsfaktors Tbx18 von bekannten Markern abzugren-
zen. Es konnte gezeigt werden, dass Tbx18 nicht nur in den mesenchymalen Vorläufern des 
Ureters, sondern auch vorrübergehend in der adrenogonadalen Organanlage exprimiert war. 
Genetische Schicksalkartierungs- und Zellverfolgunsexperimente konnten zeigen, dass Zellen 
dieser Expressionsdomänen einen signifikanten Beitrag zur mesenchymalen Wand des Ureters 
und zum Interstitium der Niere sowie zu Geweben der Gonade und der Nebenniere leisteten. 
Die Funktion von Tbx18 war auf die Abstammungslinie des Uretermesenchyms beschränkt, um 
den zellulären Beitrag zum renalen Interstitium einzuschränken und Zellen empfänglich für 
induktive Signale aus dem Ureterepithel zu machen. 
Um den zeitlichen Verlauf der Differenzierung und die Abstammungsverhältnisse der mesen-
chymalen und epithelialen Zelltypen des Ureters genauer zu beschreiben, wurden Zelltyp-spe-
zifische Marker und Zellverfolgungsstudien eingesetzt. Eine frühe Unterteilung des Ureter-
mesenchyms in adventitiale Fibrozyten und Vorläuferzellen der glatten Muskulatur und der 
Lamina propria konnte beobachtet werden. Während adventitiale Fibrozyten bereits am Emb-
ryonaltag (E) 13.5 differenzierten, spaltete sich die glattmuskuläre Vorläuferpopulation am 
E16.5 weiter in differenzierte Glattmuskelzellen und Fibrozyten der Lamina propria auf. Die 
epithelialen Zellen der distalen Ureterknospe entwickelten sich am E14.5 zunächst zu Interme-
diärzellen und begannen zu stratifizieren. Diese differenzierten am E15.5 und E16.5 jeweils in 
Superfizial- und Basalzellen, um am E18.5 das dreischichtige Urothel hervorzubringen. In der 
Gewebehomöostase waren Intermediärzellen weiterhin Vorläufer von Basal- und Superfizial-
zellen, wohingegen Basalzellen einen terminal differenzierten Zustand einnahmen. 
Zusammenfassung 
 
VII 
Das Wachstum und die Differenzierung der epithelialen und mesenchymalen Bestandteile des 
Ureters müssen im Verlaufe der Organentwicklung räumlich und zeitlich präzise koordiniert 
werden. Vorherige Studien konnten zeigen, dass Sonic Hedgehog (SHH) Signale aus dem Ure-
terepithel die Proliferation und Differenzierung des Uretermesenchyms steuern. In dieser Arbeit 
wurde eine Kombination aus genetischen Funktionsverlust- und Funktionsgewinnexperimenten 
genutzt, um den SHH Signalweg in der Ureterentwicklung genauer zu untersuchen. Der gene-
tische Verlust oder die Aktivierung des SHH Signalvermittlers Smoothened im Uretermesen-
chym bestätigten die Notwendigkeit des Signalwegs für das Wachstum und die Differenzierung 
des Mesenchyms und konnten bisher unbekannte Funktionen für das mesenchymale Überleben 
und die urotheliale Differenzierung aufdecken. Der Forkhead Transkriptionsfaktor Foxf1 wurde 
als ein Zielgen des SHH Signalwegs im Uretermesenchym identifiziert und die Misexpression 
eines dominant-negativen Allels konnte die Proliferations- und Differenzierungsdefekte des 
SHH Verlusts rekapitulieren. Genetische und pharmakologische Rettungsexperimente konnten 
die Funktion einer SHH-FOXF1-BMP4 Signalachse in der Kopplung des Wachstums und der 
Differenzierung der epithelialen und mesenchymalen Gewebe des Ureters entschlüsseln. 
Expressionsstudien von Komponenten und Zielgenen des Retinsäure (RS) Signalwegs zeigten, 
dass dessen Aktivität auf die mesenchymalen und epithelialen Vorläuferpopulationen des Ure-
ters beschränkt war. Um eine mögliche Funktion von RS zu adressieren, wurden pharmakolo-
gische Funktionsverlust- und Funktionsgewinnstudien in Gewebekulturen des Ureters durch-
geführt. Eine Hemmung des Signalwegs vor dem Einsetzen der Differenzierung führte zu einer 
Ausweitung des glattmuskulären Kompartiments zu Lasten der Lamina propria in der Ureter-
wand und zu einer Vermehrung von Superfizialzellen zu Lasten von Intermediärzellen des 
Urothels. Eine Aktivierung des Signalwegs hatte den gegenteiligen Effekt. Ein Schwund der 
mesenchymalen und epithelialen Vorläuferpopulationen durch eine verfrühte zelluläre Diffe-
renzierung wurde als Ursache für die beobachteten Phänotypen erkannt. Zudem wurden poten-
tielle Zielgene des Signalwegs identifiziert, welche eine Funktion von RS in der Aufrechterhal-
tung der Vorläuferzellen erklären könnten. Die Beschreibung einer Familie mit einer autoso-
mal-dominanten Form von angeborenen Fehlbildungen der Niere und des Harnleiters durch 
eine humangenetische Forschergruppe lieferte weitere Anregungen zur Studie des RS Signal-
wegs in der Entwicklung des Harnsystems. Eine heterozygote Mutation des NRIP1 Gens wurde 
von ihnen als ursächlich für die Erkrankung erkannt. Ihre biochemischen Studien legten nahe, 
dass NRIP1 die transkriptionelle Aktivität von RS durch eine direkte physikalische Interaktion 
mit RS Rezeptoren beeinträchtigt. Ich konnte zu dieser Studie beitragen und zeigen, dass die 
Zusammenfassung 
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Nrip1 Expression im Nephrischen Gang und der Ureterknospe der Maus abhängig von RS Ak-
tivität reguliert wird. 
Insgesamt konnte die vorliegende Arbeit neue Einsichten in die multipotenten Vorläufergewebe 
und in das zeitliche und räumliche Profil der Diversifizierung und Differenzierung der Zellty-
pen des Ureters liefern. Eine SHH-FOXF1-BMP4 Signalkaskade wurde als wichtiges regula-
torisches Modul identifiziert, welches das Wachstum und die Differenzierung der mesenchyma-
len und epithelialen Bestandteile des Ureters in der Organentwicklung koordiniert. Zudem 
konnte eine Funktion des RS Signalwegs mit der Aufrechterhaltung der Vorläuferpopulation 
des Ureters in Zusammenhang gebracht werden.
 
Schlagworte: Ureterentwicklung, genetische Abstammungsverfolgung, Hedgehog Signal-
weg, Retinsäure Signalweg   
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Introduction 
Structure and function of the ureter 
The ureters are paired muscular ducts that connect the renal pelvis to the urinary bladder to 
facilitate an efficient drainage of the urine which is produced in the kidneys. They are positioned 
in the retroperitoneal space where they are attached to fibrous and adipose connective tissue. 
The upper aspects of the ureters emanate from the sinus of the kidneys in a funnel-shaped form 
and pass through the abdomen into the pelvic region where they integrate into the urinary blad-
der.1  
The ureteric wall is composed of two tissue compartments, an inner epithelial lining and an 
outer mesenchymal coat. The luminal lining of the ureter is formed by a specialized transitional 
epithelium, the urothelium, which is highly distensible yet provides efficient sealing towards 
the hypertonic urine. The urothelium is stratified into three to four cell layers and is comprised 
of at least three distinct cell types: the superficial, intermediate and basal cells (Figure 1).2 The 
ureteric lumen is sealed by one layer of large squamous superficial cells which covers the whole 
surface of the longitudinally folded urothelium. Underneath a population of small cuboidal in-
termediate cells is located which only represent a minor fraction of the urothelium. The major 
cell type of the urothelium are small cuboidal or column-shaped basal cells which are organized 
in two to three cell layers at the urothelial base and tightly adhere to the mesenchymal coat of 
the ureter.1, 2 The ureteric mesenchyme is organized into three histologically distinct compart-
ments: the lamina propria, the tunica muscularis and the tunica adventitia (Figure 1).1 The lam-
ina propria is a loose connective tissue, comprised of fibrocytes and fibroelastic material, which 
connects urothelial basal cells to the smooth muscle coat of the tunica muscularis. Ureteric 
smooth muscle cells are elongated and organized in bundles with circular or longitudinal ar-
rangement which are separated by collagen fibers.3 Individual smooth muscle cells are inter-
connected via gap junctions and form a functional syncytium.4 The tunica muscularis is thin-
walled in the proximal, funnel-shaped aspect of the ureter and thickens as the ureter proceeds 
antegrade towards the urinary bladder. A surrounding sheet of connective tissue, rich in colla-
gen fibers and interspersed with circularly arranged fibrocytes, forms the tunica adventitia 
which is covered by adipose tissue and anchored in the extraperitoneal cavity.1 The abdominal 
aspect of the ureter is supplied with blood from the renal and ovarian or testicular arteries 
whereas the pelvic aspect is vascularized from vesical and rectal vessels. The vasculature of the 
ureter is longitudinally arranged in the tunica adventitia from where it branches and supplies  
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the tunica muscularis with capillaries. These capillaries form plexi in the lamina propria from 
where the urothelial cell types are supplied.1 The innervation of the ureter runs in close associ-
ation with the ureteric vasculature and forms plexi in the inner and outer connective tissue com-
partments whereas free nerve endings are not observed in the smooth muscle layer or urothe-
lium.5 
 
 
Figure 1: Schematic illustration of ureter morphology and histology. 
(A) The ureters are paired tubular organs that connect the kidneys with the urinary bladder to actively 
drain urine. (B) Schematic representation of a transvers section of the proximal ureter. Urothelial cell 
types and mesenchymal tissue compartments are illustrated. Urothelial cell shapes were adapted from 
Hicks, 1965.2 
The urine that is collected in the renal pelvis is not merely drained passively through the ureter 
but actively propelled towards the urinary bladder via coordinated peristaltic contractions of 
the smooth muscle layer.6 These peristaltic contractions are myogenic in nature and originate 
from atypical smooth muscle cells at the pelvicalyceal junction which show electrical auto-
rhythmicity and propagate action potentials to the electrically quiescent typical smooth muscle 
cells.6-8 The pelvicalyceal origin of rhythmicity and the long refractory period of ureteric 
smooth muscle cells assure a proximodistal directionality of contractions which prevents urine 
reflux and kidney damage.9 
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The structural and functional integrity of the ureteric tissues and the patency of the ureteric 
junctions to the renal pelvis and the urinary bladder are essential for efficient urine drainage 
and maintenance of kidney function. Functional or physical obstruction of the urinary tract re-
sults in dilatation of the ureter (hydroureter) and the renal pelvis (hydronephrosis) due to in-
creased hydrostatic pressure and culminates in the destruction of the renal parenchyma. Con-
genital ureter anomalies represent a prominent subgroup of congenital anomalies of the kidney 
and urinary tract (CAKUT) which are among the most common human birth defects, affecting 
approximately 1:500 live births and are the leading cause of end-stage renal disease in  
infants.10, 11 CAKUT comprises a broad spectrum of phenotypes including hydro- and megaure-
ter, ureteropelvic junction obstruction, vesicoureteral reflux and hydronephrosis as well as renal 
agenesis, renal hypoplasia, duplex kidneys and multicystic kidneys. All of these malformations 
originate from defects in the development of the kidney and the urinary tract which disturb 
normal morphogenesis or cellular differentiation programs.12, 13 The study of normal and patho-
logical kidney and ureter development is thus pivotal to understand the etiology of these com-
mon human birth defects. 
Development of the mouse ureter 
The development of the ureters is closely associated and coordinated with the development of 
the kidneys and the lower urinary tract, i.e. the bladder and urethra, and involves tissues of 
different germ layers. Whereas the kidneys and the ureters derive from the intermediate meso-
derm, the lower urinary tract originates from endodermal tissues.14 In the mouse, kidney devel-
opment is initiated with the emergence of the nephric duct at embryonic day (E) 8.5 via an 
epithelial-mesenchymal transition in the intermediate mesoderm of each body side.15 The neph-
ric ducts extend caudally until they reach and fuse with the cloaca, the endodermal precursor of 
the lower urinary tract, at E9.5. This fusion process and additional tissue remodeling are crucial 
steps for the integration of the ureters into the urinary bladder which is essential for efficient 
urine drainage.16, 17 During its caudal elongation the nephric duct induces two generations of 
transient kidney structures in the adjacent intermediate mesoderm, the pro- and the mesoneph-
ros, which degenerate in higher vertebrates and only constitute ontogenetic relicts.18 Definitive 
kidney (metanephros) development starts at E10.5 with the evagination of the ureteric bud from 
the nephric duct epithelium at the approximate level of the hind limb buds. The ureteric bud 
subsequently elongates and invades a specialized mesenchymal population, the metanephric 
mesenchyme, which harbors all progenitors for nephrons and the renal stroma.19 Whereas the 
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proximal portion of the ureteric bud initiates nephrogenesis in the metanephric mesenchyme 
and undergoes serial events of dichotomous branching to establish the collecting duct system 
of the kidney, the distal, unbranched stalk of the ureteric bud merely elongates and interacts 
with the surrounding ureteric mesenchyme to form the ureter (Figure 2). 
 
The ureteric bud forms as an evagination of the nephric duct and its proximal end invades the metaneph-
ric mesenchyme to undergo serial branching events that form the collecting duct tree of the kidney. At 
E11.5 the distal, unbranched ureteric stalk epithelium is single-layered and surrounded by a homogenous 
mass of mesenchymal cells. Between E12.5 and E14.5 the ureteric mesenchyme is subdivided into two 
tissue compartments. The inner compartment is densely packed and harbors spherical cells whereas the 
outer compartment is loosely organized and interspersed with tangentially oriented fibrocytes. The ure-
teric epithelium which remains single-layered at E12.5 becomes double-layered at E14.5. From E16.5 
onwards all three mesenchymal compartments, i.e. the lamina propria, tunica muscularis and tunica ad-
ventitia, are established. Urothelial stratification proceeds and the luminal surface is fully covered with 
differentiated superficial cells. Abbreviations: IM, inner mesenchyme; K, kidney; LP, lamina propria; 
MM, metanephric mesenchyme; ND, nephric duct; OM, outer mesenchyme; U, ureter; UE, ureteric 
epithelium; UM, ureteric mesenchyme; US, ureteric stalk. Adapted from Trowe et al., 2012.20 
Figure 2: Schematic illustration of mouse ureter development. 
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At E11.5 the single layered ureteric epithelium is surrounded by a homogenous mass of mes-
enchymal cells which is cellular and molecular distinct from the metanephric mesenchyme.21 
This ureteric mesenchyme becomes radially subdivided at E12.5 into an inner compartment 
harboring densely packed spherical cells and an outer compartment interspersed with tangen-
tially oriented fibrocytes.20 While the ureteric epithelium is still single-layered at E12.5 strati-
fication is initiated at E13.5 and the epithelium becomes double-layered by E14.5.22 With the 
onset of substantial urine production at E16.5 all mesenchymal compartments, i.e. the lamina 
propria, tunica muscularis and tunica adventitia are established and the ureter becomes peristal-
tically active and thus functional.20, 23 The now three-layered urothelium is sealed with one layer 
of superficial cells that covers the whole luminal surface and protects the underlying tissues 
from the hypertonic urine.24 Differentiation of urothelial basal and intermediate cells has also 
been reported but the temporal and spatial profile of their emergence is not well  
characterized.22, 25 Thereafter the ureter continues to grow and terminally differentiates shortly 
after birth. 
Molecular control of ureter development 
Beside its important function in urine drainage and the clinical significance of congenital ure-
teral anomalies, the ureter represents a simple model system to study epithelial-mesenchymal 
interactions and the molecular control of growth, patterning and differentiation in the develop-
ment of a tubular organ. The analysis of genetically modified mouse models has shed light on 
some key regulators of ureter development and helped to elucidate the causality of genetic mu-
tations to CAKUT phenotypes in human patients, but still many open questions remain.13, 14 
Specification and diversification of ureteric cell lineages 
The differentiated cell types of the urothelium and the mesenchymal wall of the ureter originate 
from multipotent precursor cells in the early metanephric field, the distal ureteric bud and its 
surrounding mesenchyme. While the distal aspect of the ureteric bud is designated to become 
the ureter, the proximal portion and the surrounding metanephric mesenchyme are fated to form 
the collecting duct tree and the nephrons of the kidney. Embryonic explant cultures of kidney 
rudiments and tissue separation experiments clearly indicated that these processes are inde-
pendent from extrinsic cues and solely rely on reciprocal signals between the ureteric bud epi-
thelium and its surrounding mesenchyme.26, 27 Interestingly, ureter development also proceeds 
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in absence of kidneys, indicating that the early metanephric field is intrinsically segmented into 
a proximal and distal portion with different fates that do not intermingle.28 Both the urothelium 
and the collecting duct epithelium are derived from the Pax2+ nephric duct lineage.15 However, 
an early molecular subdivision of the unbranched ureteric stalk and the branching proximal 
aspect of the ureteric bud has not been described. Instead, it is likely that distinct molecular 
properties of the ureteric and metanephric mesenchyme guide the fate of the distal and proximal 
ureteric bud, respectively. While the metanephric mesenchyme is defined by the expression of 
a set of transcriptional regulators including Six2 or Pax2 and Eya1 that culminate in nephro-
genesis or the activation of a GDNF/Ret signaling module that drives kidney branching mor-
phogenesis, the ureteric mesenchyme is devoid of these factors.18 Molecular lineage tracing of 
descendants of Osr1 expressing cells indicated that the intermediate mesoderm initially con-
tributes to all cell types of the metanephros including ureteric smooth muscle cells but that an 
early lineage segregation occurs that separates the ureteric mesenchyme from nephron and renal 
stromal progenitors.29 Indeed, the ureteric mesenchyme specifically expresses the T-box tran-
scription factor gene Tbx18 in a narrow band of cells in between the nephric duct and the met-
anephric mesenchyme as early as E10.5.21 Genetic lineage tracing experiments revealed that 
cells from this expression domain are designated to constitute all differentiated cell types of the 
mesenchymal wall of the ureter.20 However, it is not known whether these cells also contribute 
to additional lineages of the excretory system. The early subdivision of the ureteric mesen-
chyme into an inner domain with densely packed spherical cells and an outer domain with tan-
gentially oriented cells with a fibrocyte-like shape already indicates that further lineage re-
strictions take place. It has been postulated but not formerly shown that the inner compartment 
harbors smooth muscle precursors whereas the outer domain is fated to differentiate into ad-
ventitial fibrocytes.20 Furthermore, it has been speculated that lamina propria cells arise from 
smooth muscle precursors by spatial inhibition of the smooth muscle gene program but clear 
evidence is still lacking.23 Further lineage tracing studies using tissue specific approaches 
should be performed to delineate the origin of differentiated cell types and clarify the lineage 
relations in the developing urogenital system. 
Growth and differentiation of the ureteric mesenchyme 
With completion of the proximal-distal compartmentalization of the metanephric field, the ure-
teric stalk is surrounded by an initially uniform mesenchymal tissue. The knowledge of the 
molecular and cellular mechanisms that transform this homogenous ureteric mesenchyme in a 
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precise temporal and spatial fashion into a radial arrangement of fibrocytes and smooth muscle 
cells has remained scarce.14 However, emerging evidence suggests that epithelial signals like 
sonic hedgehog (SHH) and members of the WNT family guide the growth, patterning and dif-
ferentiation of the ureteric mesenchyme.20, 23, 30 
In renal development Shh expression is confined to the ureteric epithelium and medullary col-
lecting ducts from E11.5 to E18.5. Specific expression of the hedgehog receptor and target gene 
of the pathway, patched homolog 1 (Ptch1), in the adjacent ureteric mesenchyme and medullary 
stroma suggests that signaling occurs in a paracrine fashion.23 Systemic loss of Shh or tissue 
specific ablation from the ureteric epithelium results in decreased mesenchymal proliferation 
and delayed smooth muscle differentiation that culminate in hydroureter development.23, 30 On 
the other hand conditional overactivation of the hedgehog signal transducer smoothened (SMO) 
in the ureteric mesenchyme leads to mesenchymal hyperplasia with an expanded smooth mus-
cle layer.30 In contrast, treatment of primary ureteric mesenchymal cells with SHH protein dose-
dependently inhibits smooth muscle differentiation. Moreover Ptch1 expression becomes re-
stricted to the lamina propria, a tissue that is devoid of smooth muscle cells, from E16.5 on. 
These observations suggest that hedgehog signaling either dose- or context-dependently acti-
vates or inhibits differentiation to allow the development of the smooth muscle layer and the 
lamina propria.23 The factors that mediate growth and differentiation downstream of hedgehog 
signaling remain poorly understood. The bone morphogenetic protein 4 (BMP4) signaling path-
way is a likely mediator of hedgehog function in the ureteric mesenchyme. On the one hand, 
Bmp4 expression resembles Ptch1 expression in the ureteric mesenchyme and is completely 
lost in Shh-deficient ureters.23 On the other hand, phosphorylation of SMAD1/5/8, a transcrip-
tional mediator of canonical BMP4 signaling, is strongly increased after overactivation of 
SMO.30 BMP4 signaling has multiple crucial functions in ureter development. First, BMP4 
controls elongation of the ureter and prevents ectopic budding from the nephric duct.31 Second, 
it acts as a chemoattractant for ureteric mesenchymal cells and promotes their differentiation 
towards smooth muscle cells in vitro.32 In support of this observation, genetic ablation of Bmp4 
or antagonism of BMP4 signaling in the ureteric mesenchyme disrupts smooth muscle invest-
ment of the ureter and leads to hydroureter formation.30, 33 This function is at least partially 
mediated by the canonical branch of the signaling pathway, as genetic deletion of Smad4, a 
transcriptional mediator of canonical BMP4 signaling, results in decreased ureteric smooth 
muscle differentiation and ureteropelvic junction obstruction.34, 35 The transcription factor tea-
shirt zinc finger homeobox 3 (TSHZ3) has been identified as a potential effector of BMP4 
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signaling in the ureteric mesenchyme.36 Loss of Tshz3 results in hydronephrosis without ana-
tomical obstruction due to impaired ureteric smooth muscle differentiation. Whereas Ptch1 and 
Bmp4 expression are unaltered in Tshz3-deficient ureters Tshz3 expression is inducible by ex-
ogenous BMP4 indicating that it acts downstream of the SHH-BMP4 signaling axis.36 Never-
theless, it is unlikely that BMP4 and TSHZ3 are the only downstream effectors of hedgehog 
signaling in the ureteric mesenchyme and that they can fully explain the growth and differenti-
ation defects that underlie the hedgehog loss-of-function phenotype. Further transcriptional pro-
filing and detailed cellular and molecular analyses of hedgehog signaling in the ureter should 
provide us with a better understanding of the regulatory modules that control growth and dif-
ferentiation downstream of this important pathway. 
The canonical WNT signaling pathway is the second described mediator of epithelial-mesen-
chymal interactions in the control of ureteric growth and differentiation programs.20 The WNT 
ligand genes Wnt7b and Wnt9b are specifically expressed in the ureteric epithelium from E11.5 
to E18.5 and E11.5 to E14.5, respectively.  Expression of the WNT receptor gene Fzd1 and the 
bona fide target gene of the signaling pathway Axin2 in the adjacent ureteric mesenchyme sug-
gests a paracrine or juxtacrine mode of action. Conditional inactivation of Ctnnb1, the unique 
intracellular mediator of canonical WNT signaling, in the ureteric mesenchyme results in a 
hypoplastic hydroureter and hydronephrosis formation with a complete loss of differentiated 
smooth muscle cells. Misexpression of a stabilized form of CTNNB1 in the ureteric mesen-
chyme results in an ectopic cluster of differentiated smooth muscle cells along the ureter indi-
cating that this pathway is not only required but also sufficient to induce their differentiation. 
Differentiation defects in Ctnnb1-deficient ureters are preceded by a loss of mesenchymal com-
partmentalization and reduced mesenchymal proliferation at E12.5. Furthermore, the expres-
sion of fibrocyte markers which is usually restricted to the outer compartment of the ureteric 
mesenchyme is expanded towards the urothelium at E16.5. These observations suggest that 
canonical WNT signaling controls the pattering of the ureteric mesenchyme by specification of 
smooth muscle precursor cells in direct vicinity of the urothelium or by repression of an adven-
titial fibrocyte fate.20 The transcriptional effectors of canonical WNT signaling in the ureteric 
mesenchyme remain poorly understood. On the one hand WNT signaling is required to main-
tain the expression of Tbx18 from E12.5 on. Tbx18 is a crucial transcriptional mediator of ureter 
development which is probably involved in the early specification of the ureteric mesenchyme 
and thus required for subsequent differentiation programs.21 Tbx18 expression is initially con-
fined to a small band of mesenchymal cells surrounding the ureteric stalk and separating the 
nephric duct from the metanephric mesenchyme. Expression is maintained in smooth muscle 
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precursors but subsequently downregulated with the progression of differentiation at E16.5. 
Tbx18-deficient mice develop severe shortened hydroureter that completely lack a smooth mus-
cle coat.21 However, reconstitution of Tbx18 expression in Ctnnb1-deficient mice is not able to 
rescue smooth muscle differentiation defects and hydroureter formation indicating that it only 
has a minor contribution to the phenotype.20 Another transcription factor that acts downstream 
of WNT signaling and Tbx18 is the SRY-box protein SOX9. Expression of Sox9 is restricted to 
the undifferentiated ureteric mesenchyme from E11.5 to E13.5 and is absent in Ctnnb1- and 
Tbx18-deficient ureters.20, 21, 37 Embryos with conditional inactivation of Sox9 in the ureteric 
mesenchyme develop hydroureteronephrosis due to impaired smooth muscle differentiation and 
decreased extracellular matrix deposition.37 Moreover a recent study suggests that SOX9 is 
critically involved in the timing of ureteric smooth muscle differentiation.38 Both SOX9 and 
TSHZ3 compete with serum response factor (SRF) for binding to the master regulator of smooth 
muscle genes myocardin (MYOCD) and are suggested to repress the myogenic program. In 
support of this hypothesis prolonged expression of Sox9 after E14.5 does not interfere with 
Myocd expression but strongly delays the expression of structural smooth muscle genes.37, 38  
Although the SHH and WNT pathways are already active in the undifferentiated ureteric mes-
enchyme at E11.5, it is unclear how these signaling activities are balanced to activate the MY-
OCD-driven smooth muscle gene program only at E14.5. It is plausible to assume that addi-
tional permissive and restrictive factors converge on the initiation of the smooth muscle differ-
entiation to provide a functional ureter at the onset of substantial urine production. Further tem-
poral characterization of signaling activities and expression patterns of transcriptional regula-
tors in the ureter should provide us with new candidates involved in this complex regulatory 
network. 
Growth and differentiation of the urothelium 
In contrast to the proximal aspect of the ureteric bud that branches into the single layered epi-
thelial system of the renal collecting duct tree, its distal portion remains unbranched and devel-
ops into a multilayered and watertight transitional epithelium, the urothelium. The molecular 
mechanisms which guide the elongation and stratification of the distal ureteric bud and the 
differentiation of specialized urothelial cell types that provide elasticity yet efficient sealing 
towards the hypertonic urine have remained poorly understood. 
Genetic and pharmacological manipulation of BMP4 signaling in the early metanephric field 
indicated that this signaling pathway is critically involved in the segmentation of the ureteric 
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bud by inhibition of branching morphogenesis and promotion of elongation of its distal por-
tion.31, 39 The elongation of the urothelium is under further control of the fibroblast growth 
factor (FGF) signaling pathway which shows a mitogenic function on urothelial cells in vitro 
and in vivo and controls elongation and branching of the ureteric bud.40, 41  
In contrast to the ureter where the knowledge of the molecular regulators of urothelial stratifi-
cation and differentiation has remained scarce, more insights have been gained in the develop-
ing and regenerating bladder urothelium. A specific function for FGF7 in the stratification of 
the bladder urothelium has been proposed based on the findings that the Fgf7-deficient urothe-
lium is thinned and lacks the intermediate cell layer. Furthermore, FGF7 maintains intermediate 
cells in vitro and inhibits their differentiation into superficial cells.42 The lineage relations of 
urothelial cell types and the nature of urothelial stem and progenitor cells is controversially 
discussed. Genetic fate mapping experiments in the regenerating bladder urothelium suggested 
that intermediate and superficial cells arise in a linear sequence from Shh expressing basal 
cells.43 This hypothesis has been recently challenged by Gandhi and coworkers.44 On the one 
hand they showed that Shh is not specifically expressed in basal cells but also marks interme-
diate cells in development and adulthood. On the other hand they thoroughly characterized the 
temporal profile of urothelial stratification and differentiation in development using cell type 
specific markers. In the adult urothelium, basal cells are positive for the intermediate filament 
protein cytokeratin 5 (KRT5) and an isoform of the transcription factor P63 (∆NP63), whereas 
intermediate cells are KRT- ∆NP63+ and additionally express uroplakins (UPK), and superficial 
cells are KRT- ∆NP63- UPK+. In development, intermediate cells appear first at E13.5 and are 
succeeded by superficial cells at E14.5. Basal cells just appear from E16.5 on but expand sub-
sequently to constitute the major cell type of the mature urothelium. Moreover, an additional 
transient cell population of P-cells was proposed in the undifferentiated urothelium at E11.5 
that shares the molecular profile of intermediate cells but is furthermore positive for the endo-
dermal marker FOXA2. The late appearance of basal cells already indicates that these cells are 
unlikely to be progenitors in the developing urothelium. Indeed, genetic lineage tracing studies 
confirmed that basal cells are a unipotent cell population and that P-cells or intermediate cells 
are progenitors in the developing and regenerating urothelium, respectively. The retinoic acid 
(RA) signaling pathway was shown to be critically involved in the specification of these pro-
genitors in development and repair of the bladder urothelium.44 First, RA signaling is active in 
P-cells during development and becomes upregulated in intermediate cells under injury condi-
tions in the adult. Second, misexpression of a dominant negative allele of the RA receptor alpha 
gene Rara leads to a loss of intermediate and superficial cell differentiation in development and 
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impaired urothelial regeneration after injury.44 Whether these findings can be transferred to the 
ureteric epithelium remains an open question. Given the distinct developmental origin of the 
ureter and the bladder from the intermediate mesoderm and the endoderm, respectively, it is 
possible that significant differences exist in the molecular control of their development. 
In the ureter deletion of the Brg1 gene, encoding a component of the SWI/SNF chromatin re-
modeling complex, leads to severe urothelial stratification and differentiation defects.22 Expres-
sion of ∆NP63 and the peroxisome proliferator activated receptor gamma (PPARG) are reduced 
in Brg1-deficient ureter. A loss of ∆NP63 results in a mono-layered urothelium which correlates 
with the stratification defects observed in Brg1 mutant ureters whereas a loss of PPARG dimin-
ishes superficial cell differentiation. In support of this observation a function of PPARG sig-
naling in urothelial differentiation has previously been reported in vitro.45, 46 Furthermore, Shh 
expression is decreased after loss of Brg1. SHH signaling has been reported to guide mesen-
chymal growth and differentiation in the ureter but it cannot be excluded that mesenchymal 
signals downstream of this pathway act back on the urothelium. In support of this notion, loss 
of Tbx18 in the ureteric mesenchyme also affects terminal differentiation of the urothelium 
which suggests the presence of such paracrine signals.21 Interestingly, genetic ablation of Bmp4 
in the ureteric mesenchyme leads to reduced UPK expression.39 Furthermore, loss of the bone 
morphogenetic protein receptor type 1a gene Bmpr1a from the bladder urothelium impairs 
urothelial proliferation and regeneration after bacterial infection which renders BMP4 signaling 
a likely candidate for a paracrine pathway that controls urothelial self-renewal and differentia-
tion.47 
Despite the significant body of knowledge that has been gathered especially in the control of 
urothelial development and regeneration in the bladder the transferability of these findings to 
the developing ureter is unclear. Future studies should carefully address the temporal profile of 
differentiation and the lineage relations specifically in the developing ureter urothelium and 
reassess the involvement of the reported molecular mediators that control these processes in 
bladder development and repair.
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Aims of the thesis 
The differentiated cell types of the ureter derive from multipotent progenitor cells of the ureteric 
bud and its surrounding mesenchyme. How these precursor cells diversify and differentiate into 
their prospective lineages is poorly understood. This thesis shall address in different independ-
ent experimental efforts the temporal and spatial profile of cellular diversification and differen-
tiation and shall give mechanistic insights into the molecular pathways that control ureter de-
velopment. 
 
1. The fate of TBX18+ cells in the urogenital ridge. 
The mesenchymal progenitor cells of the ureter specifically express the T-Box transcription 
factor gene Tbx18. While TBX18+ cells give rise to all differentiated cell types of the mesen-
chymal coat of the ureter, it is unclear if these cells also contribute to other components of the 
urogenital system and if TBX18 is functionally required for their development. Careful expres-
sion, fate mapping and phenotype analyses shall be performed to address these open questions.  
 
2. Lineage diversification and differentiation in ureter development. 
Several studies already described cellular differentiation of mesenchymal and epithelial tissues 
in the ureter. However, a precise temporal and spatial characterization of the diverse differen-
tiation programs is still lacking, as is the timing of lineage segregation in this organ. This thesis 
shall provide a framework for further functional studies of ureteric progenitors and their differ-
entiation into the respective lineages. To achieve this goal, a quantitative description of the 
temporal and spatial profile of ureteric differentiation shall be performed using cell type specific 
markers. Moreover, tissue and cell type specific reporter assays shall be utilized to delineate 
lineage relations in the developing ureter and to characterize stem and progenitor cells in de-
velopment and homeostasis.  
 
3. The cellular and molecular function of SHH signaling in ureter development. 
Previous work suggested a critical role for Shh in differentiation of the ureteric mesenchyme. 
However, the full entity of the cellular functions of these pathways as well as its downstream 
effector genes in the ureteric mesenchyme have remained elusive. For this reason, genetic and 
pharmacologic loss- and gain-of-function studies shall be performed to identify and character-
ize the cellular programs triggered by SHH signaling in the ureter. Furthermore, molecular 
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analyses shall identify and functionally characterize the molecular mediators of hedgehog sig-
naling in the ureteric mesenchyme, and define their precise epistatic relation. 
 
4. The cellular and molecular function of RA signaling in ureter development. 
Recent work suggested a role for RA signaling in specifying the urothelium in the bladder. 
Whether a similar role exist in the ureter has remained enigmatic. Therefore, this thesis shall 
screen for expression and targets of RA signaling in ureter development. A functional involve-
ment in ureter development shall be addressed by pharmacological loss- and gain-of-function 
experiments in explants of embryonic ureters of different developmental stages. Further assays 
shall address the cellular function of RA signaling as well as its molecular targets in this organ. 
 
5. Characterization of the Nrip1 gene as a target of RA signaling in ureter development. 
A heterozygous truncating mutation in the Nrip1 gene was identified in a kindred with an au-
tosomal dominant form of CAKUT. Biochemical characterization of the protein revealed that 
NRIP1 negatively regulates RA signaling via direct physical interaction with the RA receptor. 
The expression of Nrip1 in the developing ureters and kidneys shall by analyzed and a potential 
dependency on the RA signaling pathway shall be tested. 
 
Together, these projects shall provide novel insight into the cellular and molecular programs 
that guide the development of the mesenchymal and epithelial tissue compartments of the mam-
malian ureter.  
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a b s t r a c t
The mammalian urogenital system derives from multipotent progenitor cells of different germinal
tissues. The contribution of individual sub-populations to specific components of the mature system, and
the spatiotemporal restriction of the respective lineages have remained poorly characterized. Here, we
use comparative expression analysis to delineate sub-regions within the developing urogenital system
that express the T-box transcription factor gene Tbx18. We show that Tbx18 is transiently expressed in the
epithelial lining and the subjacent mesenchyme of the urogenital ridge. At the onset of metanephric
development Tbx18 expression occurs in a band of mesenchyme in between the metanephros and the
Wolffian duct but is subsequently restricted to the mesenchyme surrounding the distal ureter stalk.
Genetic lineage tracing reveals that former Tbx18+ cells of the urogenital ridge and the metanephric field
contribute substantially to the adrenal glands and gonads, to the kidney stroma, the ureteric and the
bladder mesenchyme. Loss of Tbx18 does not affect differentiation of the adrenal gland, the gonad, the
bladder and the kidney. However, ureter differentiation is severely disturbed as the mesenchymal lineage
adopts a stromal rather than a ureteric smooth muscle fate. DiI labeling and tissue recombination
experiments show that the restriction of Tbx18 expression to the prospective ureteric mesenchyme does
not reflect an active condensation process but is due to a specific loss of Tbx18 expression in the
mesenchyme out of range of signals from the ureteric epithelium. These cells either contribute to the
renal stroma or undergo apoptosis aiding in severing the ureter from its surrounding tissues. We show
that Tbx18-deficient cells do not respond to epithelial signals suggesting that Tbx18 is required to
prepattern the ureteric mesenchyme. Our study provides new insights into the molecular diversity
of urogenital progenitor cells and helps to understand the specification of the ureteric mesenchymal
sub-lineage.
& 2013 Elsevier Inc. All rights reserved.
Introduction
The urinary system is a multi-component entity consisting of
the kidneys, the ureters, the bladder and the urethra that together
control the water and ionic balance of the blood by excretion of
excess water, solutes and waste products. The urinary system is
structurally and functionally tightly associated with the adrenal
glands, as well as with the genital system that consists of sexually
dimorphic gonads, sex ducts and external genitalia.
A number of studies have begun to identify the progenitor
populations, their interaction and the temporal specification of
sublineages for the different components of the urogenital system
in the mouse. While the lower parts of the urogenital system
including the bladder epithelium, the urethra, and the lower
aspect of the vagina derive from an infolding of the endoderm,
the cloaca, and its surrounding mesenchyme, most other compo-
nents are thought to be derivatives of the intermediate mesoderm
(Mugford et al., 2008; Wang et al., 2011). Expression of the
transcriptional regulator gene Osr1 is activated broadly within
the intermediate mesoderm starting from embryonic day (E) 7.5,
and is required for the development of adrenals, gonads, kidneys
and sex ducts suggesting that Osr1 marks the progenitors for all of
these components at this stage (James et al., 2006; Wang et al.,
2005). Within the urogenital ridge of E9.5-E10.5 embryos, the first
sublineages emerge. Osr1 expression becomes gradually excluded
from the (coelomic) epithelium that lines the urogenital ridge and
from the epithelial Wolffian duct to be restricted to the
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mesenchymal compartment of the intermediate mesoderm, and
later at around E10.5, to the most posterior aspect from which all
cell types of the metanephros will arise (Mugford et al., 2008). The
Wolffian duct epithelium that expresses the transcription factor
genes Lhx1, Pax2 and Gata3 (Grote et al., 2006; Pedersen et al.,
2005) contributes exclusively to the vas deferens in the male, the
epithelium of the ureter and the collecting duct system of the
kidney (Saxen, 1987), whereas the epithelial lining of the ridge
harbors a common pool of precursor cells for the gonads and the
adrenal glands (Hatano et al., 1996). This adrenogonadal primor-
dium that is marked by expression of the orphan nuclear receptor
gene Sf1 divides between E10-E11 into distinct progenitor popula-
tions for the adrenals and gonads (Ikeda et al., 1994; Keegan and
Hammer, 2002; Luo et al., 1994). The Sf1+ cells eventually differ-
entiate into the cortical cells of the adrenal gland, Sertoli and
Leydig cells of the testis, and granulosa and theca cells of the ovary
(Bingham et al., 2006). At E10.5, signals from the mesenchymal
condensation at the posterior end of the intermediate mesoderm,
the metanephric blastema, induce the formation of an epithelial
diverticulum from the Wolffian duct, the ureteric bud. During
further development the ureteric bud invades the metanephric
blastema and initiates a program of branching morphogenesis to
generate the collecting duct system of the mature kidney. The
distal part merely elongates and differentiates into a highly
specialized type of epithelium, the urothelium. With each branch-
ing event a portion of the metanephric mesenchyme adjacent to
the branch tip, is induced by tip signals to condense and undergo a
mesenchymal–epithelial transition and form a renal vesicle from
which the nephron will mature (for a recent review see (Little and
McMahon, 2012). This cap or metanephrogenic mesenchyme is a
self-renewing population of nephron progenitors that expresses
the transcription factor genes Six2 and Uncx (Boyle et al., 2008;
Karner et al., 2011; Kobayashi et al., 2008; Neidhardt et al., 1997;
Self et al., 2006). Nephron progenitors are surrounded by Foxd1+
mesenchymal cells that will give rise to the stromal cells of the
renal capsule, cortex and medulla as well as to mesangial and
vascular smooth muscle cells (Hatini et al., 1996; Humphreys et al.,
2010; Levinson et al., 2005). Separation of the Six2+ nephron
lineage from the Foxd1+ stromal lineage within the Osr1+ pre-
cursor pool is thought to occur between E10.5 and E11.5 (Mugford
et al., 2008). Finally, Flk1+ cells within the metanephric mesench-
yme may contribute to the renal vasculature system (Gao et al.,
2005). While the developmental origin of most of the cell types of
the mature kidney has been characterized to an appreciable level,
much less is known about the specification of the mesenchymal
progenitor pool of the smooth muscle and fibroblast coatings of
the ureter and the bladder, and the temporal separation of this
lineage from the Six2+ and Foxd1+ progenitors of the metanephros.
Notably, it has been suggested that stromal cells of the kidney and
the ureteric mesenchyme do not actually arise from the inter-
mediate mesoderm but originate in the paraxial and/or tail-bud
mesoderm (Brenner-Anantharam et al., 2007; Guillaume et al.,
2009).
We have previously shown that the T-box transcription factor
gene Tbx18 marks the undifferentiated ureteric mesenchyme from
E12.5 to E14.5. At E11.5, Tbx18 is expressed in a narrow band of
cells between the mesenchyme surrounding the Wolffian duct and
the metanephros (Airik et al., 2006). Prior to metanephric devel-
opment expression of Tbx18 was also noted in the mesonephros
(Kraus et al., 2001). In Tbx18−/−mice, descendants of former Tbx18-
positive cells (short: Tbx18+ descendants) do not differentiate into
smooth muscle cells of the ureter but dislocalize to the kidney and
differentiate into fibroblast-like cells. As a consequence, the renal
pelvis becomes dramatically enlarged at the expense of the ureter,
and hydronephrosis develops at birth (Airik et al., 2006). This
suggested that the ureteric mesenchymal lineage is separated
early from other mesenchymal lineages of the renal system, and
that separation is disturbed in Tbx18-deficient mice. Fate mapping
efforts based on a cre knock-in in the Tbx18 locus harbored on a
BAC identified smooth muscle cells of the ureter and the bladder
as derivatives of former Tbx18+ progenitor cells (Wang et al.,
2009). However, it remained unclear whether the genomic region
covered by the BAC contained all Tbx18 control elements for
specific urogenital expression. Further, we neither know when
the ureteric lineage is specified nor do we know the mechanisms
by which the ureteric mesenchyme becomes localized around the
ureteric epithelium.
Here, we characterize the expression of Tbx18 in the developing
urogenital system. We describe the cell lineages to which Tbx18+
descendants contribute in the mature urogenital system, and
analyze their Tbx18-dependancy. We investigate the mechanisms
that restrict Tbx18 expression to the ureteric mesenchyme, and
provide evidence for the role that Tbx18 plays within this tissue.
Materials and methods
Mice
R26mTmG (Gt(ROSA)26Sortm4(ACTB-tdTomato-EGFP)Luo) reporter mice
(Muzumdar et al., 2007), Tbx18lacZ (Tbx18tm3Akis), Tbx18GFP
(Tbx18tm2Akis) and Tbx18cre (Tbx18tm4(cre)Akis) knock-in alleles
(Bussen et al., 2004; Christoffels et al., 2006; Trowe et al., 2010)
were all maintained on an NMRI outbred background. Embryos
for gene expression analysis were derived from matings of
NMRI wildtype mice. Tbx18cre/+;R26mTmG/+ mice were obtained
from matings of Tbx18cre/+ males and R26mTmG/mTmG females.
Tbx18cre/lacZ;R26mTmG/+ mice were obtained from matings of
Tbx18cre/+;R26mTmG/mTmG males and Tbx18lacZ/+ females. Tbx18GFP/+
embryos were obtained from matings of Tbx18GFP/+ males with
NMRI females. For timed pregnancies, vaginal plugs were checked
in the morning after mating, noon was taken as embryonic day
(E) 0.5. Embryos, whole urogenital systems and kidneys were
dissected in PBS. For in situ hybridization and immunofluorescence
analyses specimens were fixed in 4% paraformaldehyde (PFA) in
PBS and stored in methanol at −20 1C. Genomic DNA prepared
from yolk sacs or tail biopsies was used for genotyping by PCR.
Organ cultures
Explant cultures of embryonic kidneys or urogenital systems
were performed as previously described (Airik et al., 2010). The
culture medium was replaced every 24 h.
For labeling experiments with the fluorescent carbocyanine dye
DiI, a tungsten wire was dipped into the DiI tissue labeling paste
(Invitrogen) and excessive material was removed with a tissue
towel. The tungsten wire was then clamped into a micromanipu-
lator. Labeling of mesenchymal subpopulations within the meta-
nephric field of E11.5 Tbx18GFP/+ kidney rudiments was performed
under visual control. Kidney explants were documented before
and after treatment and the perpendicular distance of labeled cells
from the ureteric epithelium was measured using ImageJ software
(Schneider et al., 2012). After two days of culture the distribution
of DiI labeled cells was assessed and plotted against the distance.
For the detection of apoptotic tissue in the metanephric field
E11.5 kidney rudiments (Tbx18GFP/+) were explanted and cultured
for 24 h. The medium was subsequently replaced with 1 ml of
2.5 mM LysoTracker red DND-99 (L-7528, Invitrogen) in PBS and
the explant cultures were incubated for 30 min at 37 1C. Cultures
were then rinsed in PBS and documented.
For tissue recombination experiments, E11.5 acceptor kidney
rudiments (Tbx18GFP/+) were explanted. E12.5 ureters (Tbx18cre/+;
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Fig. 1. Tbx18 expression during early urogenital development: (A,J) In situ hybridization analysis of whole wildtype embryos for Tbx18: (B,D). Histological staining (HE) of
transverse sections through the posterior trunk region on the planes indicated in (A,J) to describe anatomical landmarks. (C–H,L–Q) In situ hybridization analysis on adjacent
sections to compare expression of Tbx18 and markers of the intermediate mesoderm. (I,R) Co-immunofluorescence analysis for SF1 and GFP on adjacent sections of Tbx18GFP/
+ embryos. Probes and stages are as indicated. ce: coelomic epithelium; da: dorsal aorta; wd: Wolffian duct.
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R26mTmG/+) were subsequently prepared and the ureteric epithe-
lium was mechanically separated from the mesenchyme using
forceps. The uncoated ureteric epithelium was transplanted into
the Tbx18+ domain of the acceptor tissue distant to the endogen-
ous ureteric epithelium. The recombined tissues were cultured for
3 days with daily documentation.
For bead implantation experiments, E11.5 acceptor kidney
rudiments (Tbx18GFP/+) were explanted. AffiGel Blue beads (153-
7302, Bio-Rad) were rinsed in PBS and incubated with 50 mg/ml
rmWNT9B (3669-WN, R&D Systems), 1.6 mg/ml rmSHH (PMC8034,
Invitrogen), both or 1 mg/ml BSA for 4 hours at 4 1C. Beads were
implanted into the GFP+ domain of the acceptor kidneys. Cultures
were maintained for 2 days and GFP expression was documented
daily.
Histological and histochemical analyses
Fixed embryos were dehydrated, paraffin embedded, and sec-
tioned to 5 mm. For histological analyses sections were stained
with haematoxylin and eosin. For the detection of antigens on
these sections, the following primary antibodies and dilutions
were used: mouse anti-UPK1B (WH0007348M2-100UG, Sigma,
1:200), mouse anti-ACTA2 (F3777 and C6198, Sigma, 1:200), rabbit
anti-CDH1 (kindly provided by R. Kemler, MPI for Immunobiology
and Epigenetics, Freiburg, Germany, 1:200), rabbit anti-SF1 (Trans-
Genic Inc., preparation of antibodies by Dr. Ken-Ichirou Morohashi,
1:200), rabbit anti-DDX4 (ab13840, Abcam, 1:50), rabbit anti-
FOXD1 (kindly provided by A.P. McMahon, Harvard University,
MA, USA, 1:2000), rabbit anti-SIX2 (kindly provided by A.P.
McMahon, Harvard University, MA, USA, 1:1000), anti-SOX9
(AB5535, Millipore Chemicon, 1:200), rat anti-EMCN (kindly pro-
vided by D. Vestweber, MPI for Molecular Medicine, Münster,
Germany, 1:10), mouse anti-GFP (11 814 460 001, Roche, 1:200),
rabbit anti-GFP (sc-8334, Santa Cruz, 1:200). Fluorescent staining
was performed using Alexa 488/555-conjugated secondary anti-
bodies (A11034; A11008; 711-487-003; A21202; A21422; A21428,
Invitrogen/Dianova; 1:500) or biotin-conjugated secondary anti-
bodies (Dianova; 1:500) and the TSA Tetramethylrhodamine
Amplification Kit (Perkin-Elmer).
Labeling with primary antibodies was performed at 4 1C over-
night after antigen retrieval (Antigen Unmasking Solution, Vector
Laboratories; 15 min, 100 1C), blocking of endogenous peroxidases
with 3% H2O2/PBS for 10 min (required for TSA) and incubation in
Fig. 2. Tbx18 expression during early metanephric and ureter development. (A) In situ hybridization analysis of whole posterior trunk halves at E10.5 (first row), of transverse
sections through the metanephric anlagen of the posterior trunk region at E10.5 (posterior is to the right, ventral to the bottom, second row), of whole E11.5 kidneys (third
row), of transverse sections through the E11.5 metanephric kidney (fourth row) and of E12.5 kidneys with ureters (fifth row) to compare expression of Tbx18 with an early
pan-metanephric marker (Osr1), and with markers of the nephron lineage (Uncx, Pax2), of the collecting duct and ureter epithelium (Pax2) and of the stromal lineage (Foxd1)
in wildtype embryos. and (B) Co-immunofluorescence analysis on sections through the metanephros at E10.5 and E11.5 with antibodies against GFP (visualizing TBX18
expression), FOXD1 and UNCX in Tbx18GFP/+ embryos. k: kidney; u: ureter; ue: ureteric epithelium; us: ureter stalk; wd: Wolffian duct.
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blocking solutions provided with the kits. For monoclonal mouse
antibodies an additional IgG blocking step was performed using
the Mouse-on-Mouse Kit (Vector Laboratories). Sections were
mounted with Mowiol (Roth) or IS mounting medium (Dianova).
Paraffin sections used for TUNEL assay were deparaffinized,
rehydrated and than treated according to the protocol provided
with the Apop Tag Fluorescence Apoptosis detection kit (S7111,
Millipore).
In situ hybridization analysis
Whole-mount in situ hybridization was performed following a
standard procedure with digoxigenin-labeled antisense riboprobes
(Wilkinson and Nieto, 1993). Stained specimens were transferred
in 80% glycerol prior to documentation. In situ hybridization on
10 mm paraffin sections was done essentially as described
(Moorman et al., 2001). For each marker at least three indepen-
dent specimens were analyzed.
Image analysis
Whole-mount specimens were photographed on Leica M420
with Fujix digital camera HC-300Z, sections on Leica DM5000 B
with Leica digital camera DFC300 FX. All images were processed in
Adobe Photoshop CS4.
Results
Tbx18 is expressed in a subregion of the urogenital ridge
Earlier work showed expression of Tbx18 in the urogenital ridge
but failed to delineate the precise subdomain (Kraus et al., 2001).
We therefore performed comparative in situ hybridization analysis
of expression of Tbx18 and of markers of (subregions of) the
urogenital ridge on transverse sections of E9.5 and E10.5 wildtype
embryos (Fig. 1). At E9.5, the entire urogenital ridge was marked
by expression of Osr1 and Wt1; the Wolffian duct by expression of
Pax2, the adjacent tubule-forming mesonephric mesenchyme by
Pax2, and the epithelial (coelomic) lining of the ridge by Aldh1a2.
Sf1 was not expressed at this stage. Tbx18 expression was never
detected in the epithelial Wolffian duct and the Pax2+ mesoneph-
ric mesenchyme but was present in the more medially located
mesenchyme close to the dorsal aorta, and overlapping with
Aldh1a2 expression in the coelomic epithelium (Fig. 1C H). At
E10.5, the coelomic epithelium of the urogenital ridge was positive
for Sf1 and Aldh1a2, and the Wolffian duct for Pax2 expression.
Osr1 was confined to the mesenchymal compartment of the
intermediate mesoderm. Tbx18 was found in a subregion of the
Osr1+ mesenchyme in the medial aspect close to the hinge
between the urogenital ridge and the dorsal mesenterium, com-
plementary to Wt1 that was expressed in the epithelium and the
lateral mesenchyme. Expression of Tbx18 was no longer detected
in the epithelial lining of the ridge that was positive for Sf1 at this
stage (Fig. 1K Q). Co-immunofluorescence analysis for GFP and SF1
(in Tbx18GFP/+ embryos) confirmed the expression domain of Tbx18
Fig. 3. Lineage analysis of Tbx18+ descendants in the urogenital system. (A–C) GFP/
RFP epifluorescence analysis of urogenital systems from Tbx18cre/+;R26mTmG/+
embryos at E18.5 (A) and at 3-weeks of age (B,C) of both male (A,B) and female
sex (C). GFP (green) marks Tbx18+ cells and their descendants, RFP (red) marks all
other cells in the urogenital system. (D–Y) Immunofluorescence analysis of
expression of the lineage marker GFP on sections of E18.5 testis (D–I), adrenal
gland (J–L), kidney (M–S), ureter (T–V) and bladder (W–Y). Boxed areas are
magnified for co-expression analysis of GFP and cell type markers as indicated.
Scale bars represent 100 mm (D,J), 500 mm (M,W), 50 mm (T–V,Y), 10 mm (E–I,K,L,N–S,
X). a: adrenal gland; b: bladder; c: cortex; cm: cap mesenchyme; g: glomerulus; k:
kidney; Lc: Leydig cell; m: medulla; p: pelvis; t: testis; tc: testis cord; u: ureter; ue:
ureteric epithelium; um: ureteric mesenchyme; ut: ureter tip; v- vessel. (For
interpretation of the references to color in this figure legend, the reader is referred
to the web version of this article.)
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at both stages and the exclusion from SF1+ cells (Fig. 1I,R). Hence,
Tbx18 is expressed transiently in the coelomic epithelium and in a
mesenchymal subdomain of the urogenital ridge.
Tbx18 is expressed in a mesenchymal subregion of the metanephric
field before it is restricted to the ureteric mesenchyme
Our previous work showed that during metanephric develop-
ment Tbx18 is expressed in a narrow band of mesenchymal cells
abutting the mesenchyme of the Wolffian duct and the meta-
nephric kidney at E11.5 before expression becomes confined to the
mesenchyme surrounding the ureter from E12.5 onwards (Airik
et al., 2006). To determine the onset of Tbx18 expression in the
mesenchymal cells of the metanephric anlage (the metanephric
field) and define the relationship to the precursor populations of
known metanephric cell lineages, we performed in situ hybridiza-
tion analysis of whole kidney rudiments as well as of adjacent
sections through the posterior trunk at E10.5 and E11.5. At each
stage, we compared expression of Tbx18 to that of Foxd1, a marker
for the stromal lineage of the metanephros (Hatini et al., 1996), to
that of Uncx, a marker for the cap mesenchyme (Karner et al.,
2011), to Pax2 which marks the cap mesenchyme as well as the
Wolffian duct and its epithelial outgrowths (Dressler et al., 1990),
and to Osr1 (Mugford et al., 2008; So and Danielian, 1999).
At E10.5, Osr1 expression encompassed the mutually exclusive
domains of Tbx18 and Uncx/Pax2. Expression of Foxd1 was scarcely
detectable at this stage. At E11.5, Foxd1 expression surrounded in a
circle-like fashion the cap mesenchyme that was positive for Osr1,
Uncx and Pax2. Tbx18 expression surrounded the ureter stalk in an
exclusive fashion. At E12.5, Tbx18 was restricted to the mesench-
yme surrounding the distal ureter whereas expression of Foxd1
and Uncx/Pax2/Osr1 was restricted to the stromal and the cap
mesenchyme of the kidney, respectively (Fig. 2A). Immunofluor-
escence analysis of GFP (visualizing TBX18) and FOXD1/UNCX
expression on transverse sections of E10.5 and E11.5 Tbx18GFP/+
embryos confirmed that TBX18 protein was not co-expressed with
either of these markers (Fig. 2B). These data show that Tbx18
expression defines a molecularly distinct sub-population of
mesenchymal cells in the early metanephric field.
Tbx18+ cells of the urogenital ridge and the early metanephric field
contribute to multiple components of the mature urogenital system
To determine the contribution of Tbx18+ cells in the urogenital
ridge and the early metanephric field to the components of the
mature urogenital system, we irreversibly labeled the descendants
of these populations using a cre/loxP-based genetic approach with
a Tbx18cre-line generated in our laboratory and the sensitive
Rosa26mTmG reporter (Muzumdar et al., 2007; Trowe et al., 2010).
In the Rosa26mTmG reporter line cells that have undergone recom-
bination express membrane-bound GFP while non-recombined
cells express membrane-bound RFP.
In E18.5 and 3-week old whole urogenital systems, GFP
epifluorescence was found in the gonads, the kidneys, the ureters,
Fig. 4. Lineage analysis of Tbx18+ descendants in the metanephric/ureteric development. (A) Co-immunofluorescence analysis of expression of the lineage marker GFP and
the marker of smooth muscle cells, ACTA2 on sagittal sections of the ureter at E18.5. (B) Co-immunofluorescence analysis of expression of the lineage marker GFP on sagittal
sections of the kidney at E18.5. Z1-3 relate to three regions used to determine the contribution of GFP+ cells. (C) Quantification of the contribution of GFP+ cells to stromal
cells in the three regions of the kidney. Z1: control: 39+/−4, mutant: 40+/−4, p¼0.935; Z2: control: 27+/−10, mutant: 23+/−5, p¼0.504; Z3: control: 4+/−1, mutant: 17+/−3,
p¼ 0.001. (D) in situ hybridization analysis of GFP expression in Tbx18cre/+;R26mTmG/+ kidneys at different developmental stages as indicated. (E) GFP/RFP epifluorescence
analysis of metanephric explants from E11.5 Tbx18cre/+;R26mTmG/+ embryos at 0, 2 and 4 days of culture. GFP (green) marks Tbx18+ cells and their descendants, RFP (red)
marks all other cells in the explants. a: adrenal; k: kidney; u: ureter; ut: ureter tip. (For interpretation of the references to color in this figure legend, the reader is referred to
the web version of this article.)
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the bladder and additionally in the adrenals that are associated
with the urogenital system (Fig. 3A–C). To characterize the con-
tribution of Tbx18+ descendants to the differentiated cell types in
these organs, we performed co-immunofluorescence analysis with
antibodies directed against GFP and cell-type specific markers on
sections of E18.5 Tbx18cre/+;Rosa26mTmG/+ embryos. In the testis,
GFP expression was found in the tunica albuginea, interstitium and
testis cords in a dorsal to ventral gradient (Fig. 3D). Coexpression
analysis with cell-type specific markers showed that Tbx18+
descendants contributed to Leydig cells in the interstitium (SF1)
(Luo et al., 1994), to most but not all Sertoli cells (SOX9) (Morais da
Silva et al., 1996), to smooth muscle cells of the tunica albuginea
(ACTA2) but not to germ cells (DDX4) (Fujiwara et al., 1994)
(Fig. 3E–I). In adrenals, GFP+ cells were restricted to the SF1+
steroidogenic cells of the cortex (Luo et al., 1994) (Fig. 3J–L).
Compatible with the notion that Tbx18+ descendants contribute
to steroidogenic cells of the gonad and the adrenal gland, we
observed coexpression of the lineage marker GFP with SF1, a
marker for the adrenogonadal precursor pool (Bingham et al.,
2006), in the coelomic lining of E10.5 Tbx18cre/+;Rosa26mTmG/+
embryos (Supplementary Fig. S1).
In E18.5 kidneys, the distribution of GFP expression appeared
graded being more prominent at the medial (where Tbx18+ cells
originally resided) than at the lateral side of the organ (Fig. 3M). In
the medial region of the kidney, GFP expression was excluded
from cells expressing the epithelial marker CDH1 (Vestweber et al.,
1985), the endothelial marker EMCN (Morgan et al., 1999), and the
cap mesenchyme marker SIX2 (Karner et al., 2011; Self et al., 2006)
indicating that Tbx18+ descendants do not contribute to the
collecting duct system, the endothelial network of the kidney, or
the nephron lineage, respectively (Fig. 3N–P). Coexpression in the
cortical stroma with FOXD1 and with the smooth muscle marker
ACTA2 in arteries and in glomeruli argue that a substantial fraction
of interstitial cells, vascular smooth muscle and mesangial cells
in the medial kidney region derive from Tbx18+ progenitors
(Fig. 3Q–S). In the ureter, all cells of the mesenchymal coating
(fibroblasts of the lamina propria, smooth muscle cells and
adventitial fibroblasts) expressed GFP confirming earlier results
Fig. 5. Lineage analysis and apoptosis of Tbx18+ mesenchymal cells in early kidney rudiments. (A) Combined brightfield and epifluorescence analysis of metanephric
explants from E11.5 Tbx18GFP/+ embryos at 0, 1 and 2 days of culture. GFP (green) marks the Tbx18 expression domain, the red fluorescence indicates DiI-injected cell clusters.
Shown are two representative examples of DiI-injected cells ending up in the renal stroma (upper row), and of cells localizing to the space between kidneys and the Wolffian
duct (lower row). Boxed regions are shown in higher magnifications below. (B) Quantitative evaluation of localization of DiI-injected cells in dependence from the distance
from the ureteric epithelium at E11.5. (C) Analysis of cell death by lysotracker staining in explants of E11.5 kidney rudiments from Tbx18GFP/+ embryos cultured for 0 and
1 day. Arrows point to cell death in the lateral ureteric mesenchyme. (D) Analysis of cell death by the TUNEL assay in E11.5 and E12.5 kidneys rudiments from Tbx18GFP/+ and
Tbx18GFP/GFP embryos. Arrows point to cell death in the lateral ureteric mesenchyme. u, ureter; Wd, Wolffian duct. (For interpretation of the references to color in this figure
legend, the reader is referred to the web version of this article.)
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Fig. 6. Regulation of Tbx18 expression and ureteric fates by signals from the ureteric epithelium. (A) Combined brightfield and GFP/RFP epifluorescence analysis of E11.5
metanephric explants from E11.5 Tbx18GFP/+ embryos at 0, 1, 2 and 3 days of culture; GFP (green) marks Tbx18+ cells in unmanipulated cultures (control), in cultures from
which the ureter was removed (w/o ureter); after transplantation of an RFP+ (red) R26mTmG/+ ureter stripped of mesenchymal cells into the distal domain of Tbx18+ cells
(ectopic ureter) in Tbx18GFP/+ and Tbx18GFP/GFP rudiments. (B) In situ hybridization analysis of transverse ureter sections of E12.5 control (wt) and Tbx18GFP/GFP embryos of
expression of Tcf21, of the target of SHH-signaling, Ptch1, and of the target of canonical WNT-signaling, Axin2. (C) GFP epifluorescence analysis of explants from E11.5 Tbx18GFP/+
embryos cultured for 0 and 2 days in the presence of BSA-, WNT9B-, SHH- or WNT9B/SHH-soaked beads. (For interpretation of the references to color in this figure legend,
the reader is referred to the web version of this article.)
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of our group that the ureteric mesenchyme completely derives
from Tbx18+ mesenchymal cells (Fig. 3T–V) (Trowe et al., 2012). In
the bladder, GFP expression was graded from dorsal to ventral
within the smooth muscle cell layer but was absent from the
urothelium (Fig. 3W–Y).
We conclude, that Tbx18+ cells in the developing urogenital
system are multipotent and contribute to all mesenchymal cell
types in the ureter but also to a large degree to the stromal,
mesangial and smooth muscle cells of the medial region of the
kidney, to the bladder mesenchyme, to the cortical steroidogenic
cells of the adrenal gland and to somatic cells of the gonads.
Tbx18 is required for ureteric differentiation of mesenchymal cells
Our previous analysis has shown that Tbx18 is required for
differentiation of the ureteric mesenchyme into smooth muscle
cells but has not addressed a critical involvement of the gene in
the development of the other organs of the urogenital system, to
which Tbx18+ descendants largely contribute. We, therefore, ana-
lyzed Tbx18-deficient embryos (Tbx18cre/lacZ;R26mTmG/+) at E18.5, i.e.
shortly before these mice die due to skeletal defects, for histolo-
gical and molecular changes in the development of these organs.
Analysis of the adrenal gland by histological staining, co-
immunofluorescence of the lineage marker GFP and the marker
of steroidogenic cells SF1, and quantification of GFP+ cells in the
cortex did not detect any difference in the distribution
and differentiation of Tbx18+ descendants in wildtype and
Tbx18-deficient adrenals at this stage. Expression of Akr1c18 and
Cyp11b1, markers of the inner cortical layer (Lalli, 2010), and of
Wnt-4, a marker of the outer cortical layer (Heikkila et al., 2002),
was unaffected in the mutant showing that zonation into medulla
and inner and outer cortex occurred normally (Supplementary
Fig. S2). Histological staining and co-expression analysis with
subsequent quantification of the previously used differentiation
markers SOX9 (Sertoli cells), DDX4 (germ cells), and SF1 (Leydig
cells) did not detect any difference between wildtype and
Tbx18-deficient testes at this stage either (Supplementary Fig.
S3). Differentiation of mesenchymal and epithelial lineages was
also unaffected in the bladder and the kidney in the absence of
Tbx18 (Supplementary Figs. S4,S5).
However, in the kidney, the contribution of GFP+ cells to both
the medullary and cortical stroma on the lateral side was
enhanced, whereas the few GFP+ cells of the ureter failed to
differentiate into smooth muscle cells (Fig. 4A–C). In situ hybridi-
zation of the lineage marker Gfp on sections of kidneys of earlier
stages revealed that Tbx18+ descendants dislocalized laterally onto
the kidney as early as E12.5 (Fig. 4D). To further visualize the
altered contribution to stromal cells in Tbx18-deficient kidneys, we
explanted E11.5 metanephric rudiments and followed the GFP
epifluorescence in culture (Fig. 4E). In the control (Tbx18cre/+;
R26mTmG/+) GFP+ cells localized to the ureteric mesenchyme and
the stromal cells of the kidney particularly those of the medial
cortex. In Tbx18-deficient embryos (Tbx18cre/lacZ;R26mTmG/+), GFP
expression was reduced around the short ureter but strongly
enhanced in the medullary stroma around the distorted pelvic
region. Of note, GFP+ cells now surrounded branching ureteric
epithelium unlike in the control (Fig. 4E). We conclude from this
analysis that Tbx18 is required in uncommitted precursor cells to
adopt the ureteric fate. In absence of Tbx18 these cells contribute
to the renal stroma.
A spatially restricted subset of Tbx18+ mesenchymal cells contributes
to the definite ureteric mesenchyme after E11.5
As Tbx18 is exclusively required within the ureteric mesench-
ymal lineage, we wished to learn about the mechanisms that
confine Tbx18 expression in the early metanephric field, and
suppress the stromal in favor of the ureteric mesenchymal fate.
To determine whether Tbx18+ cells of the early metanephric field
contribute randomly or in a spatially defined manner to the
ureteric mesenchyme, we isolated kidney rudiments of E11.5
Tbx18GFP/+ embryos and explanted them onto filter membranes.
The red fluorescent dye DiI was injected at defined distances from
the ureteric epithelium onto small cell clusters within the Tbx18+
domain (as visualized by GFP fluorescence from the Tbx18GFP
allele) and the distribution of the red fluorescence was determined
after 2 days (Fig. 5A, Supplementary Fig. S6). Two outcomes were
observed: DiI injected into mesenchymal cells in a distance of up
to 200 mm from the ureteric epithelium contributed to the kidney
stroma whereas DiI injected more distally ended up as an
amorphous mass in between the Wolffian duct and the kidney.
Localization of DiI+ cells to the GFP+ ureteric mesenchyme was
never observed (Fig. 5B). Lysotracker staining of E11.5 metanephric
rudiments explanted for 1 day detected apoptotic cells in the
lateral domain of the ureteric mesenchyme that had lost Tbx18
expression at this time but not in those adjacent to the ureteric
epithelium (Fig. 5C). To exclude a culture artefact, we also
analyzed apoptosis by TUNEL staining in sections of E11.5 and
E12.5 embryos. At both stages we detected apoptosis in mesench-
ymal cells lateral to but not adjacent to the short ureter stalk.
Intriguingly, apoptosis in this domain was completely lost in
Tbx18-deficient embryos (Fig. 5D).
We conclude that only a minor fraction of the mesenchymal cells
initially positive for Tbx18 contribute to the definite ureteric
mesenchyme, most likely those in direct proximity to the epithe-
lium (that we were unable to label by this technique). Cells within
a 200-mm range of the ureteric epithelium contribute to the
kidney stroma whereas cells further away undergo apoptosis. In
Tbx18-deficient embryos, lateral Tbx18+ descendants fail to undergo
apoptosis but may additionally contribute to the renal stroma.
Epithelial signals impose a ureteric fate onto Tbx18+ cells
Given the finding that only cells in direct vicinity of the ureteric
epithelium are likely to contribute to the definitive ureteric
mesenchyme, we wished to test the role of epithelial signals in
maintaining Tbx18 expression and directing a ureteric fate to cells
in the early metanephric field, and performed tissue recombina-
tion experiments in cultured explants of metanephric rudiments
of E11.5 Tbx18GFP/+ embryos (Fig. 6A). In a control experiment, GFP
expression was confined to the mesenchymal tissue layer covering
the ureteric epithelium after 3 days of culture. Removal of the
ureter from E11.5 kidney explants resulted in a dispersal of GFP+
cells and their complete loss after 3 days. We then transplanted an
RFP-labeled ureteric epithelium (obtained from E12.5 R26mTmG/+
embryos) into the Tbx18+ domain in a position distant from the
ureteric epithelium of the host tissue. Interestingly, GFP expres-
sion was maintained in the lateral mesenchyme and GFP+ cells
accumulated around the ectopic RFP+ ureteric epithelium. In
contrast, when a RFP-labeled ureteric epithelium was transplanted
into the lateral GFP+ domain of kidney explants of E11.5 Tbx18GFP/lacZ
embryos, GFP+ cells did not accumulate around the ectopic ureter
(Fig. 6A). Together, these results strongly suggest that epithelial
signals are required and sufficient to maintain Tbx18 expression
and to impose a ureteric fate onto Tbx18+ cells. Epithelial signals
do not act in a distance to induce a condensation process but
merely seem to impinge onto the adjacent layer of mesenchymal
cells. In absence of Tbx18, mesenchymal cells can no longer
respond to signals from the ureteric epithelium.
We have recently shown that canonical (Ctnnb1-dependent)
WNT signaling is required to maintain Tbx18 expression and
induce smooth muscle differentiation in the ureteric mesenchyme
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(Trowe et al., 2012). The latter process also requires SHH signals
from the epithelial compartment (Yu et al., 2002). In Tbx18-
deficient ureters, Tcf21+-mesenchymal cells surrounding the ureter
did not express Axin2 and Ptch1, targets of the canonical WNT- and
SHH-signals that are secreted from the epithelial compartment in
the mutant (Fig. 6B). We conclude that Tbx18 is required in
uncommitted precursor cells to respond to epithelial signals and
to adopt the ureteric fate.
To address the question whether WNT and/or SHH signals are
sufficient to maintain Tbx18 expression in the lateral domain in
which it is lost after E11.5, we explanted E11.5 kidney rudiments
and implanted beads soaked with SHH and/or WNT9B protein
(Wnt9b is co-expressed with Wnt7b in the ureteric epithelium)
into this domain (Trowe et al., 2012). Neither BSA control nor
WNT9B-, SHH- or WNT9B/SHH-beads maintained GFP, i.e. Tbx18
expression, in the lateral domain (Fig. 6C), arguing that WNTs
cooperate with other as yet unknown epithelial signals to main-
tain Tbx18 expression and possibly determine the ureteric fate.
Discussion
Tbx18+ progenitors contribute to multiple cell types in the urogenital
system
We have demonstrated that descendants of Tbx18+ cells con-
tribute to a variety of cell types within the urogenital system
including cells within the gonads, the kidney, ureter, bladder and
adrenal gland. Our expression analysis together with the genetic
lineage tracing of Tbx18+ cells argue that cellular contribution to
the adrenal gland and gonads on one hand and to the kidney,
ureter and bladder on the other hand reflect two independent
expression domains of Tbx18; one in the urogenital ridge and the
other one in the metanephric field, and that the latter represents a
novel subpool of progenitors fromwhich the ureteric mesenchyme
will eventually arise.
Transient expression in the epithelial lining of the urogenital
ridge around E9.5 is likely to present a common precursor pool for
the gonads and the adrenals. In fact, the contribution to interstitial,
Sertoli and tunica albuginea cells in the gonad and steroidogenic
cells of the adrenal cortex is virtually identical to that identified by
a genetic approach based on expression of Sf1, a marker for this
primordium (Bingham et al., 2006). Tbx18 expression in the
epithelial lining of the ridge is transient and seems to slightly
precede that of Sf1 in this domain. Compatible with expression in
the unseparated progenitor pool for both tissues, we recently
noted sex reversal and loss of adrenals in mice with conditional
Tbx18cre-mediated deletion of Ctnnb1 (Trowe et al., 2012). In fact,
identical phenotypes were observed upon an Sf1cre-mediated
deletion of this mediator of the canonical branch of WNT signaling
in mice (Kim et al., 2008; Liu et al., 2009). At this point, we do not
have the technical means to independently evaluate the contribu-
tion of the mesenchymal expression domain of Tbx18 in the early
urogenital ridge. However, since this domain does not overlap
with Pax2 in the mesonephros, we suggest that it does not mark
progenitors for mesonephric tubules but for stromal cells that are
associated with these structures.
In contrast to our initial expectations, we found that the Tbx18+
cells that are located in the metanephric field between the
mesenchymal populations of the metanephros and the Wolffian
duct, are not yet specified to a ureteric mesenchymal fate but are a
multipotent population that contributes to interstitial cells of the
kidney (cortical and medullary stromal cells, mesangial cells and
vascular smooth muscle cells), to all mesenchymal cells of the
ureter and to a subset of smooth muscle cells of the bladder. Most
notably, our expression analysis as well as the fate mapping clearly
shows that the Tbx18+ lineage is at all time points separated from
the Six2+Uncx+ progenitors from which nephrons will develop.
Tbx18 expression does not overlap with the stromal marker Foxd1
at E11.5. However, Foxd1 is not expressed at E10.5 in the meta-
nephric field strongly suggesting that Tbx18 expression at this
stage encompasses progenitors of renal stromal cells as well as of
the ureteric mesenchyme. Hence, within the Osr1+ metanephric
field two lineages are established at E10.5: the Six2+Uncx+ nephron
lineage and the Tbx18+ lineage of kidney stromal cells/ureter and
bladder mesenchyme. Between E10.5 and E11.5 the Tbx18+ and
Foxd1+ lineages are completely separated. Tbx18+ cells lying in
direct proximity to the ureteric epithelium will maintain Tbx18
and differentiate into all mesenchymal cell types of the ureter.
Cells which loose Tbx18 expression will either die or contribute to
the renal stroma and the bladder mesenchyme. Due to lack of
appropriate markers and adequate culture settings we cannot
firmly state when the mesenchymal lineages of the ureter and
bladder separate but assume that it occurs around the same time.
Tbx18-Cre cell lineage tracing with a BAC-based approach
recently reported contribution of Tbx18+ descendants to smooth
muscle cells of the bladder and the ureter in the mature urogenital
system. The more restricted contribution in this genetic setting
may relate to a less sensitive detection system used but more
likely reflects the lack of regulatory elements in the BAC used for
construction of a Tbx18–Cre transgene (Wang et al., 2009). Our
Tbx18cre allele was constructed by inserting a cre orf into the start
codon of the Tbx18 locus (Trowe et al., 2010). Analysis of cre
expression in the urogenital system as well as at extrarenal sites
showed that expression of cre faithfully mimics endogenous
expression of Tbx18 strongly arguing that all control elements of
Tbx18 are preserved and direct appropriate expression of cre from
this allele (Christoffels et al., 2009; Trowe et al., 2012). Further-
more, the sensitive Rosa26mTmG reporter line allows a cellular
resolution of all recombination events. Hence, we are convinced
that our genetic lineage tracing system is technically sound and
provides a true image of the widespread distribution of Tbx18+
descendants in the urogenital system.
Tbx18+ cells do not condense to form the definitive ureteric
mesenchyme
We previously suggested that the band of Tbx18+ mesenchymal
cells in the E11.5 metanephric field condenses around the ureteric
epithelium to form the definite ureteric mesenchyme until E12.5.
Our genetic lineage tracings as well as our DiI injection in the
Tbx18+ domain at E11.5 contradict this “condensation” model but
suggest that only a minor fraction of the cells initially positive for
Tbx18 become the precursors for smooth muscle cells and fibro-
blasts of the ureter. In fact, the majority of cells in this domain
switch off Tbx18 expression, and depending on the distance from
the ureter contribute to the kidney stroma (the more proximal
ones) or localize to the tissue in between the kidney and the
Wolffian duct (the more distal ones). The latter population under-
goes apoptosis, a process that may aid in severing the connections
between the two organs. Only the few cells in proximity to the
ureteric epithelium maintain Tbx18 expression. Our further experi-
ments suggest that the ureteric mesenchyme is specified between
E11.5 and E12.5 by signals from the ureteric epithelium. Data from
canonical WNT pathway manipulation presented in this study as
well in a recent report from our lab strongly suggest that WNT
signals are required to maintain but are not sufficient to induce
Tbx18 expression (Trowe et al., 2012). We suggest that other
signals from the epithelium, but not SHH, cooperate with WNT
signals to maintain Tbx18 expression and specify a ureteric fate to
allow further differentiation of ureteric fibroblasts and smooth
muscle cells.
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Our analysis of Tbx18-deficient embryos has shown that Tbx18
is not required for development of any of the components of the
urogenital system except the ureter. Tbx18 seems to act in a sub-
pool of mesenchymal precursors of the metanephric field to favor
a ureteric at the expense of a renal stromal fate. Since target genes
for signals from the ureteric epithelium (i.e. SHH and WNTs) are
not activated in Tbx18-deficient cells, we suggest that Tbx18 acts as
a prepatterning gene to make the cells competent to receive
signals emanating from the epithelial compartment. However,
our analysis has also shown that transient Tbx18 expression in
mesenchymal cells of the early metanephric field is required to
induce apoptosis in the lateral domain to avoid the formation of
ectopic ligaments between the gonads, the kidney and the ureter
as observed in Tbx18-deficient urogenital systems.
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Supplementary Fig. S1. Tbx18+-descendants are positive for SF1 in the coelomic lining 
at E10.5. (Co-)immunofluorescence analysis of expression of the lineage marker GFP 
(green) and the marker for the adrenogonadal primordium, SF1 (red), on transverse sections 
through the posterior trunk of E9.5 and E10.5 Tbx18cre/+;R26mTmG/+ embryos. At E9.5, SF1 
protein is not yet expressed in the coelomic lining and recombination of the lineage reporter 
has not yet occurred. At E10.5, cells formerly positive for Tbx18 in the coelomic lining 
express SF1. 
 
Part 1 - Tbx18 lineage in urogenital development
!29
 
 
Supplementary Fig. S2. Loss of Tbx18 does not affect testis development. (A,B) 
Histological analysis by haematoxylin and eosin staining of sagittal testis sections in E18.5 
control (Tbx18cre/+;R26mTmG/+) and Tbx18-deficient embryos (Tbx18cre/lacZ;R26mTmG/+) does not 
detect changes of the testicular tissue organization. (C-L) (Co-)immunofluorescence analysis 
of expression of the lineage marker GFP and markers of differentiated cell types on sections 
of E18.5 testis does not detect changes in the number and distribution of smooth muscle 
cells of the capsule (ACTA2), of Sertoli cells (SOX9), of germ cells (DDX4) and of Leydig 
cells (SF1) between control and Tbx18-deficient embryos. Scale bars represent 100 µ m 
(A,B,C,D) and 10 µm (E-L). (M-O) Quantification of SOX9+ Sertoli cells, DDX4 germ cells and 
SF1+ Leydig cells in the testis. (M) SOX9+ cells/all cells in the counted area (in%), control: 
3.5+/-0.5, mutant: 3.2+/-0.5 p=0.515. (N) DDX4+ cells/testis cord cells (somatic and germ 
cells) (in %). control: 23.3+/-5.0, mutant: 28.3+/-4.0 p=0.093. (O) SF1+ Leydig cells/all 
interstitial cells (in %), control: 4.5+/-1.9, mutant: 4.0+/-2.5 p=0.801. 
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Supplementary Fig. S3. Loss of Tbx18 does not affect adrenal development at E18.5. (A,D) 
Histological analysis by haematoxylin and eosin staining, (B,E) immunofluorescence analysis 
of expression of the lineage marker GFP, (C,F) co-immunofluorescence analysis of 
expression of the lineage marker GFP and of the steroidogenic marker SF1, on sections of 
control (Tbx18cre/+;R26mTmG/+) and Tbx18-deficient embryos (Tbx18cre/lacZ;R26mTmG/+) does not 
detect changes in adrenal development. Size bars represent 0.1 mm (A-D) and 10 µm (C,F). 
(G-I) Immunofluorescence analysis of cells expressing the lineage marker GFP in a defined 
cortical area and subsequent quantification of GFP+ cells (control is set to 1) reveals 
unchanged contribution of Tbx18+ descendants to the cortical area of the Tbx18-deficient 
adrenal gland. Control: 1+/-0.037, mutant: 1.034+/-0.04, p=0.26 (J-M) In situ hybridization 
analysis of markers of the inner cortical region shows normal zonation in the mutant adrenal 
gland. Genotypes, probes and antigens are as shown. 
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Supplementary Fig. S4. Loss of Tbx18 does not affect bladder development. (A,C) 
Histological analysis by haematoxylin and eosin staining, (B,D) immunofluorescence analysis 
of expression of the lineage marker GFP, (E,G) co-immunofluorescence analysis of 
expression of the lineage marker GFP and the smooth muscle marker ACTA2, (F,H) co-
immunofluorescence analysis of expression of the lineage marker GFP and of the urothelial 
marker UPK1B on sections of control (Tbx18cre/+;R26mTmG/+) and Tbx18-deficient embryos 
(Tbx18cre/lacZ;R26mTmG/+) does not detect changes in contribution of Tbx18+ descendants and 
cellular differentiation in the bladder. Size bars represent 0.5 mm (A-D) and 10 µm (E-H). 
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Supplementary Fig. S5. Loss of Tbx18 does not affect differentiation of renal cell lineages. 
Co-immunofluorescence analysis of expression of the lineage marker GFP, with the 
endothelial marker EMCN, the cap mesenchyme marker SIX2, the epithelial marker CDH1, 
the cortical stroma marker FOXD1 and the smooth muscle marker ACTA2 on sections of 
control (Tbx18cre/+;R26mTmG/+) and Tbx18-deficient embryos (Tbx18cre/lacZ;R26mTmG/+) does not 
detect changes in contribution of Tbx18+ descendants and cellular differentiation in the 
kidney. Size bars represent 10 µm. 
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Supplementary Figure S6. Lineage analysis of Tbx18+ mesenchymal cells in early 
kidney rudiments. (A) Combined brightfield and epifluorescence analysis of 
metanephric explants from E11.5 Tbx18GFP/+ embryos at 0, 1 and 2 days of culture. 
GFP (green) marks the Tbx18 expression domain, the red fluorescence indicates DiI-
injected cell clusters. Shown are two representative examples of DiI-injected cells 
localizing to the space between kidneys and the Wolffian duct (lower row). Boxed 
regions are shown in higher magnifications below. 
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Diversification of Cell Lineages in Ureter Development
Tobias Bohnenpoll, Sarah Feraric, Marvin Nattkemper, Anna-Carina Weiss, Carsten Rudat,
Max Meuser, Mark-Oliver Trowe, and Andreas Kispert
Institut für Molekularbiologie, Medizinische Hochschule Hannover, Hannover, Germany
ABSTRACT
The mammalian ureter consists of a mesenchymal wall composed of smooth muscle cells and surrounding
fibrocytes of the tunica adventitia and the lamina propria and an inner epithelial lining composed of layers
of basal, intermediate, and superficial cells. How these cell types arise from multipotent progenitors is
poorly understood. Here, we performed marker analysis, cell proliferation assays, and genetic lineage
tracing to define the lineage relations and restrictions of the mesenchymal and epithelial cell types in the
developing and mature mouse ureter. At embryonic day (E) 12.5, the mesenchymal precursor pool began
to subdivide into an inner and outer compartment that began to express markers of smooth muscle
precursors and adventitial fibrocytes, respectively, by E13.5. Smoothmuscle precursors further diversified
into lamina propria cells directly adjacent to the ureteric epithelium and differentiated smoothmuscle cells
from E16.5 onwards. Uncommitted epithelial progenitors of the ureter differentiated into intermediate
cells at E14.5. After stratification into two layers at E15.5 and three cell layers at E18.5, intermediate cells
differentiated into basal cells and superficial cells. In homeostasis, proliferation of all epithelial and mes-
enchymal cell types remained low but intermediate cells still gave rise to basal cells, whereas basal cells
divided only into basal cells. These studies provide a framework to further determine the molecular mech-
anisms of cell differentiation in the tissues of the developing ureter.
J Am Soc Nephrol 28: ccc–ccc, 2016. doi: 10.1681/ASN.2016080849
Themammalianureterhasacompartmentalizedtissue
architecture that is functionally adapted to mediate
efficient urinary drainage from the renal pelvis to the
bladder. The outer mesenchymal compartment
harbors a thick layer of peristaltically active smooth
muscle cells (SMCs), the tunica muscularis, that is
ensheathed by flexible and anchoring fibroelastic ma-
terial, the tunica adventitia on the outside and the
lamina propria on the inside. The inner compartment
is a highly distensible epithelium that provides sealing
to the luminal space. This urothelium features a single
layer of cuboidal basal cells (B cells) that is attached to
the lamina propria via a basement membrane, one or
two layers of intermediate cells (I cells) that resemble B
cells in shape and size, and a luminal layer of large
squamous superficial cells (S cells) that exert a barrier
function at least partly due to expression of uroplakins
(UPKs) that form crystalline plaques on the apical
surface.1,2
The differentiated cell types of the two ureteric tis-
sue compartments arise from multipotent precursors
during embryonic development. In the mouse, these
precursor pools are established around embryonic day
(E) 11.5 when the distal aspect of an epithelial diver-
ticulum of the nephric duct, the ureteric bud, and its
surroundingmesenchyme adopt a distal ureteric rather
than a proximal renal fate. For the next days, themes-
enchymal and epithelial progenitors multiply to sup-
port ureter elongation. At E16.5, i.e., shortly after
onset of urine production in the kidney, expression
of smooth muscle (SM) structural proteins and of
UPKs testifies that SMC and S cell differentiation
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has been initiated. Around birth, the three epithelial and mes-
enchymal cell layers can be histologically clearly distin-
guished.3,4 Embryologic experiments have shown that the
survival, patterning, and subsequent differentiation of the
primitive ureteric epithelium and its surrounding mesen-
chyme depend on each other. Genetic analysis has identified
some of the trans-acting signals and the downstream tran-
scription factors that regulate these cellular programs.4 How-
ever, how the different cell types arise in time and how they
relate to each other has been poorly studied.
Here, we set out to probe the developmental origin and
relationship of the different epithelial and mesenchymal cell
types of the mouse ureter. We describe the temporal profile of
cell differentiation and proliferation in the ureter, and trace the
fate of the two progenitor pools. We provide evidence that I
cells are precursors for both B and S cells in development.
RESULTS
Cell Differentiation Occurs in a Temporally
Controlled and Coordinated Manner in the Epithelial
and Mesenchymal Tissue Compartments of the
Embryonic Ureter
Previous work reported expression of cell-type–specific genes
at selected stages of ureter development but did not address
the precise temporal profile of the mesenchymal and epithelial
differentiation programs.3,5,6We therefore wished to correlate
histologic changes with expression profiles of cell-type–specific
marker sets in either tissue compartment at all stages of embryonic
ureter development.
In the mature ureteric mesenchyme, adventitial fibrocytes
are marked by expression of periostin (POSTN), whereas
SMCs canbe identified by transgelin (TAGLN) and actin, alpha
2, smoothmuscle, aorta (ACTA2) expression.6,7 For the cells of
the lamina propria no specific protein marker has been de-
scribed, but they can be identified as mesenchymal cells neg-
ative for SMC markers adjacent to the ureteric epithelium
(Figure 1, A–C, P40 panel). We have recently shown that the
T-box transcription factor gene Tbx18 is expressed in the un-
differentiated ureteric mesenchyme, and that the descendants
of this expression domain constitute the ureteric mesenchy-
mal wall throughout development and in adulthood.8,9
To detect and quantify cell differentiation in the ureteric mes-
enchyme, we therefore analyzed coexpression of cell-type–
specific markers with a membrane-bound GFP reporter by
immunofluorescence on proximal ureter sections in mice
double heterozygous for a cre knock-in in the Tbx18 locus
and the Rosa26mTmG reporter line (Tbx18cre/+;R26mTmG/+)
(Figure 1, A–E).10,11
At E12.5, two histologically distinct cell populations were
present in the GFP+ ureteric mesenchyme. Cells adjacent to
the ureteric epithelium were densely packed and spherical,
whereas the outermost layers contained loosely organized,
radially oriented, and spindle-shaped cells. Differentiation
markers were not expressed at this stage. At E13.5, the num-
ber of GFP+ mesenchymal cells was strongly increased and
the outermost spindle-shaped cells started to express
POSTN. POSTN expression expanded to cover most cells
of the outer mesenchymal compartment at E14.5. At E15.5,
few TAGLN+ACTA2+ SMCs appeared in the dense inner
mesenchyme that was surrounded by POSTN+ adventitial
fibrocytes. At E16.5, a contiguous SMC layer had developed
that was separated from the urothelium by a TAGLN2 layer
of lamina propria cells. Most of the spindle-shaped outer
fibrocytes were POSTN+. At E18.5, the ureteric mesenchyme
was fully patterned and differentiated in TAGLN2GFP+ lam-
ina propria cells, a dense TAGLN+ACTA2+GFP+ SMC layer,
and radially organized POSTN+GFP+ adventitial fibrocytes.
The ratio of these cell types was dramatically changed at P40
by relative expansion of the lamina propria and the SMC
layer and reduction of the tunica adventitia (Figure 1, A–E,
Supplemental Table 1A).
Work in the bladder has shown that combinatorial expres-
sion of cytokeratin 5 (KRT5), of an isoformof the transcription
factor p63 (∆NP63), and of UPKs distinguishes the three
urothelial cell types in this tissue.12We confirmed for the adult
ureter that B cells are KRT5+∆NP63+UPK1B2, I cells are
KRT52∆NP63+UPK1B+, and S cells are KRT52∆NP632
UPK1B+, with levels of UPK1B being significantly lower in I
than in S cells (Figure 1, F and G, P40 panel); hence, that these
markers can be used to profile urothelial differentiation in this
organ (Figure 1, F–J). At E12.5, the mono-layered urothelium
was negative for all of these differentiation markers. ∆NP63
expression occurred in single cells at E13.5 but was expressed
in increasing cell numbers at E14.5 and labeled the majority of
cells of the now double-layered urothelium at E15.5. Expres-
sion of Upk1b mRNAwas weakly found throughout the uro-
thelium at these stages as well characterizing these cells as I
cells. At E15.5, single cells on the luminal side were negative
for ∆NP63 which correlated with the advent of superficial
UPK1B expression. At E16.5, the urothelium was composed
of two to three layers. Coexpression of KRT5 and high levels of
∆NP63 indicated the presence of B cells that were intermingled
with I cells (KRT52∆NP63+UPK1B+[low]) in the basal layer.
UPK1B expression was strong in the intermediate and apical
layer. The abundance of B cells significantly increased from
E16.5 to E18.5, and B cells constituted the majority of urothelial
cells at P40. The relative number ofKRT52∆NP63+UPK1B+(low)
I cells significantly decreased from E16.5 to E18.5 and remained
at low abundance in the adult. KRT52∆NP632UPK1B+(high) S
cellswere clearly identifiable at E16.5 andE18.5, but decreased in
abundance until P40 (Figure 1, F–J, Supplemental Table 1B).
Interestingly, the relaxed adult urothelium showed a pyramidal
topology on sections with large binucleated S cells at the tip,
small I cells in the middle, and numerous B cells at the base
(Figure 1, F–J, Supplemental Figure 1).
Comparative analysis ofmesenchymal and epithelial differ-
entiation markers at proximal, medial, and distal levels of the
ureter revealed that the expression patterns of differentiation
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Figure 1. Cell differentiation in ureter development occurs in a temporally and spatially controlled manner. (A–E) Time course of cell dif-
ferentiation in the ureteric mesenchyme. (A) Hematoxylin and eosin (H&E) staining on transverse sections of the proximal ureter. At E12.5, the
inner and outer mesenchymal region (IM and OM) and the ureteric epithelium (UE) are indicated. At P40, the three subregions of the
mesenchyme, the lamina propria (LP), the smooth muscle (SM), and the tunica adventitia (TA) are marked adjacent to the urothelium (U). (B and
C) Coimmunofluorescence analysis of expression of the SMC marker TAGLN and the lineage marker GFP (B) and of the SMC marker ACTA2
and the adventitial marker POSTN (C) on transverse sections of the proximal ureter in Tbx18cre/+;R26mTmG/+ mice. Nuclei are counterstained
J Am Soc Nephrol 28: ccc–ccc, 2016 Cell Lineages in the Ureter 3
www.jasn.org BASIC RESEARCH
Part 2 - Lineage diversification in the ureter
!38
markers are spatially conserved but are activatedwith a delay of
1–2 days at more distal levels (Supplemental Figures 2 and 3).
We conclude that differentiated cell types arise in a distinct
order and in a proximal to distal wave along the ureteric tube.
In the mesenchyme adventitial fibrocytes precede SMCs and
lamina propria cells, whereas in the epithelial compartment I
cells differentiate before B and S cells.
Proliferation Rates Explain Differential Cell-Type
Expansion in the Developing Ureter
Our analysis has shown that the different epithelial and mes-
enchymal cell types of the ureter start to differentiate at dif-
ferent time points and change in abundance over time. To find
out if this relates to differences in the temporal profiles of cell-
cycle activity, we determined cell proliferation during ureter
development and homeostasis using the BrdU incorporation
assay.
At E12.5 andE14.5, proliferation rates reached20%–23% in
both the ureteric epithelium and the inner and outer region of
the ureteric mesenchyme, showing that the precursor pools
coordinately drive the expansion of the early organ rudiment
(Figure 2, A and B, Supplemental Table 2A). From E16.5 on-
wards, the three mesenchymal and epithelial cell types could
be molecularly distinguished. In the mesenchyme, the cells of
the lamina propria maintained high proliferation rates similar
to precursors at the previous stages, whereas SMCs reduced
proliferation from 19% at E16.5 to 13% at E18.5, and adven-
titial fibrocytes from 12% to 8% in line with the relative ex-
pansion of SM and lamina cells at the expense of adventitial
cells at these stages (Figure 1E). At P40, SMCs were quiescent,
whereas cells of the lamina and adventitia divided at a very
low rate (0.3% and 0.8%) (Figure 2, C and D, Supplemental
Table 2B).
In theepithelial compartment,BandScellsmaintainedhigh
proliferation at E16.5, whereas I cells proliferated at approxi-
mately half the rate (9%). At E18.5, proliferation rates were
further reducedwith S cells beingmoreproliferative thanBand
I cells. In the adult ureter, only B cells divided occasionally,
whereas S and I cell proliferationwas under the detection limit
(Figure 2, E and F, Supplemental Table 2C). Together, these
findings suggest that mesenchymal and epithelial cell-types
withdraw at different time-points from the cell cycle, explain-
ing their changing ratios particularly at late embryonic and at
postnatal stages.
Adventitial Cells are Separated Early in Mesenchymal
Development Whereas Lamina Propria Cells Derive
from SMC Precursors
Our expression analysis showed that the homogenous mesen-
chymal progenitor pool is separated into a histologically and
molecularly distinct inner and outer domain as early as E12.5.
To determine whether this subdivision represents a compart-
ment boundary between prospective adventitial fibrocytes and
SMCs, and to define the origin of the lamina propria cells, we
performed genetic lineage tracing experiments using cre lines
that are specific to the outer or innermesenchymal domain. To
detect the descendants of outer mesenchymal cells, we took
advantage of the fact that Foxd1 is expressed in this domain
exclusively at E12.5 and E14.5 (Supplemental Figure 4A).
Marker analysis on sections of proximal E12.5 and E18.5 ure-
ters double heterozygous for a Foxd1cre allele13 and the R26mTmG
reporter (Foxd1cre/+;R26mTmG/+) at E12.5 and E18.5 showed that
the descendants of this expression domain localized to the outer
mesenchymal ring at E12.5 and E18.5, and expressed POSTN
but not the SMC markers TAGLN and ACTA2 (Figure 3A),
clearly indicating that outer mesenchymal cells are lineage-
restricted to become adventitial fibrocytes as early as E12.5.
Axin2 is expressed at E12.5 and subsequent stages in the
inner ring of mesenchymal cells in the ureter as a response to
WNT signals emitted from the adjacent epithelium (Supple-
mental Figure 4B).6 To trace the descendants of this Axin2+
domain, we crossed mice with a creERT2 knock-in in the
Axin2 locus14 with the R26mTmG reporter line and induced
recombination by a single oral administration of 4mg tamoxifen.
To confirm the region-specificity of the labeling reaction,
we treated Axin2creERT2/+;R26mTmG/+ embryos at E12.5 and
E13.5 and analyzed the distribution of GFP+ cells in the inner
and outer mesenchymal compartment 24 hours later. In em-
bryos injected at E12.5, 23% of the GFP+ cells were detected in
the outer compartment, 77% in the inner compartment; in
E13.5 embryos, the relation was 6%–94%, indicating that the
labeling reaction in E13.5 ureters almost exclusively occurred
in the inner ring (Figure 3, B and C, Supplemental Table 3).
When Axin2creERT2/+;R26mTmG/+ embryos were analyzed at
E18.5, GFP+ descendants localized to 71% to the SMC layer,
to 18% to the lamina propria, and to 11% to the tunica ad-
ventitia when tamoxifen administration was done at E12.5.
For embryos tamoxifen-treated at E13.5 the numbers were
73% and 17%, whereas only 10% of labeled cells were
withDAPI (blue). (D) Schematic representationof cell differentiation in theuretericmesenchyme. Fibrocytesof the tunica adventitia (yellow)
are defined as POSTN+GFP+, SMCs (red) as TAGLN+ACTA2+GFP+, and lamina propria cells (orange) as TAGLN2GFP+. (E) Quantification
of differentiated cell types in the ureteric mesenchyme on the basis of marker expression as explained in (D). For numbers see Supple-
mental Table 1A. (F–J) Time course of epithelial differentiation in the ureter. (F andG) Coimmunofluorescence analysis of expression of the
B cell marker KRT5, the B and I cell marker ∆NP63 (F), and the I and S cell marker UPK1B (G) with DAPI-stained nuclei (blue), and (H) in situ
hybridization for Upk1b expression on transverse sections of the proximal ureter in Tbx18cre/+;R26mTmG/+ mice. (I) Schematic represen-
tation of cell expansion and differentiation in the ureteric epithelium. B cells (green) are defined as KRT5+∆NP63+UPK1B2Upk1b2, I cells
(turquois) as KRT52∆NP63+UPK1B+(low)Upk1b+, and S cells (blue) as KRT52∆NP632UPK1B+(high)Upk1b+. (J) Quantification of differen-
tiated cell types in the ureteric epithelium on the basis of marker expression as explained in (I). For numbers see Supplemental Table 1B.
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detected in the tunica adventitia (Figure 3, B and C, Supple-
mental Table 3).We conclude thatAxin2+ innermesenchymal
cells are precursors of SMCs, and that lineage restriction to
adventitial fibrocytes occurs around E12.5 to E13.5. Lamina
propria cells derive from inner mesenchymal SMC progeni-
tors by switching off the SMC program at E14.5 to E16.5.
I Cells are Progenitors of B and S Cells in Development
The ureteric epithelium derives from the distal aspect of the
ureter bud that emerges as an outgrowth of the nephric duct
around E10.5. To confirm that the distal ureter stalk indeed
harbors precursors for all epithelial cell types of the mature
ureter, we performed genetic lineage tracing on the basis of cre
lines mediating recombination in all of these precursors. Pax2
and Shh are genes that are expressed throughout the ureteric
epithelium at E12.5 and at subsequent stages (Supplemental
Figure 4, C and D). A transgenic line, in which cre was ex-
pressed under Pax2 regulatory elements (Pax2-cre),15,16 me-
diated full recombination of the R26mTmG reporter allele in the
ureteric epithelium at E12.5; a line harboring a cre knock-in
into the Shh locus17 did so partially (Figure 4, A and B). In
Pax2-cre/+;R26mTmG/+ and Shhcre/+;R26mTmG/+ ureters ana-
lyzed at E18.5, GFP+ cells populated all three urothelial cell
layers, whereas a contribution to the uretericmesenchymewas
never observed (Figure 4, A and B).
Our expression analysis further demonstrated that the ep-
ithelial compartment of the ureter remains undifferentiated
until E13.5 and expresses markers for I cells from E14.5 on-
wards. S cells and B cells were only detected from E15.5 and
E16.5 onwards, respectively, suggesting that I cells are precur-
sors for both S and B cells in development. To validate this
hypothesis, we used cell-type–specific creERT2 lines and
traced their descendants in ureter explant cultures after
4-hydroxytamoxifen–induced stage-specific recombination of
the R26mTmG reporter allele.
To trace the fate of B cells we used a creERT2 lineage tracing
system on the basis of the B cell–specific expression of the Krt5
gene.12,18 When ureters from Krt5creERT2/+;R26mTmG/+ embryos
were explanted at E14.5, treated with 4-hydroxytamoxifen, and
analyzed after 10 days GFP+ cells were not detected, compatible
Figure 2. Proliferation rates explain differential cell-type expan-
sion in the developing ureter. (A) Coimmunofluorescence analysis
on proximal ureter sections at E12.5 and E14.5 for BrdU and the
nuclear counterstain DAPI (blue). White dotted lines demarcate
the ureteric epithelium (UE), and the inner and outer mesenchymal
cell populations (IM and OM). (B) Quantification of cell pro-
liferation by the BrdU index in the areas indicated in (A). (C)
Coimmunofluorescence analysis on proximal ureter sections at
E16.5, E18.5, and P40 for BrdU, the nuclear counterstain DAPI
(blue), and the SM marker TAGLN. (D) Quantification of cell pro-
liferation by the BrdU index in TAGLN2 outermesenchymal cells of
the tunica adventitia (TA), in TAGLN+ smooth muscle cells (SM),
and in TAGLN2 innermesenchymal cells of the lamina propria (LP).
(E) Coimmunofluorescence on proximal ureter sections at E16.5,
E18.5, and P40 for BrdU, the nuclear counterstain DAPI (blue), and
the B cell marker KRT5 (upper row) and BrdU, the nuclear coun-
terstain DAPI (blue), and the B and I cell marker ∆NP63 (lower row).
(F) Quantification of cell proliferation by the BrdU index in KRT5+ B
cells (BC), in KRT5+∆NP63+ I cells (IC), and KRT52∆NP632 S cells
(SC). For numbers see Supplemental Table 2, A–C.
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with the fact that KRT5 expression only occurs around E16.5.
When ureters from E16.5 and E18.5 embryos were treated and
analyzed after 8 and 6 days, respectively, GFP+ cells were present
and unambiguously expressed the B cell marker KRT5,
suggesting a lineage restriction of the B cell population (Figure 4,
C and D, Supplemental Table 4A).
Because cre lines specific for I cells are
not established, we used a Upk3a-GCE/+
line,12,19 that labels I and S cells but not B
cells (Supplemental Figure 5), to trace I cell
descendants. Irrespective of whether ure-
ters of Upk3a-GCE/+;R26mTmG/+ embryos
were explanted at E14.5 and analyzed after
10 days, explanted at E16.5 and analyzed
after 8 days, or explanted at E18.5 and an-
alyzed after 6 days, GFP+ cells differenti-
ated in roughly equal ratio into KRT5+ B
cells and KRT52UPK1B+ I and S cells, sug-
gesting that I cells are B cell progenitors in
development (Figure 4, E and F, Supple-
mental Table 4B).
To detect the fate of Krt5- and Upk3a-
expressing cells under homeostatic condi-
tions, we injected Krt5creERT2/+;R26mTmG/+
and Upk3a-GCE/+;R26mTmG/+ mice at
P100 with three doses of 5 mg tamoxifen
on alternating days and analyzed for GFP
expression after 4 weeks. In Krt5creERT2/+;
R26mTmG/+ ureters, all lineage-labeled cells
coexpressed KRT5, indicating that B cells
give only rise to B cells. In Upk3a-GCE/+;
R26mTmG/+ ureters, lineage-labeled cells
expressed in roughly equal ratio KRT5 or
UPK1B, indicating that I cells still give rise
to B cells (and probably S cells) in homeo-
stasis (Figure 4, C–F, Supplemental Table
4, A and B).
DISCUSSION
Early Lineage Restriction in the
Ureteric Mesenchyme Separates
Adventitial Fibrocytes from a
Common Precursor of SMCs and
Subepithelial Fibrocytes
Our previous work has shown that all mes-
enchymal cell types of the ureter derive
from a Tbx18+ mesenchymal progenitor
pool that surrounds the distal portion of
the ureter bud and separates themetaneph-
ric blastema from the nephric duct around
E11.5.9 Shortly after, at E12.5, this homog-
enous cell population is subdivided into an
inner compartment of densely packed,
spherical cells and an outer compartment of loosely organized,
spindle-shaped, and radially oriented cells, implying that mes-
enchymal cells of the two domains have acquired different
fates. Our findings support such an early lineage restriction
in the ureteric mesenchyme. First, differential gene expression
occurs around E12.5 in the twomesenchymal subregions. The
Figure 3. Adventitial cells are separated early in mesenchymal development whereas
lamina propria cells derive from SMC precursors in the ureter. (A) Coimmunofluorescence
analysis on transverse sections of the proximal ureter for the lineage marker GFP and the
epithelial marker CDH1 at E12.5, with the SMC markers TAGLN and ACTA2, and the
adventitial cell marker POSTN at E18.5 shows recombination in outer fibrocytes only in
Foxd1cre/+;R26mTmG/+ embryos. (B) Coimmunofluorescence of the lineage marker GFP
with the epithelial marker CDH1 and the SMC marker TAGLN on proximal sections of
ureters from Axin2creERT2/+;R26mTmG/+ embryos that were tamoxifen-induced at E12.5 or
E13.5 and harvested after 1 and 6 or 5 days to detect localization of recombined cells. (C)
Relative distribution of GFP+ cells localized to the inner and outer ureteric mesenchyme
(IM and OM), and to the tunica adventitia (TA), the smooth muscle (SM), and the lamina
propria (LP) in ureters shown in (B). The number of counted GFP+ cells (n) is given. For
additional numbers see Supplemental Table 3. (D) Schematic representation of the
lineage relations in the ureteric mesenchyme. Abbreviations are as explained in (C). Inner
mesenchymal cells contribute to the SM layer and the lamina propria but not to the
tunica adventitia. UM, undifferentiated mesenchyme; CP, common precursor.
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outer domain expresses POSTN and Foxd1, whereas the inner
region is positive for Axin2. Second, and more importantly,
lineage tracing of Foxd1+ cells showed that these cells exclu-
sively contribute to adventitial fibrocytes at E18.5, whereas
Axin2+ cells differentiate into cells of the lamina propria and
the SM layer. Ourmarker and proliferation analyses argue that
adventitial fibrocytes arise first and become terminally differ-
entiated before the other mesenchymal cell-types around
E16.5 to E18.5. In contrast, Axin2+ cells exist as bipotent pre-
cursors from E12.5 to E15.5, and differentiate into SMCs and
subepithelial fibrocytes around E16.5. The descent of lamina
propria and SMCs from a common precursor is also supported
by the observation that lamina cells initially also express ACTA2
but downregulate it afterward. Lamina cells and SMCsmaintain
high proliferation rates at least until E18.5, arguing that they only
terminally differentiate postnatally. Given the maintenance of
cell division at low rates in both fibrocyte populations in adults,
it is tempting to speculate that adventitial fibrocytes replenish
themselves whereas lamina cells serve as precursors for them-
selves and for SMCs.
Tissue separation experiments provided compelling evi-
dence that SMCdifferentiation in the ureter, and inmanyother
visceral tubular organs, depends on signals from the adjacent
epithelium.20 Our own work has recently shown that canon-
ical WNTsignaling is required to initiate SM precursor devel-
opment and to suppress an adventitial fate in the ureter.6
Because Axin2 is a direct transcriptional target of this signal-
ing pathway,21 this suggests that only cells adjacent to the
ureteric epithelium that perceive a WNT signal escape from
the default program to become adventitial fibrocytes, and dif-
ferentiate into SM progenitors instead. It is interesting to note
that Axin2 expression persists after E14.5 only in cells directly
in contact with the ureteric epithelium, i.e., in lamina propria
cells, supporting our idea that these cells represent a persisting
pool of SM progenitors. Whether downregulation of WNT
signaling is a prerequisite for SM progenitors to differentiate
Figure 4. I cells are progenitors of B and S cells in ureter de-
velopment and homeostasis. (A and B) Coimmunofluorescence
analysis on transverse sections of the proximal ureter of the
lineage marker GFP with the epithelial marker CDH1 at E12.5, and
the B cell marker KRT5, the B and I cell marker ∆NP63, and the S
cell markers UPK1B/UPK2 in Pax2-cre/+;R26mTmG/+ embryos (A)
and in Shhcre/+;R26mTmG/+ embryos (B) shows that Pax2+ and
Shh+ cells of the early ureteric bud contribute to all urothelial cell
types in the ureter but not the surrounding mesenchyme. (C and
E) Coimmunofluorescence analysis of the lineage marker GFP with
the B cell marker KRT5 (upper panel) and the S cell marker UPK1B
(lower panel) on transverse sections of ureters isolated at E14.5,
E16.5, and E18.5, inducedwith 500 nM4-hydroxytamoxifen for the
first 24 hours and cultured for 10, 8, and 6 days; and in adult ureters
4 weeks after tamoxifen administration in Krt5creERT2/+;R26mTmG/+
mice (C) and Upk3a-GCE/+;R26mTmG/+mice (E). (D and F) The bar
diagrams display the percentage of lineage-labeled (GFP+) cells
contributing to KRT5+UPK1B2 B cells or to KRT52UPK1B+ I and S
cells in the ureter of Krt5creERT2/+;R26mTmG/+ mice (D) and of
Upk3a-GCE/+;R26mTmG/+ mice (F) at the indicated stages and
conditions. The number of counted GFP+ cells (n) is given. For
additional numbers see Supplemental Table 4, A and B. (G)
Schematic representation of the lineage relations of urothelial cell
types. KRT5+ cells only give rise to B cells whereas UPK3A+ cells
give rise to B, I, and S cells. BC, basal cell; IC, intermediate cell; SC,
superficial cell; UE, undifferentiated epithelium.
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into SMCs is an attractive possibility that can be experimen-
tally tested.
I Cells are Progenitors for B and S Cells in Urothelial
Development and Homeostasis
Here, we have shown that all cell types of the mature urothe-
liumderive from a common Pax2+Shh+ precursor in the ureter
bud. Differentiated cell-types arise from this precursor in a
strict temporal sequence. At E14.5, all epithelial cells bear the
molecular signature of an I cell. With the onset of stratification
at E15.5, single apical cells express S cell markers. At E16.5,
KRT5+ cells appear in the basal layer but subsequently expand
and constitute the main cell-type of the mature urothelium.
The sequential appearance of differentiated cell types sug-
gests that I cells are a common precursor for S and B cells.
This hypothesis is further supported by our genetic lineage
tracing experiments. WhereasUpk3a+ cells contributed to all
cell-types throughout development and in adult tissue ho-
meostasis, Krt5+ cells only replicated themselves. Interest-
ingly, proliferation rates of I cells were low compared with
that of B and S cells, suggesting that they first differentiate
along their respective lineages and then expand. Of course,
our analysis cannot exclude that I cells are heterogeneous and
harbor distinct subpopulations that give rise to B and S cells,
respectively. Identification of additional biomarkers, possibly
by single cell transcriptome analysis, may help to resolve such
an issue in the future.
So far, urothelial progenitors have only been studied in the
bladder,mostly under conditions of regeneration. Even though
the urothelium of the bladder and the ureter are derived from
different germ layers, our study and a recent report suggest that
stratification and differentiation follow a similar time course in
bothorgans, thus,might be controlled by a commonmolecular
program.12 However, the nature of the urothelial progenitors
in the bladder has been controversially discussed. Although
initially B cells were thought to be progenitors for the other
urothelial cell types,22 Gandhi and colleagues suggested I cells
to be S cell progenitors only and defined B cells as a unipotent,
self-renewing population of unknown descent.12 A recent
work identified a KRT14+ subpopulation of B cells to give
rise to all urothelial cell types after injury.23 Whether the in-
jury conditions ablate S and I cells so much that B cells are
reprogrammed to compensate for their loss remains to be
seen. Unlike the bladder, where KRT14 expression occurs
in a large fraction of KRT5+ B cells both in the embryonic
and adult urothelium, KRT14 is not expressed in the embry-
onic ureter and is found at very low levels in few B cells in the
mature ureteric urothelium (Supplemental Figure 6). This in-
dicates that B cells in both organs are of different heterogene-
ity, and that a KRT14+ subpopulation of B cellsmight be of less
relevance for urothelial homeostasis and regeneration in the
ureter.
The molecular pathways that regulate the specification, differ-
entiation, and maintenance of the urothelium remain obscure.
Retinoic acid signaling has been implied in the specification of
the bladder urothelium from an endodermal precursor,12
whereas BMP4 was reported to be involved in the mainte-
nance of basal cell differentiation.24 Whether these signaling
pathways are involved in urothelial development of the ureter
as well should be a focus of future research.
CONCISE METHODS
Animals
Gt(ROSA)26Sortm4(ACTB-tdTomato-EGFP)Luo (synonym: R26mTmG),10
Krt5tm1.1(cre/ERT2)Blh (synonym: Krt5creERT2),18 Tg(Upk3a-GFP/cre/
ERT2)26Amc (synonym: Upk3a-GCE ),19 Foxd1tm1(GFP/cre)Amc
(synonym: Foxd1cre),13 Shhtm1(EGFP/cre)Cjt (synonym: Shhcre),17
and Axin2tm1(cre/ERT2)Rnu (synonym: Axin2creERT2)14 mouse lines
were all obtained from the Jackson Laboratory. Tbx18tm4(cre)Akis
(synonym: Tbx18cre)11 and Tg(Pax2-cre)1AKis (synonym: Pax2-cre)15,16
were previously generated in the laboratory. All lines were maintained on
an NMRI outbred background. Embryos for gene expression and pro-
liferation assays were derived from matings of NMRI wildtype mice, or
frommatings ofmales heterozygous for the credriver withR26mTmG/mTmG
females. For timed pregnancies, vaginal plugs were checked in the morn-
ing after mating, and noon was defined as E0.5. Embryos and urogenital
systems were dissected in PBS. Ureters for explant cultures were dissected
in L-15 Leibovitzmedium (Biochrom). Specimenswere fixed in 4%PFA/
PBS, transferred to methanol, and stored at220°C before immunofluo-
rescence or in situhybridization analyses. PCR genotypingwas performed
on genomic DNAprepared from yolk sac or tail biopsies. For conditional
lineage tracing experiments, tamoxifen (Sigma) was dissolved in pure
ethanol at 100 mg/ml and then emulsified in corn oil (Sigma) to a final
concentration of 12.5 mg/ml. Within 1 week, three times 5 mg of tamox-
ifen were given to 14-week-old mice via oral gavage. Urogenital systems
were harvested 4 weeks thereafter. All animal work conducted for this
study was performed according to European and German legislation.
Histologic Analysis
Embryos, urogenital systems, and ureters were paraffin-embedded
and sectioned to 5 mm. Hematoxylin and eosin staining was per-
formed according to standard procedures.
In Situ Hybridization Analysis
Nonradioactive in situ hybridization analysis of gene expression was
performed on 10 mm paraffin sections of the proximal ureter with
digoxigenin-labeled antisense riboprobes.25 At least three embryos
of each genotype were used for each analysis.
Immunofluorescence Detection of Antigens
For immunofluorescence analysis on 5 mm paraffin sections poly-
clonal rabbit–anti-TAGLN (1:250, ab14106; Abcam), monoclonal
mouse–anti-GFP (1:250, 11814460001; Roche), polyclonal rabbit–
anti-GFP (1:250, sc-8334; Santa Cruz), monoclonal mouse–anti-
ACTA2 (1:250, A5228; Sigma-Aldrich), polyclonal rabbit–anti-∆NP63
(1:250, 619001; BioLegend), polyclonal rabbit–anti-KRT5 (1:250,
PRB-160P; Covance), monoclonal mouse–anti-KRT14 (1:250, ab7800;
Abcam), monoclonal mouse–anti-UPK1B (1:250, WH0007348M2;
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Sigma-Aldrich), polyclonal rabbit–anti-POSTN (1:250, ab14041;
Abcam), monoclonal mouse–anti-BrdU (1:250, 1170376; Roche),
or polyclonal rabbit–anti-CDH1 (1:250, gift from Rolf Kemler)
were used as primary antibodies. Biotinylated goat–anti-rabbit
IgG (1:250, 111065033; Dianova), Alexa488-conjugated goat–
anti-rabbit IgG (1:500, A11034; Molecular Probes), and
Alexa555-conjugated goat–anti-mouse IgG (1:500, A21422; Molec-
ular Probes) were used as secondary antibodies. The signals of
BrdU, ∆NP63 and POSTN primary antibodies were amplified using
the Tyramide Signal Amplification system (NEL702001KT; Perkin
Elmer). For coimmunofluorescence with primary antibodies from
the same host (∆NP63 and KRT5) detectionwas performed sequen-
tially and epitopes of the first antibody were blocked with goat–
anti-rabbit Fab (1:250, 111007003; Dianova). Before staining, paraffin
sections were deparaffinized and cooked for 15 minutes in antigen un-
masking solution (H-3300; Vector Laboratories). Nuclei were stained
with 49,6-diamidino-2-phenylindole (DAPI). At least three embryos of
each genotype were used for each analysis.
Three-Dimensional Reconstruction of S cells
For three-dimensional reconstruction of S cells in the adult ureter 28
consecutive 5mm transverse paraffin sections were stained for CDH1
and DAPI as described above. CDH1 and DAPI signals were used
to highlight cell boundaries and nuclei that were reconstructed
with the Amira 5.3.3 software (FEI).
Cell Proliferation Assay
Cell proliferation rates in wildtype ureters (n=3 per stage) were in-
vestigated by the detection of incorporated BrdU on 5 mm paraffin
sections similar to published protocols.26 For embryonic stages the
BrdU incorporation time was 1 hour; for adult ureters incorporation
time was 10 hours due to low cell division rates. For each specimen 12
sections of the proximal ureter were assessed. The BrdU-labeling
index was defined as the number of BrdU-positive nuclei relative to
the total number of nuclei as detected by DAPI counterstaining in
arbitrarily or molecularly defined compartments of the ureter. Data
were expressed as mean6SD.
Organ Cultures
Ureters were dissected from the embryo, explanted on 0.4 mm
polyester membrane Transwell supports (Corning), and cultured
at the air-liquid interface for 24 hours with DMEM/F12 (Gibco)
supplemented with 10% FCS (Biochrom), 13 penicillin/streptomycin
(Gibco), 13 pyruvate (Gibco), and 13 Glutamax (Gibco). 4-
Hydroxytamoxifen (H7904; Sigma-Aldrich) was added to the me-
dium at a final concentration of 500 nM for the first 24 hours of
culture to induce recombination. Culture medium was replaced
every day.
Image Analysis
Sections were photographed using a Leica DM5000 microscope with
Leica DFC300FX digital camera or a Leica DM6000 microscope with
Leica DFC350FX digital camera and afterward processed in Adobe
Photoshop CS4.
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Supplemental Data 
 
Supplemental Figures 
 
 
Supplemental Figure 1. S-cells in the ureter are binucleate. (A) Immunofluorescence analysis of 
CDH1 expression with nuclear DAPI counterstain (blue) on transverse sections of a proximal 
ureter at P220. White arrowheads point towards binucleated S-cells. (B) Three-dimensional 
reconstruction of a single S-cell harboring two nuclei based on serial sections of an adult ureter 
stained as in (A). a, apical; b, basal.  
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Supplemental Figure 2. Cellular differentiation in the ureteric mesenchyme proceeds in a 
proximal to distal fashion. Immunofluorescence analysis of the SMC markers TAGLN (A) and 
ACTA2 (B) with nuclear DAPI (blue) on transverse sections of E14.5, E15.5, E16.5 and E18.5 
ureters sectioned each at a proximal (upper row), medial (middle row) and distal (lower row) level. 
Expression of differentiation markers at the proximal ureter level precedes their expression at more 
distal levels by approximately one day.  
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Supplemental Figure 3. Cellular differentiation in the ureteric epithelium proceeds in a proximal to 
distal fashion. Immunofluorescence analysis of the urothelial markers ∆NP63/KRT5 (A) and 
UPK1B (B) with nuclear DAPI (blue) on transverse sections of E14.5, E15.5, E16.5 and E18.5 
ureters sectioned each at a proximal (upper row), medial (middle row) and distal (lower row) level. 
Expression of differentiation markers at the proximal ureter level occurs approximately one day 
earlier than at the distal level.  
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Supplemental Figure 4. Gene expression during ureter development confirms specificity of cre 
driver lines. (A-D) In situ hybridization analysis of gene expression on proximal sections of the 
mouse ureter at the indicated stages. (A) Foxd1 expression is restricted to the outer mesenchymal 
domain at E12.5 and E14.5 while (B) Axin2 mRNA is found only in the inner mesenchymal domain 
at these two stages. (C) Pax2 expression is confined to the ureteric epithelium at E12.5 and E14.5. 
(D) Shh mRNA is expressed in the ureteric epithelium from E12.5 to E18.5 with reduced 
expression at E16.5.  
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Supplemental Figure 5. The Upk3a-GCE driver line mediates loxP-recombination in I- and S-cells 
but not in B-cells. Co-immunofluorescence analysis of expression of cytoplasmic GFP in the GFP-
creRT2 fusion protein expressed from the Tg(Upk3a-GFP/cre/ERT2)26Amc (Upk3a-GCE) 
transgene with nuclear DAPI (blue) and the B-cell marker KRT5 (upper row) and the I- and S-cell 
marker UPK1B (lower row) on proximal sections of a ureter at the indicated embryonic stages. 
GFP and KRT5 expression is mutually exclusive while GFP overlaps with UPK1B showing that the 
GFP-creERT2 fusion protein, thus, cre activity is confined to I- and S-cells.  
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Supplemental Figure 6. KRT14 expression marks a small subpopulation of KRT5+ B-cells in the 
adult ureter. Co-immunofluorescence analysis of expression of KRT14 and the B-cell marker KRT5 
with nuclear DAPI counterstain (blue) on transverse sections of the proximal ureter (upper row) 
and on mid-sagital sections of the bladder (lower row) at the indicated stages. In the ureter, KRT14 
expression is found in few KRT5+ B-cells in the P40 adult only (white arrowheads) whereas KRT14 
marks a large subpopulation of KRT5+ B-cells in the bladder from E16.5 onwards. 
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Supplemental Tables  
 
 
Stage	 Undiff.	(%)		 TA-cells	(%)		 SM-cells	(%)		 LP-cells	(%)		
E12.5	 100	 0	 0	 0	
E13.5	 57.1	±	6.1	 42.9	±	6.1	 0	 0	
E14.5	 47.8	±	3.3	 52.2	±	3.3	 0	 0	
E15.5	 34.6	±	8.1	 54.3	±	2.2	 11.1	±	8.3	 0	
E16.5	 15.5	±	7.2	 49.2	±	4.5	 26.2	±	6.2	 9.1	±	1.1	
E18.5	 0	 53.7	±	3.6	 37.0	±	2.3	 9.3	±	1.4	
P40	 0	 15.0	±	1.1	 62.6	±	2.9	 22.4	±	2.8	
 
Supplemental Table 1A. Distribution of mesenchymal cell types during ureter development. 
Values are displayed in % as mean ± sd of undifferentiated cells (Undiff.), adventitial cells (TA-
cells), smooth muscle cells (SM-cells) and Lamina propria cells (LP-cells) with respect to the total 
cell number. Quantification is based on 6 sections from three individuals at each stage. 
 
 
 
Stage	 Undiff.	(%)		 B-cells	(%)		 I-cells	(%)		 S-cells	(%)		
E12.5	 100	 0	 0	 0	
E13.5	 97.4	±	4.3	 0	 2.6	±	4.3	 0	
E14.5	 17.5	±	8.9	 0	 82.5	±	8.9	 0	
E15.5	 0	 0	 95.5	±	1.6	 4.5	±	1.6	
E16.5	 0	 37.9	±	9.8	 39.5	±	8.8	 22.5	±	2.4	
E18.5	 0	 53.8	±	5.1	 26.9	±	4.8	 19.4	±	3.8	
P40	 0	 71.3	±	3.2	 21.8	±	3.6	 6.9	±	1.5	
 
Supplemental Table 1B. Distribution of epithelial cell types during ureter development. Values are 
displayed in % as mean ± sd of undifferentiated cells (Undiff.), basal cells (B-cells), intermediate 
cells (I-cells) and superficial cells (S-cells) with respect to the total cell number. Quantification is 
based on 6 sections from three individuals at each stage. 
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Stage	 IM			 OM		 UE			
E12.5	 0.236	±	0.030	 0.217	±	0.017	 0.228	±	0.028	
E14.5	 0.198	±	0.009	 0.202	±	0.014	 0.230	±	0.013	
 
Supplemental Table 2A. Proliferation rates in the developing ureter at E12.5 and E14.5. Shown 
are the BrdU indices for the inner mesenchymal domain (IM), the outer mesenchymal domain 
(OM) and the ureteric epithelium (UE). The BrdU index is displayed as mean ± sd, 12 sections 
from three individuals were used for quantification.  
 
 
 
Stage	 LP			 SMC			 TA		
E16.5	 0.233	±	0.022	 0.191	±	0.008	 0.122	±	0.007	
E18.5	 0.267	±	0.025	 0.134	±	0.009	 0.081	±	0.004	
P40	 0.003	±	0.002	 0	 0.008	±	0.003	
 
Supplemental Table 2B. Proliferation rates in the ureteric mesenchyme at E16.5, E18.5 and at 
P40. Shown are the BrdU indices for the inner Lamina propria (LP), the smooth muscle cells 
(SMC) and the Tunica adventitia (TA). The BrdU index is displayed as mean ± sd, 8 sections from 
three individuals were used for quantification.  
 
 
 
Stage	 BC			 IC			 SC		
E16.5	 0.203	±	0.040	 0.098	±	0.008	 0.175	±	0.022	
E18.5	 0.035	±	0.012	 0.014	±	0.009	 0.087	±	0.024	
P40	 0.001	±	0.002	 0	 0	
 
Supplemental Table 2C. Proliferation rates in the ureteric epithelium at E16.5, E18.5 and at P40. 
Shown are the BrdU indices for basal cells (BC), intermediate cells (IC) and superficial cells (SC). 
The BrdU index is displayed as mean ± sd, 8 sections from three individuals were used for 
quantification. 
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Stage	 IM	(%)		 OM	(%)		 Numbers		
E12.5	+	1d	 76.7	±	5.3	 23.3	±	5.3	 269	
E13.5	+	1d	 94.3	±	3.5	 5.7	±	3.5	 129	
 
Supplemental Table 3A. Lineage labelling in the ureteric mesenchyme of Axin2creERT/+;R26mTmG/+ 
embryos that were Tamoxifen-induced at E12.5 or E13.5 and analysed for distribution of 
recombined GFP+ cells 24 h later. Values are displayed in % as mean ± sd of all GFP-labelled cells 
found in the inner (IM) or outer (OM) mesenchymal compartment of the ureter. Additionally, the 
total number of GFP+ cells detected in a total of four individuals is displayed. 
 
 
 
Stage	 LP	(%)		 SMC	(%)		 TA	(%)		 Numbers	
E12.5	+	6d	 18.0	±	2.8	 70.7	±	0.6	 11.3	±	2.6	 521	
E13.5	+	5d	 17.1	±	4.4	 73.2	±	4.0	 9.7	±	4.6	 583	
 
Supplemental Table 3B. Lineage tracing in the ureteric mesenchyme of Axin2creERT/+;R26mTmG/+ 
embryos that were tamoxifen-induced at E12.5 or E13.5 and analysed for distribution of 
recombined GFP+ cells 6 or 5 days later. Values are displayed in % as mean ± sd of all GFP-
labelled cells found in the Lamina propria (LP), smooth muscle layer (SMC) or Tunica adventitia 
(TA) of the ureter. Additionally, the total number of GFP+ cells detected in a total of four individuals 
is displayed. 
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Stage	 KRT5
+
	UPK1B
-
	(%)		 KRT5
-	
UPK1B
+
	(%)		 Numbers	
E14.5	+	10d	 0	 0	 0	
E16.5	+	8d	 100	 0	 135	
E18.5	+	6d	 100	 0	 409	
Adult	+	4w	 100	 0	 552	
 
Supplemental Table 4A. Lineage tracing in Krt5creERT2/+;R26mTmG/+ ureter explants from E14.5, 
E16.5 and E18.5 mice cultured for 10 d, 8 d, and 6 d, respectively, and in adult mice after 4 weeks 
of labelling. First row: KRT5+UPK1B-. Values are displayed in % as mean ± sd of all GFP-labelled 
cells found in the KRT5+UPK1B- basal cell layer. Second row: KRT5-UPK1B+. Values are displayed 
in % as mean ± sd of all GFP-labelled cells found in the KRT5-UPK1B+ intermediate and superficial 
cell layers. Third row: Numbers. Total number of GFP+ cells detected in a total of three individual 
ureters.   
 
 
 
Stage	 KRT5
+
	UPK1B
-
	(%)		 KRT5
-
	UPK1B
+
	(%)		 Numbers		
E14.5	+	10d	 31.7	±	14.4	 68.3	±	14.4	 113	
E16.5	+	8d	 57.1	±	9.4	 42.9	±	9.4	 271	
E18.5	+	6d	 55.0	±	13.4	 45.0	±	13.4	 384	
Adult	+	4w	 41.7	±	1.2	 58.3	±	1.2	 652	
 
Supplemental Table 4B. Lineage tracing in Upk3a-GCE/+;R26mTmG/+ ureter explants from E14.5, 
E16.5 and E18.5 mice cultured for 10 d, 8 d, and 6 d, respectively, and in adult mice after 4 weeks 
of labelling.  First row: KRT5+UPK1B-. Values are displayed in % as mean ± sd of all GFP-labelled 
cells found in the KRT5+UPK1B- basal cell layer. Second row: KRT5-UPK1B+. Values are displayed 
in % as mean ± sd of all GFP-labelled cells found in the KRT5-UPK1B+ intermediate and superficial 
cell layers. Third row: Numbers. Total number of GFP+ cells detected in a total of three individual 
ureters.   
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Abstract 
The differentiated cell types of the epithelial and mesenchymal tissue compartments of the ma-
ture ureter arise in a precisely coordinated temporal and spatial sequence from uncommitted 
precursor cells of the distal ureteric bud and its surrounding mesenchyme. How cellular pro-
grams are coupled between the two progenitor pools has remained largely unexplored. Here, 
we showed that conditional deletion of the gene encoding the Hedgehog (HH) signal transducer 
Smoothened (Smo) in the early ureteric mesenchyme of the mouse resulted in apoptosis of outer 
mesenchymal cells, reduced proliferation of inner mesenchymal and epithelial cells and failure 
of the latter two populations to differentiate into smooth muscle and urothelial cell types, re-
spectively. Complementary expression of a constitutively active form of SMO led to adventitial 
cell survival and enhanced proliferation but did not affect patterning and differentiation of inner 
mesenchymal and epithelial cells. We identified the Forkhead transcription factor gene Foxf1 
as a target of HH signaling in the ureteric mesenchyme. Expression of a repressor version of 
FOXF1 in the ureteric mesenchyme completely recapitulated the mesenchymal and epithelial 
proliferation and differentiation defects associated with loss of HH signaling; re-expression of 
a wildtype version of FOXF1 in the inner mesenchymal layer restored these cellular programs 
when HH signaling was inhibited. We further showed that expression of Bmp4 in the ureteric 
mesenchyme depends on HH signaling and Foxf1, and that exogenous BMP4 rescued cell pro-
liferation and epithelial differentiation in ureters with abrogated HH signaling or FOXF1 func-
tion. We conclude that SHH is the crucial epithelial signal that couples the proliferation and 
differentiation programs in the two tissue compartments of the developing ureter via a FOXF1-
BMP4 regulatory module.  
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Author summary 
The mammalian ureter is a simple tube with a specialized multi-layered epithelium, the urothe-
lium, and a surrounding coat of fibroblasts and peristaltically active smooth muscle cells. Be-
side its important function in urinary drainage the ureter represents a simple model system to 
study epithelial and mesenchymal tissue interactions in organ development. The differentiated 
cell types of the ureter coordinately arise from precursor cells of the distal ureteric bud and its 
surrounding mesenchyme. How their survival, growth and differentiation is regulated and co-
ordinated within and between the epithelial and mesenchymal tissue compartments is largely 
unknown. Previous work has identified sonic hedgehog (SHH) as a crucial epithelial signal for 
growth and differentiation of the ureteric mesenchyme, but the entirety of the cellular functions 
and the molecular mediators of its mesenchymal signaling pathway have remained obscure. 
Here we showed that epithelial SHH acts paracrine in the ureteric mesenchyme to activate a 
FOXF1-BMP4 regulatory module that directs growth and differentiation of both ureteric tissue 
compartments. HH signaling additionally acts in outer mesenchymal cells as a survival factor. 
Thus, SHH is an epithelial signal that coordinates various cellular programs in early ureter de-
velopment. 
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Introduction 
The ureter is a pivotal component of the urinary system by warranting the efficient removal of 
the urine from the renal pelvis to the bladder. This task is accomplished by the compartmental-
ized organization of the straight tube into an outer flexible but rigid peristaltically active mes-
enchymal coat with contractile smooth muscle cells (SMCs) and surrounding fibrocytes of the 
inner Lamina propria and the outer Tunica adventitia, and a highly distensible yet tightly seal-
ing specialized inner epithelial lining. This urothelium features at the luminal side large binu-
cleate superficial (S-) cells that exert barrier function at least partly due to expression of uro-
plakins (UPKs) that form crystalline plaques on the surface. Underneath are two layers of 
smaller intermediate (I-) and basal (B-) cells that serve as precursors in injury conditions and 
tether the underlying fibrocytes, respectively [1-4].  
Although the tissue architecture of the ureter is obviously much less complex compared to the 
adjacent kidney, our knowledge on the cellular and molecular programs that drive the growth 
and differentiation of this organ from a simple embryonic rudiment have only recently begun 
to be elucidated [5]. Cell lineage and marker analyses in the mouse have shown that the different 
epithelial and mesenchymal cell types of the ureter arise in a highly coordinated fashion from 
uncommitted progenitors that are established around embryonic day (E)11.5 from two inde-
pendent precursor pools in the early metanephric field: the distal portion of the ureteric bud and 
its surrounding mesenchyme [4]. At E12.5, the initially homogenous ureteric mesenchyme is 
radially subdivided into an inner layer of large cuboidal cells, and an outer layer of tangentially 
oriented loosely organized cells. While the latter start to differentiate into adventitial fibrocytes 
from E13.5 onwards, the first maintain a bipotential character until E15.5 when they differen-
tiate into SMCs, and subepithelial fibrocytes of the Lamina propria. Urothelial differentiation 
starts around E14.5 with the establishment of a common progenitor for S- and B-cells, the I-
cell that expresses ∆NP63 and low levels of UPKs. At E15.5, first luminal cells downregulate 
∆NP63 and express high levels of UPKs to become S-cells. KRT5+ B-cells are first recognized 
at E16.5. They substantially expand thereafter to constitute the major cell type of the adult 
urothelium [4]. 
Survival, growth and differentiation of the ureteric mesenchyme and epithelium are tightly cou-
pled and rely on the exchange of signals between and within the two tissues [5-7]. While our 
knowledge of the signaling systems that underlie urothelial development has remained scarce, 
WNTs, BMP4 and SHH have been identified as crucial signals for SMC differentiation in the 
mesenchyme [8-11]. The latter is expressed in the ureteric epithelium throughout development 
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and is thought to act in a paracrine fashion onto the adjacent mesenchyme. Deletion of Shh from 
the epithelium resulted in reduced mesenchymal proliferation and delayed SMC differentiation, 
and culminated in hydroureter, i.e. dilatation of the ureter by urinary pressure [8]. The molecu-
lar targets of SHH signaling are poorly understood. So far, expression of the genes encoding 
the transcription factor TSHZ3 and the signaling molecule BMP4 have been described to de-
pend on SHH pathway activity in the ureteric mesenchyme [8, 12]. Both genes are essential for 
SMC differentiation arguing that they mediate some part of SHH function [9, 12]. Canonical 
WNT signaling is also required for SMC differentiation and may act in parallel to SHH in this 
process [10].  
Here, we further explore the cellular and molecular functions of HH signaling in the ureteric 
mesenchyme. We show that HH signaling is not only required for mesenchymal proliferation 
and differentiation but also acts as a mesenchymal survival factor and is essential for growth 
and differentiation of the ureteric epithelium. We provide evidence for a mesenchymal FOXF1-
BMP4 module acting downstream of HH signaling in the execution of these programs. 
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Results 
Conditional inactivation of Smo in the ureteric mesenchyme results in hy-
droureter formation due to functional insufficiencies of its tissue compart-
ments 
To investigate the functional requirement of HH signaling in ureter development, we employed 
a conditional gene inactivation approach using a Tbx18cre line [13] and a floxed allele of Smo 
(Smofl) [14] which encodes a unique signal transducer of this pathway [15]. As previously re-
ported, Tbx18cre mediates recombination in the undifferentiated ureteric mesenchyme from 
E10.5 onwards, i.e. in the precursors of all differentiated cell types of the ureteric wall [10, 16]. 
At E18.5, urogenital systems of Tbx18cre/+;Smofl/fl (SmoLOF) mice displayed with full penetrance 
in both sexes complete bilateral hydroureter (Fig 1A-1D). Histological analyses revealed a re-
duced pelvic space in mutant kidneys. The ureter was strongly dilated and featured a mono-
layered urothelium that was surrounded by fibroelastic material (Fig 1E-1H). Expression of the 
structural components of the SMC layer ACTA2, MYH11 and Tnnt2 as well as of the key 
regulator of the SMC transcriptional program Myocd was completely absent in the mutant ureter 
(Fig 1I-1P). Differentiation of urothelial cell types was also severely compromised in the mu-
tant ureter as indicated by a strong decrease in expression of the B- and I-cell markers KRT5 
and ∆NP63, and absence of superficial UPK1B expression (Fig 1Q-1T). To test for the conti-
guity of the ureteric lumen and the patency of the uretero-pelvic and vesicular junctions, we 
injected ink into the renal pelvis. Under conditions of increased hydrostatic pressure, the ink 
readily drained to the bladder both in control and SmoLOF urogenital systems. Furthermore, the 
ureters in SmoLOF embryos terminated in the bladder neck as in the control, arguing together 
that physical obstruction does not cause or contribute to the hydroureter phenotype in SmoLOF 
urogenital systems (Fig 1U-1X). Control ureters explanted at E14.5 and cultured for 4 days 
elongated and performed unidirectional peristaltic contractions within 2 days of culture. In con-
trast, SmoLOF ureters were strongly hypoplastic when explanted and degenerated in culture with-
out showing any signs of contractile activity (Fig 1Y-1Z’). Hence, lack of Smo, i.e. of HH 
signaling, in the ureteric mesenchyme results in tissue hypoplasia, a complete lack of differen-
tiated mesenchymal and epithelial cell types and hydroureter formation at birth. 
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Figure 1: Tbx18cre/+;Smofl/fl (SmoLOF) embryos exhibit severe ureter defects at E18.5. (A-D) Morphology of whole urogen-
ital systems of male (A,B) and female (C,D) embryos. Arrows point to hydroureters in SmoLOF embryos. (E-H) Hematoxylin 
and Eosin (HE) stainings on midsagittal sections of the kidney (E,F) and of the proximal ureter (G,H). (I-T) Cytodifferentiation 
of the ureteric mesenchyme (I-P) and urothelium (Q-T) is compromised in SmoLOF embryos as shown by immunofluorescence 
(I-L,Q-T) or RNA in situ hybridization (M-P) analysis on transverse sections of the proximal ureter. (U-X) Absence of physical 
obstruction in the SmoLOF ureter as revealed by ink injection experiments (U,V) and HE stainings of the vesicoureteral junction 
(W,X). (Y-Z’) Explants of E14.5 ureters after 0d and 4d of culture. Genotypes and markers are as shown. 
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SmoLOF ureters show early hypoplasia and do not initiate the SMC and 
urothelial differentiation programs 
To characterize the onset and progression of the growth and differentiation defects in SmoLOF 
ureters, we performed histological and molecular analysis at earlier embryonic stages (Fig 2A-
2F). At E12.5, SmoLOF ureters appeared histologically unremarkable. The mono-layered ureteric 
epithelium was surrounded by up to two layers of spherical, densely packed mesenchymal cells 
with a clear compartment boundary to the outer spindle-shaped and radially oriented cells as in 
the control, indicating that initial tissue patterning of the ureteric mesenchyme was normal (Fig 
2A, left panel). At E14.5, the urothelium of control embryos started to stratify and appeared 
occasionally double-layered, the compartmentalization of the ureteric mesenchyme was en-
hanced. In contrast, the SmoLOF urothelium remained mono-layered and the mesenchymal cell 
mass was sparse (Fig 2A, middle panel). At E16.5, the onset of substantial urine production in 
the embryonic kidney, SmoLOF mutants showed a strongly dilated ureter with a mono-layered 
urothelium surrounded by loosely packed fibrocytes (Fig 2A, right panel). 
To characterize the initiation and progression of ureteric SMC differentiation we analyzed the 
expression of the regulatory gene Myocd as well as of the SMC structural genes Myh11 and 
Tagln. Myocd expression was homogenously strong in the wildtype at E14.5 and E16.5 whereas 
Myh11 and Tagln expression was spotty at E14.5 and became stronger at E16.5. SmoLOF ureters 
never expressed any of these markers, indicating that SMC differentiation was not initiated in 
the mutants (Fig 2B-2D). Urothelial differentiation started in the wildtype at E14.5 with the 
expression of ∆NP63 and continued at E16.5 with the appearance of ∆NP63+KRT5+ B-cells 
and UPK1B+∆NP63- S-cells. In SmoLOF mutant ureters, only few cells expressed ∆NP63 at low 
levels at E16.5, KRT5 expression and UPK1B was not observed (Fig 2E and 2F). Taken to-
gether, SmoLOF ureters develop severe mesenchymal and epithelial hypoplasia and fail to initiate 
the SMC and urothelial differentiation programs. 
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Figure 2: Ureter anomalies arise early in Tbx18cre/+;Smofl/fl (SmoLOF) embryos.  
(A) Hematoxylin and Eosin (HE) stainings of transverse sections of the proximal ureter at E12.5, E14.5, and E16.5. (B-D) 
Cytodifferentiation of the ureteric mesenchyme into SMCs as detected by in situ hybridization of expression of SMC marker 
genes, and (E,F) cytodifferentiation of the ureteric epithelium as detected by immunofluorescence of B-, I- and S-cell markers 
fail in SmoLOF embryos. Nuclei are counterstained with DAPI (blue). (G) Cell death as detected by the TUNEL assay (green) 
occurs in the outer mesenchymal region of SmoLOF ureters at E12.5. Nuclei are counterstained with DAPI. (H) Determination 
of cellular proliferation by the BrdU incorporation assay on transverse sections of the proximal ureter at E12.5 and E14.5. Black 
circles in H mark the epithelium (ue) and the inner (im) and outer (om) mesenchymal compartments of the ureter that were 
analyzed to quantify proliferation. Proliferation in SmoLOF embryos is reduced in the inner mesenchymal region and the epithe-
lium of the E12.5 ureter. (I) Quantification of BrdU-positive cells. E12.5 (n=3), wildtype versus mutant: IM, 0.267±0.030 vs 
0.155±0.006, P=0.007; OM, 0.176±0.025 vs 0.169±0.009, P=0.709; UE, 0.190±0.079 vs 0.071±0.019, P=0.019. E14.5 (n=4), 
wildtype versus mutant: IM, 0.208±0.015 vs 0.205±0.014, P=0.839; OM, 0.191±0.013 vs 0.185±0.033, P=0.774; UE, 
0.196±0.068 vs 0.222 ±0.037, P=0.526. Values are displayed as mean ± sd. *, P≤0.05; **, P≤0.01; two-tailed Student’s t-test.  
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HH signaling is required for survival and proliferation programs in the un-
differentiated ureteric tissues 
To address the cellular causes for the severe tissue hypoplasia observed in SmoLOF ureters, we 
examined survival and proliferation in the epithelial and mesenchymal tissue compartments 
(Fig 2G-2I). We used the terminal dUTP nick end-labeling (TUNEL) assay to detect apoptotic 
bodies. At E12.5, only few apoptotic bodies were detected in control specimens whereas 
SmoLOF ureters showed numerous strong signals specifically in the outer mesenchymal com-
partment. At E14.5, no signals were detected in either control or mutant ureters (Fig 2G). To 
assess proliferation rates, we performed bromodeoxyuridine (BrdU) incorporation assays. At 
E12.5, SmoLOF ureters showed significantly decreased proliferation in the inner mesenchymal 
compartment and the epithelium; outer mesenchymal cells proliferated at normal rates. At 
E14.5, no changes in proliferation were observed in SmoLOF ureters (Fig 2H and 2I). We con-
clude that Smo is required for the survival of the outer mesenchymal compartment and the pro-
liferation of inner mesenchymal and epithelial cells, specifically at E12.5. 
SmoGOF ureters develop severe mesenchymal hyperplasia but show nor-
mal tissue patterning and differentiation 
The analysis of the Smo loss-of-function phenotype revealed a critical requirement of HH sig-
naling in survival, growth and differentiation of the ureter. To test for a possible sufficiency in 
these cellular processes we performed a complementary gain-of-function study by conditional 
(Tbx18cre-mediated) misexpression of a constitutive active form of Smo from the Rosa26 locus 
(R26SmoM2) [17] in the ureteric mesenchyme. Tbx18cre/+;R26SmoM2/+ (SmoGOF) embryos died 
around E12.5 possibly due to cardiovascular defects. To circumvent this lethality and enable an 
endpoint analysis of ureter differentiation, we explanted E11.5 kidney rudiments and cultured 
them for 8 days. We took advantage of a membrane-bound GFP reporter from the Rosa26mTmG 
reporter line [18] to visualize the descendants of the undifferentiated ureteric mesenchyme after 
Tbx18cre-mediated recombination. In Tbx18cre/+;R26mTmG/+ control explants, GFP+ cells initially 
localized to a band of mesenchymal cells that surrounded the ureter stalk and separated the 
metanephric mesenchyme from the nephric duct. In the following days, GFP+ cells became 
restricted to a condensed cell layer directly adjacent to the ureteric epithelium and to stromal 
cells of the medial kidney cortex as previously reported [16]. 
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In SmoGOF (Tbx18cre/+;R26mTmG/SmoM2) explants, GFP+ cells localized to these domains as well 
but additionally persisted in the lateral ureteric mesenchymal region to form a large ectopic cell 
mass after 4 and 8 days of culture (Fig 3A and 3B). Histological analysis on proximal ureter 
sections of SmoGOF E11.5 + 8d explants confirmed severe mesenchymal hyperplasia (Fig 3C 
and 3D). Coimmunofluorescence analysis of GFP and the SMC markers TAGLN and ACTA2 
revealed correct tissue compartmentalization into a GFP+TAGLN-ACTA2- Lamina propria ad-
jacent to the urothelium, a GFP+TAGLN+ACTA2+ SMC layer and an outer coat of GFP+TA-
GLN-ACTA2- adventitial fibroblasts. All three tissue compartments, particularly the adventitial 
layer were massively expanded in SmoGOF explants (Fig 3E-3H). Urothelial differentiation as 
analyzed by ∆NP63 and UPK1B expression was unaltered (Fig 3I and 3J). Markers of the Lam-
ina propria (Aldh1a2, Col1a2) and the Tunica adventitia (Col1a2 and Fbln2) showed normal 
spatial restriction but highlighted adventitial hyperplasia in SmoGOF ureters (Fig 3K-3P). Dpt 
expression which marks terminal differentiation of adventitial fibroblasts in vivo [10] was not 
detectable in explant cultures indicating that terminal differentiation of fibrocytes is hampered 
in this experimental setting (Fig 3Q and 3R). We conclude that mis- and overactivation of HH 
signaling in the ureteric mesenchyme leads to massive mesenchymal hyperplasia but does not 
affect tissue patterning or cell differentiation programs. 
HH signaling is sufficient to induce survival and proliferation of the ureteric 
mesenchyme 
To unravel the cellular cause of tissue hyperplasia in SmoGOF ureters, we analyzed both histol-
ogy, cell proliferation and apoptosis at the onset of ureter development. At E12.5, SmoGOF ure-
ters were shortened and surrounded by a large mass of fibrous tissue (Fig 4A and 4B). On the 
histological level, the subdivision of the ureteric mesenchyme into an inner region with large 
cuboidal cells and an outer region of more loosely organized tangentially oriented cell bodies 
was normal but the outer mesenchymal domain appeared strongly expanded (Fig 4C and 4D). 
The BrdU incorporation assay revealed significantly increased proliferation in the epithelium 
and the inner mesenchymal domain of SmoGOF ureters at E12.5 (Fig 4E-4G). Incorporation of 
Lysotracker (DND-99), a chromogenic marker for programmed cell death [19], into whole 
E11.5 explants after 1 day of culture indicated absence of apoptotic cells in the entire ureteric 
mesenchyme, with the lateral aspect of SmoGOF explants being most prominently affected (Fig 
4H and 4I). 
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Figure 3: Conditional activation of Smo in the ureteric mesenchyme leads to mesenchymal hyperplasia but normal 
tissue patterning and differentiation. (A,B) GFP/RFP epifluorescence in E11.5 kidney/ureter explants of 
Tbx18cre/+;R26mTmG/+ (control) and Tbx18cre/+;R26mTmG/SmoM2 (SmoGOF) embryos after 0, 2, 4 and 8 d of culture. (C-R) Analysis 
of proximal sections of ureter explants of E11.5 wildtype and Tbx18cre/+;R26mTmG/SmoM2 embryos cultured for 8 d by Hematox-
ylin and Eosin staining (C,D), immunofluorescence of SMC markers TAGLN and ACTA2 (E-H) and urothelial markers 
∆NP63/UPK1B (I,J), and in situ hybridization analysis of fibroblast markers Aldh1a2, Col1a2, Fbln2, Dpt (K-R). 
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Moreover, mesenchyme mechanically separated from the ureteric epithelium and cultured for 
6 days in the presence of 2 µM of the SMO agonist purmorphamine [20] survived while DMSO 
treated control explants disappeared (Fig 4J and 4K).  
These experiments show that tissue hyperplasia after mis- and overactivation of HH signaling 
in the ureteric mesenchyme is caused by a combination of reduced cell death in adventitial 
precursors and increased cell proliferation in SMC progenitors and the epithelial compartment. 
  
Figure 4: HH signaling is sufficient to maintain survival and proliferation of the ureteric mesenchyme. (A,B) Morphol-
ogy of whole urogenital systems of wildtype (control) and Tbx18cre/+;R26mTmG/SmoM2 (SmoGOF) embryos at E12.5. (C,D) Hema-
toxylin and Eosin staining on transverse sections of the proximal ureter at E12.5. (E,F) Determination of cellular proliferation 
by the BrdU incorporation assay on transverse sections of the proximal ureter at E12.5. Black circles in E and F mark the 
epithelium (ue) and the inner (im) and outer (om) mesenchymal compartments of the ureter that were analyzed to quantify 
proliferation. (G) Quantification of BrdU-positive cells. E12.5 (n=4), wildtype versus mutant: IM, 0.276±0.006 vs 
0.375±0.020, P=0.0001; OM, 0.214±0.015 vs 0.250±0.034, P=0.0966; UE, 0.167±0.080 vs 0.341±0.066, P=0.0211. Values 
are displayed as mean ± sd. *, P≤0.05; ***, P≤0.001 two-tailed Student’s t-test. (H,I) Analysis of cell death by Lysotracker 
(DND-99) incorporation of E11.5 control and SmoGOF explants after 1 day of culture. (J,K) GFP epifluorescence of E12.5 
Tbx18cre/+;R26mTmG/+ ureteric mesenchyme that was mechanically separated from the ureteric epithelium and cultured for 6 
days with DMSO or 2 µM Purmorphamine (Pur). 
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A number of genes critical for ureteric SMC differentiation completely or 
partially depend on HH signaling 
In order to analyze molecular changes that may have caused the defective differentiation of 
SMCs after abrogation of SHH signaling in the ureteric mesenchyme, we screened expression 
of a panel of genes that have been implicated in the early development of the ureteric mesen-
chyme and the initiation of the SMC program [5], by in situ hybridization analysis on sections 
of both SmoLOF and SmoGOF ureters (Fig 5).  
In E12.5 wild-type ureters, Ptch1, a direct target of HH signaling [21], Bmp4, Tshz3, Tcf21, 
Tbx18 and Sox9 were expressed throughout the mesenchymal compartment with increased lev-
els in cells adjacent to the epithelium. Expression of the target of canonical WNT signaling, 
Axin2 {Jho, 2002 #36}, was confined to the inner mesenchymal region. Expression of Ptch1, a 
transcriptional target of HH signaling [21], was completely lost in SmoLOF ureters and expanded 
at high levels to the outer mesenchymal region in SmoGOF ureters, confirming the suitability of 
our HH inactivation and misexpression approaches. Bmp4 expression was lost in SmoLOF ure-
ters, and increased in the inner mesenchymal ring in SmoGOF ureters. Expression of Axin2 was 
not affected by either condition. Tshz3, Tcf21, Tbx18 and Sox9 exhibited reduced expression in 
the ureteric mesenchyme in SmoLOF ureters, and were weakly expanded to the outer mesenchy-
mal domain in SmoGOF ureters. In E14.5 SmoLOF ureters, expression of Ptch1 and Bmp4 was 
lost while expression of Axin2, Tshz3, Tcf21, Tbx18 and Sox9 was maintained at low levels in 
the inner mesenchymal region (Fig 5). Together, these assays show that HH signaling is re-
quired but not sufficient to induce Bmp4 expression in the ureteric mesenchyme. Other genes 
relevant for SMC differentiation including Tcf21, Tbx18, Tshz3 and Sox9 partially depend on 
HH signaling, while canonical WNT signaling acts upstream or in parallel to this pathway in 
the ureteric mesenchyme.  
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Figure 5: Molecular characterization detects altered marker expression in the SmoLOF and SmoGOF ureteric mesen-
chyme. RNA in situ hybridization analysis on transverse sections of the proximal ureter region of control, SmoLOF and SmoGOF 
embryos at E12.5, and of control and SmoLOF embryos at E14.5. 
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Foxf1 is a target of HH signaling in the ureteric mesenchyme  
To get further insight into the spectrum of genes controlled by HH signaling in the ureteric 
mesenchyme, we wished to determine the global transcriptional changes caused by inhibition 
of the pathway in the ureter. Rather than comparing mutant (SmoLOF) and wildtype ureters, we 
deemed that pharmacological inhibition of HH signaling by the SMO antagonist cyclopamine 
[22, 23] in ureter explant cultures would provide a better handle to identify primary transcrip-
tional changes. Treatment of E12.5 ureters with 10 µM cyclopamine led to a robust down-
regulation of expression of the direct target of HH signaling Ptch1 in the ureteric mesenchyme 
(S1 Fig). Moreover, administration of 10 µM cyclopamine to E11.5 kidney/ureter explants for 
2 days led to a complete loss of ureteric SMC differentiation after 8 days of culture while inhi-
bition in later time intervals left this differentiation program unaffected (S2 Fig). Since these 
findings delimited the requirement of HH signaling in the ureteric mesenchyme to E11.5 to 
E13.5, we decided to treat E12.5 ureters with 10 µM cyclopamine for 18 h to perform microar-
ray profiling of differential gene expression with untreated controls. 
Using an intensity threshold of 150, we identified in two independent pools of treated and un-
treated ureters a small set of 20 genes that were consistently more than 2-fold downregulated 
and only one gene that was upregulated in expression in cyclopamine treated ureters (Fig 6A 
and S1 Table). Among the downregulated transcripts were the three bona fide SHH target genes 
Hhip (-11.9x), Ptch1 (-3.2x) and Gli1 (-2.3x), confirming the specificity of our assay [21, 24-
27]. Another group of prominently downregulated transcripts comprised three members of the 
forkhead transcription factor family, Foxf1 (-5.3x), Foxl1 (-3.9x) and Foxf2 (-3.3x), which have 
been reported to be primary SHH target genes in several other contexts [28-30] (Fig 6B). Inter-
estingly, we did not find Tcf21, Tshz3, Tbx18 and Bmp4 in the list of top-downregulated genes 
suggesting that their change in expression in SmoLOF ureters is secondary in nature. To validate 
our microarray results and determine the spatial expression of selected candidates we performed 
in situ hybridization analysis on proximal sections of E12.5 control SmoLOF and SmoGOF and of 
E14.5 control and SmoLOF ureters (Fig 6C and S3 Fig). Hhip expression was barely detectable 
at E12.5 and E14.5 in the ureteric mesenchyme of wildtype embryos but was abrogated in 
SmoLOF and weakly induced in SmoGOF ureters. Gli1 was strongly expressed in the entire ure-
teric mesenchyme at E12.5 in the control and completely lost in SmoLOF and induced in SmoGOF 
ureters. At E14.5, the expression in the inner mesenchymal compartment was HH signaling-
dependent whereas outer mesenchymal cells expressed normal levels of Gli1. Foxf1 expression 
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was detectable at E14.5 in the inner mesenchymal compartment of wildtype embryos. Expres-
sion was completely lost in SmoLOF ureters at this stage but was not induced in SmoGOF ureters 
at E12.5. Expression of Ddit4l (-3.2x) and Avpr1a (-2.5x) was detected in the inner mesenchy-
mal compartment of controls at E12.5, and was down-regulated in SmoLOF but not induced in 
SmoGOF ureters (Fig 6C). The sensitivity of the method was not sufficient to detect expression 
of Foxl1, Foxf2, Crym, Ndp and Wif1 (S3 Fig). Together, these assays identify Foxf1, Ddit4l 
and Avpr1a as novel targets of SHH signaling in the ureteric mesenchyme. 
  
Figure 6: Microarray analysis detects transcriptional changes after loss of HH signaling in the ureteric mesenchyme. 
(A) Pie-chart summarizing the results from the microarray analysis of E12.5 ureters explanted and treated with DMSO or 10 
µM cyclopamine for 18 h filtered with an intensity (Int) threshold of 150 and a fold change (FC) cut-off of 2.0. (B) Table of 
the downregulated transcripts. Shown are average intensities of transcripts in control and cyclopamine treated ureters and 
average fold changes (FC) of RNA intensities between the pools in two independent experiments. (C) In situ hybridization 
analysis of expression of microarray candidates on proximal ureter sections of control, Tbx18cre/+;Smofl/fl (SmoLOF) and 
Tbx18cre/+;R26mTmG/SmoM2 (SmoGOF) ureters at E12.5 and E14.5. 
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Foxf1 is required for proliferation and cell differentiation in the developing 
ureter  
Previous work identified prominent functions for Foxf1 and Foxf2 as targets of epithelial SHH 
signals in SMC differentiation of the intestinal mesenchyme [29]. Given that Foxf1 is expressed 
in the ureteric mesenchyme at E14.5, i.e. prior to the onset of SMC and S-cell differentiation, 
we wondered whether this transcription factor mediates part of the function of HH signaling in 
these programs in the ureteric mesenchyme. To test this hypothesis, we used a conditional 
Cre/loxP-based transgenic approach to misexpress a dominant negative version of FOXF1 in 
the ureteric mesenchyme in vivo. We deemed such a strategy more efficient than a conditional 
knockout considering the possible redundancy of Foxf1 and Foxf2. We generated the dominant 
negative version of FOXF1 by fusing the open reading frame of this transcriptional activator to 
a cDNA fragment harboring the strong transcriptional repression domain of the Drosophila 
ENGRAILED (ENG) protein [31, 32]. This coding region was followed by a fragment encoding 
an IRES-GFP sequence to allow visualization of misexpressing cells. The bicistronic transgene-
cassette was integrated in the ubiquitously expressed X-chromosomal Hypoxanthine guanine 
phosphoribosyl transferase (Hprt) locus (HprtFoxf1DN) [33, 34]. Transgene expression was 
driven by the Tbx18cre line. Due to random X-chromosome inactivation, female 
Tbx18cre/+;HprtFoxf1DN/+ embryos possessed a mosaic expression. Male Tbx18cre/+;HprtFoxf1DN/y 
(Foxf1DN) embryos expressed the transgene in a uniform manner and were subsequently used 
for phenotypic analysis. 
Since Foxf1DN embryos died shortly after E14.5, we explanted E14.5 control and Foxf1DN 
ureters and cultured them for 6 days to assess tissue integrity and terminal differentiation. He-
matoxylin and eosin staining of sections demonstrated mesenchymal hypoplasia and a reduction 
of the urothelium from three to two cell layers in cultured Foxf1DN ureters (Fig 7A and 7B). 
Immunofluorescence analysis revealed a strong reduction of TAGLN and ACTA2 expression 
and absence of ∆NP63/UPK1B indicating severely compromised mesenchymal and epithelial 
cell differentiation in Foxf1DN ureters at this stage (Fig 7C-7F). 
To characterize the onset of these phenotypical changes, we analyzed earlier embryonic stages 
of Foxf1DN ureters. Hematoxylin and eosin stainings at E12.5 and E14.5 revealed no dramatic 
effects on overall tissue size in the epithelial and mesenchymal compartments of the mutant 
ureter. However sub-division of the ureteric mesenchyme into inner cuboidal SMC precursors 
and outer spindle shaped adventitial fibrocytes appeared less clear (Fig 7I).  
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  Figure 7: Foxf1 is a crucial factor for ureter de-velopment. (A-H) Histological and molecular anal-
ysis of E14.5 control and Tbx18cre/+;HprtFoxf1DN/y 
(Foxf1DN) ureters after 6 d of culture. (A,B) He-
matoxylin and Eosin (HE) stainings and (C-H) 
analysis of cytodifferentiation by immunofluores-
cence for ACTA2/CDH1 (C,D), TAGLN (E,F) and 
∆NP63/UPK1B (G,H) on proximal ureter sections. 
(I-Q) Histological and molecular analysis of control 
and Tbx18cre/+;HprtFoxf1DN/y (Foxf1DN) ureters at 
E12.5 and E14.5. (I) Hematoxylin and Eosin stain-
ing on transverse sections of the proximal ureter at 
E12.5 and E14.5. (J-N) RNA in situ hybridization 
analysis for Ptch1 (J), Bmp4 (K), Myocd (L), 
Myh11 (M) and Tagln (N) on transverse sections of 
the proximal ureter at E12.5 and E14.5. (O-Q) 
Analysis of cell death by the TUNEL assay (O), and 
of cellular proliferation by the BrdU incorporation 
assay (P) on transverse sections of the proximal 
ureter at E12.5 and E14.5. Black circles in H mark 
the epithelium (UE) and the inner (IM) and outer 
(OM) mesenchymal compartments of the ureter for 
which proliferation was quantified. (Q) Quantifica-
tion of BrdU-positive cells. E12.5 (n=3), wildtype 
versus mutant: IM, 0.329±0.007 vs 0.276±0.011, 
P=0.002; OM, 0.216±0.015 vs 0.234±0.019, 
P=0.310; UE, 0.412±0.016 vs 0.311±0.026, 
P=0.004. E14.5 (n=3), wildtype versus mutant: IM, 
0.199±0.013 vs 0.216±0.003, P=0.153; OM, 
0.209±0.005 vs 0.197±0.013, P=0.288; UE, 
0.225±0.014 vs 0.256±0.020, P=0.144. Values are 
displayed as mean ± sd. **, P≤0.01; two-tailed Stu-
dent’s t-test. 
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Expression of the HH target gene Ptch1 was strongly reduced in the inner mesenchymal region 
at E12.5 and E14.5 indicating a possible role of FOXF1 as a feed-back activator of SHH sig-
naling (Fig 7J). Strikingly, Foxf1 was required to maintain Bmp4 expression at E12.5 and E14.5, 
suggesting that Foxf1 mediates Bmp4 expression downstream of HH signaling (Fig 7K). Tshz3, 
Tcf21, Tbx18 and Sox9 that only partially depend in their expression on HH signaling, were 
normally expressed in Foxf1DN mutants, as was Axin2 (S4 Fig). Importantly, SMC differenti-
ation as analyzed by Myocd, Myh11 and Tagln expression was not initiated in Foxf1DN ureters 
at E14.5 (Fig 7L-7N). Apoptosis in the ureter was not changed at either stage while proliferation 
in the inner mesenchymal region and the epithelium was reduced at E12.5 in Foxf1DN embryos 
(Fig 7O-7Q). We conclude that FOXF1 acts upstream of Bmp4, and is required to mediate the 
proliferation and differentiation but not the survival function of HH signaling in the ureteric 
mesenchyme. 
FOXF1 suffices to induce the ureteric differentiation program downstream 
of HH signaling 
To stringently test which of the various cellular function of HH signaling in the ureter is medi-
ated by FOXF1, we wished to restore Foxf1 expression in ureter explants in which HH signaling 
was abolished by administration of cyclopamine. For this purpose, we employed the Hprt strat-
egy again to generate an allele for conditional misexpression of Foxf1 (HprtFoxf1). Since 
Tbx18cre/+;HprtFoxf1/y male embryos showed early embryonic lethality prior to the onset of kid-
ney development at E10.5, we used an inducible Axin2creERT2 line that mediates recombination 
specifically in the inner mesenchymal domain of the ureter [4]. Axin2creERT2/+;HprtFoxf1/y ureters 
explanted at E12.5 and cultured for 3 days in the presence of 500 nM 4-Hydroxy-Tamoxifen 
showed robust expression of Foxf1 in the inner mesenchymal region and restored Bmp4 expres-
sion after cyclopamine treatment proving the suitability of our approach (S5 Fig). E12.5 
Axin2creERT2/+;HprtFoxf1/y ureters cultured for 6 days in the presence of 500 nM 4-Hydroxy-Ta-
moxifen with or without 10 µM cyclopamine were morphologically indistinguishable from 
wildtype controls indicating that reconstitution of Foxf1 expression was not able to alleviate 
cyclopamine induced tissue hypoplasia in this setting (Fig 8A). However, SMC differentiation 
as analyzed by ACTA2 and TAGLN expression and urothelial differentiation as analyzed by 
∆NP63 and UPK1B expression was rescued in cyclopamine treated Axin2creERT2/+;HprtFoxf1/y 
explants, indicating that FOXF1 controls these differentiation programs downstream of HH 
signaling (Fig 8B-8D).  
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Figure 8: Analysis of the epistatic relations of 
HH signaling, FOXF1 and BMP4 in cy-
todifferentiation of the ureter. (A-L) Analysis 
of proximal sections of ureters explanted from 
E12.5 wildtype, Axin2creERT2/+;HprtFoxf1/y or 
Tbx18cre/+;HprtFoxf1DN/y embryos and cultured 
for 6 d in the presence or absence of 10 µM cy-
clopamine and/or 100 ng/µl BMP4 or solvent by 
Hematoxylin and Eosin staining (A,E,I), by im-
munofluorescence (B-D,F-H,J-L) for the SMC 
markers ACTA2 and TAGLN with the epithe-
lial marker CDH1 (B,C,F,G,J,K), and for the 
urothelial markers ∆NP63/UPK1B (D,H,L). 
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To investigate whether this effect was solely mediated by FOXF1-dependent BMP4, we cul-
tured E12.5 ureters for 6 days with or without 100 ng/ml BMP4 and 10 µM cyclopamine. In-
terestingly, BMP4 was able to reduce cyclopamine-induced epithelial and mesenchymal hypo-
plasia and to completely restore epithelial differentiation. However, it was not sufficient to in-
duce SMC differentiation (Fig 8E-8H). Similarly, BMP4 administration to E12.5 
Tbx18cre/+;HprtFoxf1DN/y (Foxf1DN) explants did not rescue SMC differentiation but restored 
urothelial differentiation after 6 days of culture (Fig 8I-8L). 
We conclude that FOXF1 is required and sufficient to induce SMC and urothelial differentiation 
downstream of HH signaling. BMP4 controls epithelial and mesenchymal growth as well as 
urothelial differentiation downstream of FOXF1 but is on its own not sufficient to induce the 
SMC program (Fig 9). 
  
Figure 9: Model of how SHH and HH signaling direct various cellular programs in early ureter development. SHH is 
secreted from the ureteric epithelium and activates in the mesenchyme a SMO-dependent signaling pathway that induces ex-
pression of Foxf1 in the inner mesenchymal domain. FOXF1, in turn activates expression of Bmp4. BMP4 regulates mesen-
chymal and epithelial proliferation, and epithelial differentiation. SMC differentiation depends both on Bmp4 and Foxf1, and 
gets additional input from other transcription factors including TBX18, TSHZ3 and SOX9. Note that Foxf1 as well as these 
other transcription factor genes require an additional (epithelial) signaling input to upregulate and confine them to the inner 
mesenchymal domain. SMO-mediated HH signaling also directs cell survival in the outer mesenchymal domain but this activ-
ity is independent of Foxf1. 
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Discussion 
SHH has previously been characterized as an essential epithelial signal for proliferation and 
SMC differentiation of mesenchymal cells in the ureter. Here, we provided genetic evidence 
that mesenchymal HH signaling controls proliferation and differentiation both in the inner re-
gion of the mesenchyme as well as in the ureteric epithelium, and that these programs are re-
layed by a FOXF1-BMP4 module. HH signaling also regulates survival of outer mesenchymal 
cells, which however employs other effector genes. We conclude that SHH is the crucial signal 
for coordinated tissue growth and cell differentiation in early ureter development (Fig 9). 
HH signaling promotes coordinated proliferation and differentiation of 
mesenchymal and epithelial progenitors in the ureter  
It was previously reported that global or conditional loss of Shh in the ureteric epithelium leads 
to reduced mesenchymal proliferation and delayed SMC differentiation [8, 11]. Our study 
showed that deletion of HH signaling in the mesenchymal compartment leads to a reduction of 
proliferation rates in the inner mesenchymal region at E12.5 and to a failure to initiate SMC 
differentiation at E14.5. Together, these studies argue that epithelial SHH regulates in a para-
crine fashion the proliferation and SMC differentiation of adjacent mesenchymal cells. The 
difference in the severity of SMC defects in the conditional loss-of-function models may derive 
from variable efficiency of cre recombination or different genetic backgrounds. Alternatively, 
it may indicate that other HH family members provide a minor but relevant input to SMO-
mediated signaling in the ureter. A paradigm for this is found in the intestinal epithelium where 
SHH and IHH cooperatively signal to the underlying mesenchyme [35, 36]. 
Misexpression of a constitutively active form of SMO in the entire ureteric mesenchyme re-
sulted in increased cell proliferation in the inner mesenchymal region and the epithelium indi-
cating that the level of SHH is a limiting factor in this program. However, it did not result in 
ectopic or enhanced SMC differentiation in the outer mesenchymal layer. Together with our 
recent finding that loss of canonical WNT signaling in the ureteric mesenchyme abrogates the 
SMC investment of the ureter [10], it seems plausible that initiation of SMC differentiation 
depends on the combinatorial input of both epithelial SHH and WNT signals and that the short 
range signaling activity of the latter is decisive to restrict the program to mesenchymal cells 
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adjacent to the ureteric epithelium. WNT signals may also impinge on mesenchymal prolifera-
tion since proliferation rates were reduced but not stalled in mice with mesenchyme specific 
loss of both WNT and HH signaling in the ureter [10]. 
In contrast to previous studies [8, 11], we also analyzed the consequence of abrogation of HH 
signaling for epithelial development. To our excitement, we found that proliferation and differ-
entiation of the epithelial compartment was similarly affected than that of the mesenchyme; 
proliferation was reduced at E12.5 and epithelial differentiation was not initiated at E14.5 re-
sulting in epithelial hypoplasia and a complete lack of urothelial cell types at E18.5. While it is 
possible that epithelial SHH uses paracrine and autocrine signaling pathways to regulate pro-
liferation rates in the mesenchyme and epithelium, respectively, our approach to manipulate the 
signaling pathway in the mesenchyme disfavors an autocrine mode of HH signaling and rather 
suggests that mesenchymal HH signaling uses a relay signal to affect epithelial cell cycle pro-
gression and differentiation. 
Since cell density and cell number can affect cellular differentiation programs [37], the argu-
ment may arise that epithelial and mesenchymal differentiation defects are secondary to the 
severe hypoplasia found in Smo-deficient ureters. However, our genetic rescue experiments 
showed robust SMC and urothelial differentiation despite massive mesenchymal hypoplasia, 
indicating that HH controlled cell differentiation is a direct and cell-autonomous process that 
does not rely on cell number.  
All in all, our data suggest that SHH and HH signaling play a much more crucial role in early 
ureter development than previously thought, namely by directing and coordinating proliferation 
and differentiation of the mesenchymal and epithelial tissue compartments required for elonga-
tion and functionality of this simple tube. 
HH signaling employs a FOXF1-BMP4 module to mediate mesenchymal 
and epithelial proliferation and differentiation programs in the ureter  
The three Forkhead transcription factor genes Foxf1, Foxl1 and Foxf2 are expressed in numer-
ous sites of the embryo including the foregut, the lung, the vessels and the palate adjacent to 
sources of SHH protein [38-41]. HH-dependency of these expression domains and the presence 
of GLI1 binding sites in the regulatory regions of Foxf1 and Foxl1 characterized these genes as 
direct targets of HH signaling [30, 40, 42]. Individual or combined loss of Foxf1, Foxf2 and 
Foxl1 in these organs system led to severe defects that are characterized by tissue hypoplasia 
and cell immaturity [29, 30]. These defects, at least in some organs, resemble those of mice 
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with loss of SHH and/or IHH, arguing that these FOX proteins are downstream mediators of 
HH signaling [35, 41, 43, 44]. Similarly, an intricate relationship was reported between HH and 
BMP signaling. Hh and Bmp genes are coexpressed at many diverse sites of cell-cell interaction 
in the mouse embryo and similar phenotypes of mutant mice suggest the existence of a HH-
BMP signaling relay [45, 46]. Which aspects and to what extent FOX and BMP proteins medi-
ate HH signaling at these embryonic sites has, however, remained unclear.   
Here, we showed that Foxf1 is expressed in the ureteric mesenchyme and that this expression 
depends on HH signaling. Intriguingly, Foxf1 expression was upregulated at E14.5, i.e. shortly 
before the onset of SMC and epithelial differentiation while mesenchymal HH signaling is pre-
sent from at least E11.5 onwards in the ureteric mesenchyme. Together with the observation 
that ectopic HH signaling (i.e. activated SMO) in the outer mesenchymal region is not sufficient 
to induce Foxf1 in this domain, this argues that Foxf1 expression requires a critical second input 
from the epithelial compartment around E13.5. Alternatively, a mesenchymal activity may 
counteract HH activation of Foxf1 expression until that stage. Conditional misexpression of a 
variant of FOXF1 encoding a strong transcriptional repressor in the ureteric mesenchyme com-
pletely recapitulated the proliferation and differentiation defects of Smo loss-of-function mu-
tants in the inner mesenchymal domain and the epithelium of the developing ureter. Moreover, 
mesenchymal expression of FOXF1 partially ameliorated tissue hypoplasia and completely res-
cued the mesenchymal and epithelial differentiation defects in cyclopamine treated ureters ar-
guing together that FOXF1 is the crucial and unique mesenchymal mediator of inputs from 
SHH and other epithelial signals in the control of these cellular programs. Our molecular anal-
yses showed that expression of Tbx18, Sox9 and Tshz3, genes previously implicated in SMC 
differentiation in the ureteric mesenchyme partially depend on HH signaling but not on Foxf1 
arguing that they act in parallel to Foxf1 in this program. Reduced expression of Ptch1 in 
Foxf1DN ureters points to a role for FOXF1 as a feed-back activator of HH signaling.  
Our molecular analyses have shown that expression of Bmp4 in the ureteric mesenchyme 
strictly depends on HH signaling and FOXF1 activity in this tissue. While the function of BMP4 
in the control of cell proliferation has remained unclear, a number of studies have indicated that 
abrogation of BMP4 activity compromises SMC and S-cell differentiation in the ureter [8, 9, 
47, 48]. Our rescue experiment provided clear evidence that BMP4 or a similar BMP activity 
acts downstream of HH signaling and FOXF1 activity to mediate the pro-proliferative function 
in both tissue compartments as well as induce epithelial differentiation. While FOXF1 rescued 
the SMC defect of HH signaling mutants, BMP4 did not, suggesting that BMP4 can only me-
diate parts of the Foxf1 function in this program. Together, we identified a SHH-FOXF1-BMP4 
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axis controlling proliferation and differentiation in the mesenchymal and epithelial tissues of 
the ureter. 
SHH-FOXF1-BMP4 and human congenital renal anomalies  
Given the requirement of the SHH-FOXF1-BMP4 regulatory axis for SMC differentiation in 
the ureter and the severity of the hydroureter formation associated with their complete or partial 
loss in the mouse, it is obvious that the components of this axis represent candidate genes for 
human congenital anomalies of the kidney and urinary tract (CAKUT). In fact, heterozygous 
loss-of-function mutations in BMP4 and GLI transcription factor genes have been identified in 
patients with ureter anomalies, and hypo- and dysplastic kidneys [49, 50]. Since these genes are 
expressed and required in numerous embryonic programs, renal defects are often associated 
with a whole spectrum of other organ malformations. The VATER/VACTERL association de-
scribes such a combination of congenital anomalies including vertebral defects, anorectal mal-
formations, cardiac defects, tracheoesophageal fistula with or without esophageal atresia, renal 
malformations, and limb defects. Given that loss of HH signaling in mice recapitulates the 
spectrum of VATER/VACTERL phenotypes [51], and that Foxf1 is a functional target of HH 
signaling in most of the effected organ systems including the urinary tract as shown here, points 
to the relevance FOXF1 as an attractive candidate gene for at least a subset of VA-
TER/VACTERL cases. Targeted sequencing in 123 patients with VATER/VACTERL or VA-
TER/VACTERL-like phenotype detected a FOXF1 de novo mutation in one patient. In situ 
hybridization analyses in mouse embryos identified Foxf1 expression in the development of 
most VATER/VACTERL organ systems except the urinary tract [52], questioning the signifi-
cance of mutations in FOXF1 for renal disease manifestations [53]. With our finding that Foxf1 
is expressed and functionally required in ureter development in the mouse, the gene is back on 
the list of candidates for the VATER/VACTERL association of phenotypic changes. 
HH signaling promotes survival of mesenchymal progenitor cells in the 
developing ureter in a FOXF1-independent fashion  
Our study found that conditional deletion of the unique HH signal transducer Smo in the ureteric 
mesenchyme results in a massive increase of programmed cell death in the outer mesenchymal 
domain at E12.5, and severe ureter hypoplasia from E14.5 onwards. Moreover, expression of a 
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conditionally activated form of SMO completely abolished apoptosis in the lateral mesenchy-
mal domain at E11.5 and led to massive tissue hyperplasia of this region from which adventitial 
fibrocytes normally arise. Importantly, pharmacological activation of SMO was sufficient to 
trigger survival of isolated ureteric mesenchyme. Together, these findings demonstrate that HH 
signaling is required and sufficient to maintain cell survival in the outer region of the undiffer-
entiated ureteric mesenchyme. 
It is interesting to note that this domain of cells is relatively distant from the source of SHH 
signals in the ureteric epithelium. It is therefore possible that HH signaling occurs here in a 
ligand-independent fashion as previously found in other biological contexts [54, 55]. Alterna-
tively, SHH may act as a long-range signal similarly to the situation reported for the ventral 
spinal cord where notochord- and floorplate-derived SHH controls cell survival at a distance 
[56]. Strong support for the second possibility is provided by two findings. First, tissue separa-
tion and recombination experiments demonstrated that survival of mesenchymal tissues in the 
developing urinary system relies on epithelial signals [7, 10, 16]. Second, mice with a condi-
tional or global deletion of Shh from the ureteric epithelium also exhibited a severe thinning of 
the epithelial and mesenchymal tissue compartments [8, 11]. The finding that tissue hypoplasia 
in these mutants appeared less severe compared to our approach can be due to different genetic 
backgrounds or different cre activities in the conditional approaches, while the reported lack of 
apoptosis may simply reflect the fact that analysis was performed at E14.5 and not E12.5 as in 
our study.  
While our functional experiments provided compelling evidence that FOXF1 mediates the pro-
liferation and differentiation function of HH signaling in the ureter, it seems unlikely that this 
or other Forkhead factors also account for the anti-apoptotic activity of this pathway in the outer 
mesenchymal domain. First, Foxf1, Foxf2 and Foxl1 were not detectably expressed in the ure-
teric mesenchyme at E11.5 to E12.5 when this HH activity occurs. Second, apoptosis of outer 
mesenchymal cells was not detected in mutants with expression of the repressor version of 
FOXF1 in the ureteric mesenchyme. Third and most importantly, FOXF1 was not sufficient to 
rescue tissue hypoplasia after abrogation of HH signaling.  
Exogenous BMP4 at least partly rescued tissue hypoplasia of cyclopamine treated ureters. Since 
the phenotypic consequences of the complete loss of Bmp4 in the ureter have only been poorly 
analyzed, and in vitro studies provided conflicting results on pro- or anti-apoptotic activities in 
the ureter and kidney [47], it remains unclear whether BMP4 contributes to the cell survival in 
outer mesenchymal cells [8, 9, 57, 58]. In other developmental contexts (e.g. the spinal cord) it 
was shown that HH signaling directly regulates the expression of the anti-apoptotic gene Bcl2 
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[56]. Our microarray analysis showed that Bcl2 is slightly reduced upon cyclopamine treatment 
of ureter explants (S1 Table) making it a possible contributor of the pro-survival role of HH 
signaling. We detected strong reduction of expression of Ddit4l whose homologue DDIT4 in at 
least some biological contexts was reported to exert an anti-apoptotic function [59, 60] making 
it another candidate for this function.  
While molecular mediators of the anti-apoptotic function of HH signaling in the early ureteric 
mesenchyme are currently unresolved, the tight spatial and temporal regulation of this activity 
may be instrumental in defining the size of adventitial precursor pool as well as severing the 
ureter from the kidney. In any case, the finding that HH signaling suffices to maintain ureteric 
mesenchymal cells in vitro, may open avenues for easier manipulation of these progenitors in 
the future. 
  
Part 3 - SHH signaling in ureter development  
 
83 
Materials and methods  
Generation of HprtFoxf1 and HprtFoxf1DN alleles 
The Foxf1 open reading frame was PCR-amplified from cDNA with primer pairs Foxf1-for 
(NheI) ATG CAC TAG TAT GTC CGC GCC CGA CAA GC and Foxf1-rev (NdeI) ATG CCA 
TAT GTC ACA TCA CAC ACG GCT TGA TG or Foxf1∆Stop-rev (NdeI) ATG CCA TAT 
GCA TCA CAC ACG GCT TGA TG with the latter introducing a mutated stop codon. A DNA 
fragment encoding the engrailed repressor domain (ENG) was PCR-amplified from the 
pCS2+.Engrailed plasmid [32] with primer pairs Eng-for (NdeI) GAG ACA TAT GGC CCT 
GGA GGA TCG C and Eng+Stop-rev (NdeI) GAG ACA TAT GCT AGA GGC TCG AGA 
GGG ATC C.  Restriction sites introduced via primers were used to insert PCR products into 
NheI-NdeI sites of a shuttle vector containing IRES-GFP to generate FOXF1-IRES-GFP (for 
HprtFoxf1) and FOXF1ENG-IRES-GFP (for HprtFoxf1DN) constructs. These constructs were then 
subcloned into the pMP8.CAG-Stop vector [61] using restriction enzymes SwaI and MluI. To 
target the Hprt locus, linearized constructs were electroporated into E14TG2a embryonic stem 
cells that carry a deficient Hprt locus enabling HAT selection after correct targeting and resto-
ration of the locus [33, 34]. Correctly targeted ES cell clones were selected with HAT (Gibco) 
in a concentration of 1:300. Surviving colonies were expanded and genotyped by PCR. To test 
the functionality of the expression cassette in candidate ES clones, GFP epifluorescence was 
analyzed 6 d after electroporation with a cre-expression plasmid (pCAG::turbo-cre, kind gift 
from Achim Gossler).  Verified ES clones were microinjected into CD1 mouse blastocysts. 
Chimeric males were obtained and mated to NMRI females to produce heterozygous F1 fe-
males. 
Mouse strains and husbandry 
Smotm2Amc (synonym: Smofl) [14], Gt(ROSA)26Sortm1(Smo/EYFP)Amc (synonym: R26SmoM2) [17], 
Gt(ROSA)26Sortm4(ACTB-tdTomato-EGFP)Luo (synonym: R26mTmG) [18 and Axin2tm1(cre/ERT2)Rnu  
(synonym: Axin2creERT2) {van Amerongen, 2012 #47] mouse lines were all obtained from 
the Jackson Lab. The Tbx18tm4(cre)Akis (synonym: Tbx18cre) mouse line was previously generated 
in the lab [62]. All lines were maintained on an NMRI outbred background. Tbx18cre/+;Smofl/fl  
(synonym: SmoLOF) embryos were obtained from matings of Tbx18cre/+;Smofl/+ males and 
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Smofl/fl females. Tbx18cre/+;R26mTmG/SmoM2 (synonym: SmoGOF) and Tbx18cre/+;R26mTmG/+ em-
bryos were derived from matings of Tbx18cre/+;R26mTmG/mTmG males and R26SmoM2/SmoM2 and 
NMRI females, respectively. Tbx18cre/+;HprtFoxf1DN/y (synonym: Foxf1DN) and 
Tbx18cre/+;HprtFoxf1/y embryos were obtained from matings of Tbx18cre/+ males with  
HprtFoxf1DN/Foxf1DN and HprtFoxf1/Foxf1 females, respectively. Axin2creERT2/+;HprtFoxf1/y embryos 
were obtained from matings of Axin2creERT2/+ and Foxd1cre/+ males with HprtFoxf1/Foxf1 females, 
respectively. For all matings cre negative littermates were used as controls. For timed pregnan-
cies, vaginal plugs were checked in the morning after mating, and noon was defined as embry-
onic day (E) 0.5. Embryos and urogenital systems were dissected in PBS. Ureters for explant 
cultures were dissected in L-15 Leibovitz medium (Biochrom). Specimens were fixed in 4% 
PFA/PBS, transferred to methanol and stored at -20°C prior to immunofluorescence or in situ 
hybridization analyses. PCR genotyping was performed on genomic DNA prepared from yolk 
sac or tail biopsies. All mice were bred and maintained in the central animal facility of the 
Medizinische Hochschule Hannover (Hannover, Germany) according to institutional guide-
lines. All experiments were performed with approval by the State of Lower Saxony. 
Histological and expression analyses 
Embryos, urogenital systems and ureters were paraffin-embedded and sectioned to 5 µm. He-
matoxylin and eosin staining was performed according to standard procedures. 
Non-radioactive in situ hybridization analysis of gene expression was performed on whole-
mount specimens or 10-µm paraffin sections of the proximal ureter with digoxigenin-labeled 
antisense riboprobes [63, 64].  
For immunofluorescence analysis on 5-µm paraffin sections polyconal rabbit-anti-TAGLN 
(1:250, ab14106, Abcam), monoclonal mouse-anti-GFP (1:250, 11814460001, Roche), mono-
clonal mouse-anti-ACTA2 (1:250, A5228, Sigma-Aldrich), polyclonal rabbit-anti-∆NP63 
(1:250, 619001, Biolegend), monoclonal mouse-anti-BrdU (1:250, 1170376, Roche) or poly-
clonal rabbit antisera against CDH1 (1:250, gift from Rolf Kemler) and MYH11 (1:250, gift 
from Robert Adelstein) were used as primary antibodies. Biotinylated goat-anti-rabbit IgG 
(1:250, 111065033, Dianova), Alexa488-conjugated goat-anti-rabbit IgG (1:500, A11034, Mo-
lecular Probes) and Alexa555-conjugated goat-anti-mouse IgG (1:500, A21422, Molecular 
Probes) were used as secondary antibodies. The signal of the ∆NP63 antibody was amplified 
using the Tyramide Signal Amplification (TSA) system (NEL702001KT, Perkin Elmer). Be-
fore staining, paraffin sections were deparaffinized and cooked for 15 min in antigen unmasking 
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solution (H-3300, Vector Laboratories). Nuclei were stained with 4',6-diamidino-2-phenylin-
dole (DAPI).  
At least three specimens of each genotype were used for each of these analyses. 
Cellular assays 
Cell proliferation rates were analyzed by the detection of incorporated BrdU on 5 µm paraffin 
sections according to published protocols [65]. A minimum of 12 sections of the proximal ureter 
from 3 independent specimens was analyzed per genotype. The BrdU-labeling index was de-
fined as the number of BrdU-positive nuclei relative to the total number of nuclei as detected 
by DAPI counterstaining in arbitrarily defined compartments of the ureter. Data were expressed 
as mean ± standard deviation. The two-tailed Student’s t-test was used to test for significance. 
P≤0.05 was regarded as significant, P≤0.005 as highly significant and P≤0.001 as extremely 
significant. 
Apoptosis was analyzed on 5 µm paraffin sections using the ApopTag Plus Fluorescein In Situ 
Apoptosis Detection Kit (Chemicon). Alternatively, LysoTracker Red DND-99 (Thermo Sci-
entific) was used to detect cell death in organ cultures. Briefly, E11.5 kidney rudiments were 
cultured for 1 d and incubated for 1 h with 2.5 µM LysoTracker prior to documentation. 
Organ cultures 
Kidney rudiments or ureters were dissected from the embryo, explanted on 0.4 µm polyester 
membrane Transwell supports (Corning) and cultured at the air-medium interface with 
DMEM/F12 (Gibco) supplemented with 10% FCS (Biochrom), 1x Penicillin/Streptomycin 
(Gibco), 1x Pyruvate (Gibco) and 1x Glutamax (Gibco). For pharmacological manipulation of 
SHH signaling cyclopamine (Selleckchem) and purmorphamine (Millipore) were used at a final 
concentration of 10 µM and 2 µM, respectively. Recombinant mouse BMP4 (R&D Systems) 
was used at a final concentration of 100 ng/ml. To induce recombination with the Axin2creERT2 
line 4-Hydroxytamoxifen (H7904, Sigma-Aldrich) was added to the medium at a final concen-
tration of 500 nM for the first 24 h of culture. Culture medium was replaced every day. 
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Microarray 
Two independent pools of 50 E12.5 ureters were cultured with DMSO or 10 µM cyclopamine 
for 18 h. Total RNA was extracted with peqGOLD RNApure (PeqLab) and was sent to the 
Research Core Unit Transcriptomics of Hannover Medical School where RNA was Cy3-labeled 
and hybridized to Agilent Whole Mouse Genome Oligo v2 (4x44K) Microarrays. To identify 
differentially expressed genes, normalized expression data was filtered using Excel based on 
an intensity threshold of 150 and a more than 2 fold change in both pools. 
Image analysis 
Sections and organ cultures were photographed using a Leica DM5000 microscope with Leica 
DFC300FX digital camera or a Leica DM6000 microscope with Leica DFC350FX digital cam-
era. Urogenital systems were documented using a Leica M420 microscope with a Fujix HC-
300Z digital camera. Figures were prepared with Adobe Photoshop CS4. 
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Supporting information 
 
 
 
 
 
 
 
 
 
S1 Figure: 10 µM Cyclopamine is sufficient to largely inhibit HH signaling in ureter explant cultures. Wildtype ureters 
were isolated at E12.5, cultured for 18 h in the presence of DMSO or 10 µM cyclopamine (Cyc) and subjected to in situ 
hybridization analysis of expression of the SHH target gene Ptch1. Reduced expression of Ptch1 in the cyclopamine treated 
culture indicates that HH signaling is severely compromised under these conditions. 
S2 Figure: HH signaling acts at E11.5 to E13.5 in ureter development. Wildtype ureters were isolated at E11.5 and cultured 
for 8 days in the presence of DMSO or 10 µM Cyclopamine in intervals of 2 days (D) as indicated. Immunofluorescence of 
the SMC marker ACTA2 (in red) in presence of the epithelial counterstain CDH1 (in green) shows that only treatment of the 
ureter explants at day 1 and 2 of the culture abrogates SMC differentiation in the ureter. 
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S3 Figure: In situ hybridization analysis of genes downregulated in microarrays of cyclopamine treated ureters. Note 
that specific expression of Foxl1, Foxf2, Crym, Ndp and Wif was not detected in the ureter of wildtype, Tbx18cre/+;Smofl/fl 
(SmoLOF) and Tbx18cre/+;R26mTmG/SmoM2 (SmoGOF)  embryos at E12.5 and E14.5. 
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S4 Figure: Molecular analysis of marker gene expression in control and Tbx18cre/+;HprtFoxf1DN/y (Foxf1DN) ureters at 
E12.5 and E14.5. In situ hybridization on proximal ureter sections shows that markers of the inner domain of the ureteric 
mesenchyme, Axin2, Tshz3, Tcf21, Tbx18 and Sox9 are not changed in their expression in Foxf1DN ureters. 
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S5 Figure: FOXF1 induces expression of Bmp4 in the ureteric mesenchyme. Analysis of proximal sections of ureters 
explanted from E12.5 wildtype and Axin2creERT2/+;HprtFoxf1/y embryos and cultured for 3 d in the presence or absence of 10 µM 
cyclopamine or DMSO solvent by in situ hybridization for expression of Foxf1 and Bmp4. Abrogation of HH signaling by 
cyclopamine leads to loss of Foxf1 and Bmp4 expression in the ureteric mesenchyme. Axin2creERT2/+ mediated recombination 
of the HprtFox1/fy allele results in robust expression of Foxf1 and induction of Bmp4 showing that FOXF1 is required and suffi-
cient for Bmp4 expression in the ureteric mesenchyme. 
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S1 Table: List of transcripts identified by microarray analysis as dependent in their expression on HH signaling in the 
developing ureter. Shown are two lists of transcripts with reduced and enhanced expression after an 18-h treatment of E12.5 
ureter explants with 10 µM cyclopamine. Two groups each of untreated and cyclopamine-treated ureters are shown with their 
intensities, and the resulting fold changes in expression upon comparison. Intensity thresholds were 200 for the controls; fold 
changes were larger than 1.4. 
 
Identifier Gene Name Intensity Control 1 Intensity Cyclopamine 1 Intensity Control 2 Intensity Cyclopamine 2 Fold change 1 Fold change 2 Average fold change
NM_020259 Hhip 1581 123 1326 121 -12.9 -11.0 -11.9
NM_010426 Foxf1 4668 892 4757 877 -5.2 -5.4 -5.3
NM_008024 Foxl1 3028 771 3306 835 -3.9 -4.0 -3.9
NM_010225 Foxf2 1329 446 1105 311 -3.0 -3.5 -3.3
AK147626 Ptch1 1238 344 1065 377 -3.6 -2.8 -3.2
NM_016669 Crym 1573 390 1098 465 -4.0 -2.4 -3.2
NM_030143 Ddit4l 402 109 345 130 -3.7 -2.6 -3.2
AK136956 Hapln3 301 87 292 102 -3.5 -2.9 -3.2
AK014270 Ptchd4 450 135 343 116 -3.3 -2.9 -3.1
ENSMUST00000051253 ENSMUST00000051253 1748 614 1456 492 -2.8 -3.0 -2.9
NM_172485 Thsd7b 246 103 302 113 -2.4 -2.7 -2.5
NM_028443 Fam101a 1068 380 859 394 -2.8 -2.2 -2.5
NM_016847 Avpr1a 1116 420 1224 543 -2.7 -2.3 -2.5
NM_010883 Ndp 1218 474 919 408 -2.6 -2.3 -2.4
NM_011125 Pltp 888 400 860 346 -2.2 -2.5 -2.4
NM_010296 Gli1 5606 2329 5170 2311 -2.4 -2.2 -2.3
NM_053088 Ifitm5 235 110 215 95 -2.1 -2.3 -2.2
NM_001039347 Kcnd3 581 266 621 286 -2.2 -2.2 -2.2
NM_011915 Wif1 1026 476 1009 501 -2.2 -2.0 -2.1
NM_007934 Enpep 2515 1212 2583 1307 -2.1 -2.0 -2.0
NM_001024139 Adamts15 1258 650 1332 664 -1.9 -2.0 -2.0
NM_019521 Gas6 2225 1066 1998 1078 -2.1 -1.9 -2.0
NM_021342 Kcne4 300 138 233 132 -2.2 -1.8 -2.0
NM_007472 Aqp1 1077 518 873 473 -2.1 -1.8 -2.0
NM_001099299 Ajap1 785 403 757 383 -1.9 -2.0 -2.0
NM_178642 Ano1 1172 543 1035 595 -2.2 -1.7 -1.9
NM_009856 Cd83 576 267 474 274 -2.2 -1.7 -1.9
NM_013703 Vldlr 4095 2082 3883 2097 -2.0 -1.9 -1.9
NR_033803 6030408B16Rik 6137 3162 6232 3372 -1.9 -1.8 -1.9
NM_018874 Pnliprp1 1068 601 914 460 -1.8 -2.0 -1.9
NM_022316 Smoc1 2470 1401 2867 1465 -1.8 -2.0 -1.9
NR_030721 9130206I24Rik 580 316 530 295 -1.8 -1.8 -1.8
NM_001085521 Tmem90b 657 329 519 331 -2.0 -1.6 -1.8
NM_011580 Thbs1 2556 1422 2964 1693 -1.8 -1.8 -1.8
NM_008770 Cldn11 4607 2689 4651 2561 -1.7 -1.8 -1.8
NM_001190870 Kcne3 234 130 197 115 -1.8 -1.7 -1.8
NM_025807 Slc16a9 288 166 388 226 -1.7 -1.7 -1.7
NM_144945 Lgi2 611 349 505 296 -1.7 -1.7 -1.7
NM_145741 Gdf10 568 346 607 337 -1.6 -1.8 -1.7
ENSMUST00000055537 Gm22 237 137 218 131 -1.7 -1.7 -1.7
NM_054095 Necab2 1011 613 1000 576 -1.6 -1.7 -1.7
NM_172610 Mpped1 629 387 611 351 -1.6 -1.7 -1.7
NM_148938 Slc1a3 1295 707 1292 842 -1.8 -1.5 -1.7
TC1679329 TC1679329 214 117 262 171 -1.8 -1.5 -1.7
AK017236 5330406M23Rik 193 116 253 150 -1.7 -1.7 -1.7
NM_177410 Bcl2 945 555 756 462 -1.7 -1.6 -1.7
NM_011825 Grem2 191 115 238 143 -1.7 -1.7 -1.7
NM_030060 Batf3 1328 810 1229 731 -1.6 -1.7 -1.7
NM_022435 Sp5 414 261 407 235 -1.6 -1.7 -1.7
NM_001037906 Nell1 895 502 890 581 -1.8 -1.5 -1.7
NM_010500 Ier5 1749 1130 1413 868 -1.5 -1.6 -1.6
NM_153543 Aldh1l2 288 184 414 268 -1.6 -1.5 -1.6
NM_011427 Snai1 1277 825 1393 909 -1.5 -1.5 -1.5
NR_030682 2810410L24Rik 1036 686 1114 728 -1.5 -1.5 -1.5
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Identifier Gene Name Intensity Control 1 Intensity Control 2 Intensity Cyclopamine 1 Intensity Cyclopamine 2 Fold change 1 Fold change 2 Average fold change
NM_017474 Clca3 234 583 131 312 2.5 2.4 2.4
NM_008605 Mmp12 454 772 346 847 1.7 2.5 2.1
NM_001163032 Synpr 288 533 251 483 1.9 1.9 1.9
NM_133681 Tspan1 267 548 195 336 2.0 1.7 1.9
NM_001126490 Ism1 595 1098 705 1288 1.8 1.8 1.8
NM_010819 Clec4d 348 628 460 855 1.8 1.9 1.8
NM_001204233 Spp1 2787 5073 1798 3259 1.8 1.8 1.8
NM_008469 Krt15 1821 3247 1119 2029 1.8 1.8 1.8
NM_001039195 Gria2 110 195 135 245 1.8 1.8 1.8
NM_007726 Cnr1 434 790 489 842 1.8 1.7 1.8
NM_033605 Dach2 982 1771 924 1580 1.8 1.7 1.8
NM_010518 Igfbp5 16097 28770 18042 30658 1.8 1.7 1.7
NM_013602 Mt1 7461 13221 9088 14905 1.8 1.6 1.7
NM_021384 Rsad2 241 394 326 578 1.6 1.8 1.7
NM_018798 Ubqln2 820 1517 1234 1915 1.8 1.6 1.7
NM_177597 March11 518 899 539 898 1.7 1.7 1.7
NM_008147 Gp49a 529 865 474 835 1.6 1.8 1.7
NM_008509 Lpl 3199 5070 3054 5414 1.6 1.8 1.7
NM_011337 Ccl3 177 288 146 250 1.6 1.7 1.7
NM_011338 Ccl9 740 1194 629 1046 1.6 1.7 1.6
ENSMUST00000093859 Grin3a 747 1289 734 1109 1.7 1.5 1.6
NM_013532 Lilrb4 1014 1611 993 1620 1.6 1.6 1.6
NR_004414 Rnu2-10 526 823 569 906 1.6 1.6 1.6
XR_035383 A730089K16Rik 316 496 324 494 1.6 1.5 1.5
NM_009807 Casp1 205 316 192 299 1.5 1.6 1.5
NM_053155 Clmn 1189 1855 1347 2026 1.6 1.5 1.5
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Abstract 
The differentiated cell types of the two tissue compartments of the mature ureter arise from 
multipotent progenitors in embryonic development. In the mesenchyme, adventitial fibrocytes 
differentiate first in an outer domain, then common progenitors in an inner region give rise to 
smooth muscle and lamina propria cells. In the epithelium, uncommitted cells first become in-
termediate cells from which both basal and superficial cells develop. How the progenitor cells 
are maintained and differentiate in a precisely coordinated temporal and spatial fashion has 
remained enigmatic. Here, we have addressed the role of retinoic acid (RA) signaling in ureter 
development. Using comprehensive expression analysis of components and target genes of RA 
signaling, we showed that the pathway acts both in the mesenchymal and epithelial progenitor 
pools from embryonic day 11.5 to E14.5. Pharmacological pathway inhibition in ureter explant 
cultures resulted in an expansion of smooth muscle cells at the expense of lamina propria fibro-
blast in the mesenchymal wall of the ureter, and an expansion of superficial cells at the expense 
of intermediate cells in the urothelium; pharmacological activation experiments gave comple-
mentary results. A precocious differentiation of smooth muscle cells, basal cells and superficial 
cells from their uncommitted progenitors was identified as a cause for these cellular composi-
tion defects. We conclude that RA signaling acts specifically in the undifferentiated ureter to 
temporally and spatially restrict differentiation and to maintain ureteric progenitors. Finally, we 
identified transcriptional targets of RA signaling that may account for this activity. 
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Introduction 
The mammalian ureter is a tubular organ dedicated to the efficient removal of the urine from 
the renal pelvis to the bladder. Its outer mesenchymal coat is highly flexible and peristaltically 
active due to a three-layered organization of an outer fibroblastic tunica adventitia, a medial 
accumulation of smooth muscle cells (SMCs) and an inner lamina propria with fibroblasts. The 
inner epithelial compartment, the urothelium, is a three-tiered dilatable yet sealing tissue with 
a single layer of cuboidal basal cells (B-cells), one or two layers of similarly shaped intermedi-
ate cells (I-cells), and a luminal layer of large squamous superficial cells (S-cells) [1]. 
The ordered array of differentiated cell types of the mature ureter arises by a complex program 
of patterning, proliferation and differentiation from epithelial and mesenchymal precursor cells 
in early embryogenesis. In the mouse, a diverticulum of the nephric duct emerges around E10.5 
at the level of the future hindlimbs and invades the adjacent mesenchymal tissue. While the 
proximal aspect of the bud and the surrounding mesenchyme will form the different tissues of 
the kidney, the distal cell populations are specified towards a ureteric fate. From E12.5 to E14.5, 
the ureteric mesenchyme is subdivided into an inner and outer region that will differentiate from 
E15.5 onwards in a proximal to distal wave into SMCs and adventitial fibroblasts, respectively. 
The lamina propria can be recognized from E16.5 onwards as a cell-sparse layer in between the 
ureteric epithelium and the SMCs. The ureteric epithelium remains single-layered and undif-
ferentiated until E14.5. Around this stage, intermediate cell markers are switched on and strat-
ification occurs. At E16.5, the luminal layer of epithelial cells starts S-cell differentiation while 
individual cells of the basal layer initiate B-cell differentiation. Around birth, three distinct lay-
ers with differentiated B-, I- and S- cells can be distinguished [2]. 
While the signals and factors that maintain the precursor character of the ureteric tissues have 
remained enigmatic, embryological and genetic experiments have shown that mesenchymal and 
epithelial differentiation is coupled by trans-acting signaling activities. SMC differentiation de-
pends on epithelial Sonic Hedgehog (SHH) and WNT signals while SHH-dependent BMP4 
signaling has autocrine effects on mesenchymal differentiation as well as paracrine functions 
on epithelial growth [3-6]. 
Retinoic acid (RA) signaling is a conserved paracrine pathway with diverse functions in cellular 
proliferation and differentiation programs both in embryogenesis and in adult tissue homeosta-
sis [7, 8]. RA is locally produced from dietary retinol (vitamin A) by two consecutive oxidation 
steps catalyzed by retinol and retinaldehyde dehydrogenases [8]. Tissue-availability of RA is 
further controlled by specific expression of RA-degrading enzymes of the cytochrome P450 26 
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subfamily (CYP26A1-C1) [9]. RA binds to nuclear RA receptors (RARs) that form heterodi-
mers with retinoid X receptors (RXRs) which triggers the exchange of co-repressor against 
coactivator complexes to activate the expression of target genes [10, 11]. Previous studies have 
indicated diverse roles of RA signaling in the excretory system. RA from the pericloacal mes-
enchyme regulates ureter-bladder connectivity by inducing apoptosis of the most distal aspect 
of the nephric duct [12]. RA signaling is active in the renal stroma to regulate branching mor-
phogenesis [13, 14]. Studies in the bladder have recently uncovered a role for the signal in 
urothelial specification [15].   
Here, we analyze the functional involvement of RA signaling in the development of the murine 
ureter. We uncover a critical role for this pathway in the maintenance of progenitor cells in the 
early ureter and identify RA-responsive genes that may account for this function. 
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Results 
RA signaling is active in early ureter development 
To determine the spatiotemporal profile of RA signaling in ureter development, we first ana-
lyzed by in situ hybridization on proximal ureter sections of embryonic ureters the expression 
of genes responsible for the local production of RA from retinaldehyde (Aldh1a1, Aldh1a2, 
Aldh1a3). Aldh1a2 was found throughout the ureteric mesenchyme at E11.5. Expression was 
down-regulated at the proximal ureter at E12.5 but persisted at the distal most aspect of the 
organ as well as in the renal stroma until E18.5 as shown by additional analysis of whole uro-
genital systems. At E18.5, Aldh1a2 expression was newly activated in the lamina propria. 
Aldh1a3 expression was restricted to the epithelium of the nephric duct and the ureteric bud at 
E11.5. Expression was maintained in the renal collecting duct system but was lost in the ureter 
except its distal most aspect at subsequent stages (Figure 1, A-C, Supplemental Figure 1). We 
next screened for expression of genes encoding RARs (Rara, Rarb, Rarg) and RXRs (Rxra, 
Rxrb, Rxrg) that account for transcriptional activation of target genes upon RA binding. Ex-
pression of all three Rar genes was found in the ureteric epithelium and mesenchyme at E11.5 
and E12.5. Expression of Rarb, a direct transcriptional target of this pathway [16], was main-
tained at E14.5 particularly in the inner mesenchymal domain whereas expression of Rara and 
Rarg was down-regulated at this stage (Figure 1, D-F). Expression of all three Rxr genes was 
detected at E11.5 to E14.5 both in the ureteric epithelium and mesenchyme. Rxra was increased 
in the ureteric epithelium at E14.5 and was maintained in this domain until E18.5 (Figure 1, G-
I). Together this analysis shows that RA is synthesized in both tissue compartments of the ureter 
at E11.5, and that RA signaling occurs therein until E14.5, i.e. prior to the onset of ureteric cell 
differentiation. 
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Figure 1: Retinoic acid signaling is active in early ureter development. In situ hybridization analysis on transverse sections 
of the proximal ureter of wild-type embryos for expression of genes encoding RA synthesizing genes (A-C), RA receptors (D-
F) and retinoid X receptors (G-I). Stages are as indicated. k, kidney; u, ureter; ue, ureteric epithelium; um, ureteric mesenchyme; 
us, ureter stalk; wd, Wolffian duct. 
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RA signaling controls differentiation of the ureteric mesenchyme  
Given the complexity of RAR and RXR expression in ureter development, we choose pharma-
cological pathway manipulation in explant cultures rather than a genetic approach to address 
the functional involvement of RA signaling in ureter development. To inactivate RA signaling 
we used the pan RAR antagonist BMS493 in a concentration of 1 µM after showing that this 
concentration abolished expression of the RA target gene Rarb in E11.5 explants after 18 h of 
treatment [17]. (Over-)activation of the pathway was reached by 1 µM RA in the same interval 
(Supplemental Figure 2). We explanted ureter rudiments at E11.5, E12.5, E14.5, E16.5 and 
E18.5 and cultured them for 14 d, 12 d, 10 d, 8 d and 6 d to obtain similar end-points for 
histological and molecular analysis. 
We first investigated the effect of RA manipulation on mesenchymal cell types. We have re-
cently shown that the T-box transcription factor gene Tbx18 is expressed in the undifferentiated 
ureteric mesenchyme, and that the descendants of this expression domain constitute the ureteric 
mesenchymal wall throughout development and in adulthood [18, 19]. We therefore used mice 
double heterozygous for a cre knock-in the Tbx18 locus and the Rosa26mTmG reporter line 
(Tbx18cre/+;Rosa26mTmG/+) [20, 21] for visualization of the ureteric mesenchyme by GFP ex-
pression. 
Brightfield and GFP epifluorescence analysis throughout the culture period showed that the 
ureter elongated and became peristaltically active under all conditions. GFP epifluorescence 
around the ureter was strongly decreased under BMS treatment in ureter explants at E11.5, 
E12.5 and E14.5 while RA administration resulted in increased width of the ureteric wall in 
explants at these stages (Supplemental Figures 3-7). Histological and GFP expression analysis 
of proximal ureter segments at the culture end-points confirmed mesenchymal hypoplasia by 
BMS493-treatment and hyperplasia by RA treatment at E11.5 to E14.5 (Figure 2). 
To detect and quantify cell differentiation in the ureteric mesenchyme, we analyzed co-expres-
sion of the SMC marker Transgelin (TAGLN) with the GFP reporter by immunofluorescence 
on sections of ureter explants of Tbx18cre/+;Rosa26mTmG/+ mice. Adventitial fibroblasts were 
defined as GFP+TAGLN- outer ring cells, SMCs as GFP+TAGLN+ intermediary cells and lam-
ina propria cells as GFP+TAGLN- inner ring cells of the mesenchymal wall. Inhibition of RA 
signaling in cultures of E11.5 to E14.5 ureter explants resulted in a relative increase of SMCs 
largely at the expense of lamina propria cells. At the same stages RA treatment led to a reduction 
of SMCs and increased lamina formation (most obviously at E12.5). In E16.5 and E18.5 ex-
plants, neither BMS nor RA treatment affected the width or the composition of differentiated  
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Figure 2: RA signaling controls ureteric mesenchymal differentiation. Hematoxylin and eosin (upper panel) and co-immu-
nofluorescence analysis of GFP and TAGLN (lower panel) on transverse proximal sections of E11.5+14d (A), E12.5+12d (B), 
E14.5+10d (C), E16.5+8d (D) and E18.5+6d (E) Tbx18cre/+;R26mTmG/+ ureter explants that were treated with DMSO, 1 µM 
BMS493 or 1 µM RA. The bar graph displays ratios of differentiated cell types that were quantified based on the immunoflu-
orescence analysis. For numbers and statistics see Supplemental Table 1. * p≤0.01; ** p≤0.001; *** p≤0.0001. 
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cell types in the mesenchymal wall of the ureter (Figure 2, Supplemental Table 1). Hence, RA 
signaling is required in the undifferentiated ureteric mesenchyme from E11.5 to E14.5 to ex-
pand adventitial and most importantly lamina fibrocytes and inhibit SMC differentiation. 
RA signaling controls urothelial differentiation 
The three cell types of the mature ureteric epithelium can be distinguished by combinatorial 
expression of the intracytoplasmic protein KRT5, the nuclear protein ∆NP63 and the cell sur-
face protein UPK1B. B-cells are KRT5+∆NP63+UPK1B-, I-cells are KRT5-∆NP63+UPK1B+low 
and S-cells are KRT5-∆NP63-UPK1B+high [2]. Inhibition of RA signaling by BMS493 treatment 
resulted in E11.5, E12.5 and in E14.5 but not in E16.5 and E18.5 explants in a large expansion 
of S-cells at the expense of I-cells. Enhanced and prolonged RA signaling by RA administration 
prevented B-cell differentiation, reduced S-cell differentiation and expanded the pool of I-cells. 
In E16.5 and E18.5 explants, RA treatment expanded I-cells at the expense of B-cells  
(Figure 3, Supplemental Table 2). Given our recent finding that in the ureter I-cells are precur-
sors for both B- and S-cells [2], this analysis suggests that RA signaling is required from E11.5 
to at least E14.5 to prevent premature differentiation of I- into S- and B-cells. 
RA signaling has a minor function in proliferation control 
We next addressed a potential function of RA signaling in the proliferation and survival of the 
epithelial and mesenchymal tissue compartments in the ureter by performing bromodeoxyuri-
dine (BrdU) incorporation assays (Figure 4, A-C, upper row, Supplemental Table 3) and termi-
nal dUTP nick end-labeling (TUNEL) assays (Figure 4 A-C, lower row) on E11.5, E12.5 and 
E14.5 Tbx18cre/+;R26mTmG/+ explants that were cultured in the presence of 1 µM BMS493 or 1 
µM RA for 1 day. At E11.5 inhibition of RA signaling resulted in a significant decrease of 
proliferation of the inner mesenchymal compartment of the ureter but left the outer mesenchy-
mal and epithelial cells unaltered. Activation of RA signaling showed no effect on proliferation 
rates, as did inhibition or activation experiments at E12.5 and E14.5. Moreover, apoptosis was 
not altered under RA loss- and gain-of-function conditions. We conclude that RA signaling has 
a minor function in proliferation control at E11.5 only. 
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Figure 3: RA signaling controls urothelial differentiation. Co-immunofluorescence analysis of KRT5 and ∆NP63 (upper 
panel) and UPK1B (lower panel) on transverse proximal sections of E11.5+14d (A), E12.5+12d (B), E14.5+10d (C), E16.5+8d 
(D) and E18.5+6d (E) wildtype ureter explants that were treated with DMSO, 1 µM BMS493 or 1 µM RA. The bar diagram 
displays ratios of differentiated cell types that were quantified based on the immunofluorescence analysis. For numbers and 
statistics see Supplemental Table 2. ** p≤0.001; *** p≤0.0001. 
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RA signaling prevents precocious differentiation of ureteric progenitors 
To further test whether RA signaling contributes to the maintenance of precursor cells, we ex-
planted E12.5 ureters and cultured them for different intervals to score the onset of cell differ-
entiation in the mesenchymal and epithelial compartments. SMC differentiation, as analyzed 
by TAGLN (Figure 5A, upper row) and ACTA2 (Figure 5A, lower row) immunofluorescence, 
was initiated after 4 days in control cultures. TAGLN showed a comparable expression in 
BMS493 treated cultures after 4 and 5 days, but ACTA2 expression was considerably stronger 
Figure 4: RA signaling affects proliferation in a minor way. Determination of cellular proliferation by BrdU incorporation 
assay (upper row) and apoptosis by TUNEL/GFP assay (lower row) on transverse sections of the proximal ureter of E11.5 (A), 
E12.5 (B) and E14.5 (C) Tbx18cre/+;R26mTmG/+ explants that were cultured in the presence of DMSO, 1µM BMS493 or 1 µM 
RA for 1 day. The bar diagrams display the BrdU incorporation indices in arbitrarily defined compartments of the ureter under 
given conditions. For numbers and statistics see Supplemental Table 3. *** p≤0.0001. E, epithelium; IM inner mesenchyme; 
OM, outer mesenchyme. 
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under these conditions at both time-points. Expression of UPK1B and KRT5 indicated onset of 
S-cell and B-cell differentiation after 4 and 11 days, respectively, in control cultures. Both 
markers were expressed 1 day earlier in BMS493 treated cultures (Figure 5B, upper and lower 
row). Hence, RA signaling is required to prevent precocious differentiation in either tissue com-
partment of the ureter. 
  
Figure 5: RA signaling prevents precocious differentiation in the ureter. (A) Immunofluorescence analysis for TAGLN 
(upper row) and co-immunofluorescence analysis of ACTA/CDH1 (lower row) on E12.5 ureter explants that were cultured for 
3 and 4 days in presence of DMSO or 1 µM BMS493. (B) Immunofluorescence analysis for UPK1B (upper row) and co-
immunofluorescence analysis of KRT5/∆NP63 (lower row) on E12.5 ureter explants that were culture for 3 and 4 days 
(UPK1B) or 10 and 11 days (KRT5/∆NP63) in the presence of DMSO or 1 µM BMS493. 
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Characterization of the RA-responsive transcriptome in early ureter 
development 
To get more insights into the phenotypic changes and the underlying molecular program that is 
controlled by RA signaling in the early ureter, we treated E12.5 ureters with 1 µM BMS493 or 
1 µM RA for 18 h and performed microarray analysis of differential gene expression compared 
to untreated controls. We first addressed our hypothesis that RA signaling maintains the pro-
genitor status in the mesenchymal and epithelial compartments of the ureter by examining tran-
scripts that were negatively regulated by RA signaling (Figure 6A, Supplemental Table 4). 
Among the most affected transcripts were several cytokeratins which are known to be expressed 
in urothelial B-cells, including Krt6b, Krt6a, Krt14 and Krt5 [2, 22, 23] as well as transcripts 
encoding for structural components of SMCs, including Actg2, Acta1, Actc1 and Tagln (Figure 
6B, Supplemental Table 4) confirming a functional requirement of RA signaling in preventing 
precocious cell differentiation in the ureter. 
To identify potential RA target genes that may account for this function, we next focused on 
positively regulated transcripts (Figure 6C, Supplemental Table 5). Among the most deregu-
lated transcripts were the well-established RA target genes Dhrs3 and Rarb (Figure 6D; Sup-
plemental Table 5) [16, 24]. To validate the RA-responsive expression of candidate genes and 
to characterize their spatial confinement we performed RNA in situ hybridization analysis on 
explants of E11.5 kidney and ureter rudiments cultured for 1 day in the presence of 1 µM 
BMS493 or 1 µM RA (Figure 6E). As previously shown Rarb expression in the ureteric mes-
enchyme and renal stroma was strongly RA dependent. To our surprise, some genes including 
Tnfsf13b, Il33, Ecm1 and Hic1 were expressed in the renal stroma but not in the ureter of control 
explants. BMS493 treatment abolished expression of these genes, while RA treatment enhanced 
stromal expression and induced expression in the ureteric mesenchyme. Expression of Tgm5 
and Shisa3 was strong in the ureteric mesenchyme of control explants. BMS493 abolished, RA 
treatment slightly enhanced this expression. The weak expression of Shisa3 in the ureteric epi-
thelium and renal collecting ducts was not RA-responsive. Tgm2 showed a weak and ubiquitous 
expression in control explants which was slightly reduced upon BMS493 treatment. Admin-
istration of RA augmented the overall expression level of Tgm2 and induced a strong expression 
in the ureteric mesenchyme. Expression of Elf5 was restricted to the epithelium of the nephric 
duct, the ureter and the collecting ducts and was strongly reduced and enhanced upon BMS493 
and RA treatment, respectively. 
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Figure 6: Identification of RA-responsive genes in microarray experiments. Summary of the results from the microarray 
analysis of E12.5 ureters explanted and treated with DMSO or 1 µM BMS493 or 1 µM RA for 18 h filtered with an intensity 
(Int) threshold of 100 and a fold change (FC) cut-off of 1.2. (A) The Venn diagram displays transcripts that were negatively 
regulated by RA signaling, i.e. up-regulated upon BMS493 treatment (876, red) or down-regulated upon RA treatment (1051, 
green). The intersection shows the common group of negatively regulated transcripts (544). (B) Selected differentiation mark-
ers of urothelial cells and SMCs which were negatively regulated by RA signaling. Genes were ranked according to their 
average FC up-regulation upon BMS493 treatment. (C) The Venn diagram displays transcripts which were positively regulated 
by RA signaling, i.e. down-regulated upon BMS493 treatment (493, green) or up-regulated upon RA treatment (546, red). The 
intersection shows the common group of positively regulated transcripts (228). (D) Top 25 of the common positively regulated 
genes were ranked according to their FC down-regulation upon BMS493 treatment. (E) In situ hybridization analysis of ex-
pression of selected genes which were positively regulated by RA signaling on E11.5 kidney explant cultures, treated with 1 
µM BMS493 or 1 µM RA for 1 day. (F) Schematic illustration of RA signaling function in the maintenance of ureteric pro-
genitors. In the ureteric mesenchyme (left) uncommitted progenitors diversify into adventitial fibrocytes (AF-cells) and bipo-
tent progenitors of SMCs and lamina propria fibrocytes (LP-cells). RA specifically acts in the bipotent progenitors to prevent 
precocious differentiation towards the SMC lineage. In the ureteric epithelium (right) uncommitted progenitors give rise to I-
cells which are maintained by RA signaling by preventing precocious differentiation towards the B- and S-cell lineage. 
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Discussion 
RA signaling is required for the spatiotemporal control of ureteric SMC 
differentiation  
Ureteric SMCs arise in a temporally and spatially tightly controlled manner from the adluminal 
mesenchymal cell layer. Differentiation starts around E15.5 in the proximal region of the ureter 
and progresses distally within the following day [2]. The program depends on epithelial signals, 
SHH and members of WNT family, that activate autocrine BMP4 signaling in the mesenchymal 
compartment [4-6]. Intriguingly all of these signaling pathways are active from E11.5 onwards 
but culminate at E14.5 only in transcriptional activation of Myocd, which encodes the master 
regulator of the SMC differentiation program [25]. While it is conceivable that the delayed 
expression of Myocd results from a gradual build-up of positive signaling inputs, an alternative 
scenario features the presence of inhibitory activities in the undifferentiated ureteric mesen-
chyme.  
Our findings suggest that RA constitutes such an inhibitory signal that acts in the undifferenti-
ated ureteric mesenchyme to temporally and spatially restrict differentiation, possibly through 
modulation of the WNT signaling pathway. A comprehensive expression analysis of compo-
nents and target genes of the pathway revealed that RA signaling is active in the ureteric mes-
enchyme from E11.5 to E14.5, i.e. until the onset of SMC differentiation. Moreover, RA pro-
ducing enzyme genes Aldh1a2 and Aldh1a3 were transiently expressed in the proximal ureter 
but maintained in its distal aspect in line with the delayed onset of SMC differentiation at this 
site. Furthermore, our pharmacological loss- and gain-of-function experiments delimited the 
functional requirement of RA to the interval E11.5 to E14.5. A relative expansion of SMCs at 
the expense of lamina propria fibrocytes under RA loss-of-function conditions suggests that the 
mesenchymal progenitors of the ureter prematurely and preferentially differentiated towards 
the SMC lineage. This hypothesis was further supported by the relative expansion of lamina 
propria fibrocytes under RA gain-of-function conditions. Importantly, the analysis of differen-
tiation markers revealed a precocious differentiation of SMCs when RA signaling was inhib-
ited. 
Microarray analysis characterized the RA-responsive transcriptome in the early ureter. Inter-
estingly, a considerable number of identified genes including Tgm5, Tnfsf13b, Il33, Elf5 and 
Ecm1 were previously reported to be RA-responsive in a similar assay performed for the renal 
stroma of the embryonic kidney [14]. Tnfsf13b and Il33 activate NFkB signaling and have been 
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reported to control renal branching morphogenesis, while Ecm1 exerts a similar function via 
control of GNDF/RET signaling [13, 14]. The present study newly identified the RA-responsive 
expression of two genes encoding antagonists of the WNT signaling pathway in the ureter. Hic1 
encodes for a transcriptional repressor that attenuates canonical WNT signaling by sequestra-
tion of TCF-4 and CTNNB1 in specific nuclear compartments [26]. Sisha3 encodes a member 
of the SHISA family of proteins that inhibit WNT signaling by retention of WNT receptors in 
the endoplasmic reticulum and/or by promoting CTNNB1 degradation [27, 28]. Thus, a nega-
tive modulation of mesenchymal WNT signaling by RA represents a potential molecular mech-
anism to control the timing of ureteric SMC differentiation. 
Since uncommitted mesenchymal progenitors first diversify into adventitial fibrocytes and bi-
potent progenitors of SMCs and lamina propria fibrocytes, we conclude that RA is specifically 
required in the bipotent progenitor to prevent precocious differentiation towards the SMC line-
age. The late re-expression of Ald1a2 in the lamina propria suggests that this cell population 
constitutes a SMC progenitor in homeostasis and regeneration (Figure 6 F). 
RA signaling maintains urothelial progenitors by preventing precocious 
differentiation  
Our previous work has shown that I-cells arise in the ureteric epithelium at E13.5 and differen-
tiate into S-cells and B-cells at E15.5 and E16.5, respectively [2]. How this strict temporal 
sequence of differentiation is molecularly regulated has remained elusive. Studies in the devel-
oping and regenerating bladder urothelium reported a function of RA signaling in urothelial 
specification of endodermal precursors [15]. Given the distinct developmental origin of the 
ureter urothelium from the intermediate mesoderm, it has remained unclear whether this finding 
also accounts for the ureter. The present study suggests that RA signaling in the ureter urothe-
lium is involved in the temporal control of cellular differentiation rather than in the specification 
of progenitor cells. First, pharmacological inhibition of RA signaling in ureter explant cultures 
between E11.5 and E14.5 resulted in a relative expansion of S-cells at the expense of I-cells. 
Moreover, compared to control specimens S-cells and B-cells differentiated one day earlier 
under RA loss-of-function conditions. Second, pharmacological overactivation of RA signaling 
between E11.5 and E14.5 reduced S-cell differentiation, completely blocked B-cell differenti-
ation and resulted in an expansion of I-cells. Even at later time points excessive RA was suffi-
cient to decrease the abundance of B-cells and to expand I-cells. 
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A negative effect of RA signaling on epithelial differentiation and especially on the expression 
of cytokeratins has been reported in the context of keratinocytes, tracheal and bronchial epithe-
lial cells and the salivary gland epithelium [29-31]. In vitro studies of the Krt5 and Krt14 pro-
motor identified an unconventional mechanism of RA-mediated direct transcriptional repres-
sion that involves ligand bound homodimers of RARs [32]. The precocious upregulation of 
several cytokeratin genes under RA loss-of-function conditions indicates that such a mechanism 
may be utilized to control the timing of B-cell differentiation in the urothelium. Alternatively, 
RA may maintain urothelial progenitors indirectly via intermediate factors. Our transcriptome 
analysis revealed RA-dependent expression of Elf5 in the undifferentiated ureteric epithelium. 
The paralogous gene Elf3 has been reported to activate urothelial differentiation downstream 
of PPARG signaling [33]. Recent in vitro studies identified an enrichment of ELF5 binding 
sites in regulatory elements of urothelial differentiation genes [34]. Interestingly, misexpression 
of Elf5 in the lung epithelium interferes with terminal differentiation [35]. Moreover, Elf5 reg-
ulates stem cell self-renewal and counteracts precocious differentiation in the trophoblast [36, 
37]. It is conceivable that, in contrast to Elf3, Elf5 negatively regulates the urothelial differen-
tiation program.  
We conclude that RA signaling acts specifically in the urothelial progenitor, the I-cell, to pre-
vent precocious differentiation of B- and S-cells and to control progenitor self-renewal and 
maintenance in development and homeostasis (Figure 6 F). 
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Concise methods 
Mice 
Gt(ROSA)26So tm4(ACTB-tdTomato-EGFP)Luo (synonym: R26mTmG) [20] and Tbx18tm4(cre)Akis (synonym: 
Tbx18cre) [21] mouse lines were maintained on an NMRI outbred background. Embryos for 
gene expression and microarray analysis were derived from matings of NMRI wildtype mice.  
Tbx18cre/+;R26mTmG/+ embryos were obtained from mating Tbx18cre/+ males with R26mTmG/mTmG 
females. For timed pregnancies, vaginal plugs were checked in the morning after mating, and 
noon was defined as embryonic day (E) 0.5. Embryos and urogenital systems were dissected in 
PBS. Specimens were fixed in 4% PFA/PBS, transferred to methanol and stored at -20°C prior 
to immunofluorescence or in situ hybridization analyses. PCR genotyping was performed on 
genomic DNA prepared from yolk sac or tail biopsies. All animal work conducted for this study 
was performed according to European and German legislation. 
Organ cultures 
Cultures of embryonic ureter and kidney explants were performed as described [2]. BMS493 
(#3509, Tocris) or RA (#0695, Tocris) were dissolved in DMSO and added to the medium at a 
final concentration of 1 µM. Culture medium was replaced every day. 
Histological analysis 
Embryos, urogenital systems or explant cultures were paraffin-embedded and the proximal ure-
ter was sectioned to 5 µm. Hematoxylin and eosin staining was performed according to standard 
procedures. 
In situ hybridization analysis 
Whole-mount in situ hybridization was performed following a standard procedure with digoxig-
enin-labeled antisense riboprobes [38]. Stained specimens were transferred in 80% glycerol 
prior to documentation. In situ hybridization on 10-µm paraffin sections was performed essen-
tially as described [39]. For each marker, at least three independent specimens were analyzed. 
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Immunofluorescent detection of antigens 
Immunofluorescent analysis on 5-µm paraffin sections was done as described [2]. At least three 
embryos of each genotype were used for each analysis. 
Cell proliferation and apoptosis assay 
Cell proliferation rates in explant cultures (n=3 per condition) were investigated by the detec-
tion of incorporated BrdU on 5 µm paraffin sections similar to published protocols [40]. Explant 
cultures where incubated for 2 h with 3.3 µg/ml BrdU in the culture medium. For each specimen 
12 sections of the proximal ureter were assessed. The BrdU-labeling index was defined as the 
number of BrdU-positive nuclei relative to the total number of nuclei as detected by 4',6-dia-
midino-2-phenylindole (DAPI) counterstaining in arbitrarily defined compartments of the ure-
ter. Data were expressed as mean ± standard deviation. Apoptosis was analyzed on 5 µm par-
affin sections using the ApopTag Plus Fluorescein In Situ Apoptosis Detection Kit (Chemicon). 
Microarray 
Three independent pools of 50 E12.5 ureters were cultured with DMSO or 1 μM BMS493 or 1 
μM RA for 18 h. Total RNA was extracted with peqGOLD RNApure (PeqLab) and was sent 
to the Research Core Unit Transcriptomics of Hannover Medical School where RNA was Cy3-
labeled and hybridized to Agilent Whole Mouse Genome Oligo v2 (4x44K) Microarrays. To 
identify differentially expressed genes, normalized expression data was filtered using Excel 
based on an intensity threshold of 100 and a more than 1.2 fold change in all pools. 
Image documentation 
Sections and organ cultures were photographed using a Leica DM5000 microscope with Leica 
DFC300FX digital camera or a Leica DM6000 microscope with Leica DFC350FX digital cam-
era. Figures were prepared with Adobe Photoshop CS4.  
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Supplementary Material 
Supplementary Figures 
 
 
  
Supplemental Figure 1: Aldh1a2 and Aldha3 are expressed in urogenital system development. Expression analysis by 
whole mount in situ hybridization of Aldh1a2 and Aldh1a3 on E11.5 kidney rudiments and E12.5, E14.5, E16.5 and E18.5 
whole urogenital systems. Aldh1a2 expression is found in the prospective ureteric mesenchyme at E11.5. At subsequent stages 
expression is confined to the distal ureteric mesenchyme at the ureter-bladder junction and to the renal stroma. Aldh1a3 is 
expressed in the nephric duct from E11.5 to E14.5, the distal ureteric epithelium from E11.5 to E14.5 and to the ureteric tip 
and collecting duct system, respectively, from E11.5 to E18.5. 
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Supplemental Figure 2: 1 µM BMS493 or 1 µM RA are sufficient to inhibit or activate RA signaling in kidney explant
cultures. E11.5 kidney rudiments were cultured for 18 h in the presence of DMSO, 1 µM BMS493 or 1 µM RA and subjected 
to in situ hybridization analysis of expression of the RA receptor and RA target gene Rarb. Reduced expression upon BMS493 
treatment and increased expression upon RA treatment indicates that these conditions are suitable for the manipulation of RA 
signaling activity. 
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Supplemental Figure 3: Pharmacological manipulation of RA signaling in E11.5 kidney explant cultures. E11.5 
Tbx18cre/+;R26mTmG/+ kidney rudiments were explanted and cultured for 14 d in the presence of DMSO, 1 µM BMS493 or 1 
µM RA. Brightfield and GFP/RFP epifluorescence images are displayed to visualize explant growth after 0 d, 4 d, 8 d and 14 
d of culture under given conditions. GFP expression marks the ureteric mesenchyme and a sub-population of the renal stroma. 
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Supplemental Figure 4: Pharmacological manipulation of RA signaling in E12.5 kidney explant cultures. E12.5 
Tbx18cre/+;R26mTmG/+ kidney rudiments were explanted and cultured for 12 d in the presence of DMSO, 1 µM BMS493 or 1 
µM RA. Brightfield and GFP/RFP epifluorescence images are displayed to visualize explant growth after 0 d, 4 d, 8 d and 12 
d of culture under given conditions. GFP expression marks the ureteric mesenchyme and a sub-population of the renal stroma. 
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Supplemental Figure 5: Pharmacological manipulation of RA signaling in E14.5 ureter explant cultures. E14.5 
Tbx18cre/+;R26mTmG/+ ureters were explanted and cultured for 10 d in the presence of DMSO, 1 µM BMS493 or 1 µM RA. 
Brightfield and GFP/RFP epifluorescence images are displayed to visualize explant growth after 0 d, 2 d, 6 d and 10 d of culture 
under given conditions. GFP expression marks the ureteric mesenchyme. 
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Supplemental Figure 6: Pharmacological manipulation of RA signaling in E16.5 ureter explant cultures. E16.5 
Tbx18cre/+;R26mTmG/+ ureters were explanted and cultured for 8 d in the presence of DMSO, 1 µM BMS493 or 1 µM RA. 
Brightfield and GFP/RFP epifluorescence images are displayed to visualize explant growth after 0 d, 2 d, 4 d and 8 d of culture 
under given conditions. GFP expression marks the ureteric mesenchyme. 
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Supplemental Figure 7: Pharmacological manipulation of RA signaling in E18.5 ureter explant cultures. E18.5 
Tbx18cre/+;R26mTmG/+ ureters were explanted and cultured for 6 d in the presence of DMSO, 1 µM BMS493 or 1 µM RA. 
Brightfield and GFP/RFP epifluorescence images are displayed to visualize explant growth after 0 d, 2 d, 4 d and 6 d of culture 
under given conditions. GFP expression marks the ureteric mesenchyme. 
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E11.5 + 14d A-cells (%) SM-cells (%) LP-cells (%) 
DMSO 31.6 ± 4.5 44.6 ± 2.6 23.8 ± 3.2
1 µM BMS493 42.4 ± 4.7 53.7 ± 2.6 (p=2.4E-03) 3.9 ± 2.5 (p=6.2E-05)
1 µM RA 37.4 ± 0.6 35.5 ± 2.4 (p=5.4E-03) 27.1 ± 2.4
E12.5 + 12d A-cells (%) SM-cells (%) LP-cells (%) 
DMSO 43.5 ± 11.8 40.8 ± 11.7 15.7 ± 2.2
1 µM BMS493 38.1 ± 2.3 56.2 ± 2.1 (p=3.6E-06) 5.7 ± 2.2 (6.1E-05)
1 µM RA 49.5 ± 4.1 30.2 ± 5.2 (p=2.2E-03) 20.3 ± 2.0 (1.0E-02)
E14.5 + 10d A-cells (%) SM-cells (%) LP-cells (%) 
DMSO 25.6 ± 3.5 57.9 ± 4.3 16.5 ± 1.1
1 µM BMS493 19.3 ± 2.1 (p=9.2E-03) 70.1 ± 3.0 (p=8.5E-04) 10.6 ± 3.6  (p=7.2E-03)
1 µM RA 28.5 ± 2.8 54.0 ± 5.7 17.5 ± 4.4
E16.5 + 8d A-cells (%) SM-cells (%) LP-cells (%) 
DMSO 25.7 ± 2.5 59.5 ± 2.9 14.8 ± 0.8
1 µM BMS493 24.4 ± 2.1 60.5 ± 2.3 15.0 ± 1.6
1 µM RA 24.5 ± 2.1 60.7 ± 2.3 14.8 ± 1.6
E18.5 + 6d A-cells (%) SM-cells (%) LP-cells (%) 
DMSO 35.6 ± 2.2 53.0 ± 3.0 11.4 ± 1.3
1 µM BMS493 33.7 ± 3.2 54.0 ± 2.5 12.3 ± 2.9
1 µM RA 35.2 ± 1.4 53.2 ± 1.1 11.6 ± 1.5
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E11.5 + 14d B-cells (%) I-cells (%) S-cells (%) 
DMSO 35.0 ± 11.8 62.6 ± 11.7 2.4 ± 2.2
1 µM BMS493 42.0 ± 7.0 31.5 ± 10.7 (p=7.2E-04) 26.5 ± 7.4 (p=1.8E-05)
1 µM RA 2.0 ± 1.8 (p=4.8E-05) 95.0 ± 10.9 (p=4.9E-05) 3.0 ± 1.2
E12.5 + 12d B-cells (%) I-cells (%) S-cells (%) 
DMSO 44.7 ± 2.3 49.7 ± 2.3 5.6 ± 1.5
1 µM BMS493 45.3 ± 4.1 25.4 ± 9.3 (p=2.3E-04) 29.4 ± 8.2 (p=9.9E-05)
1 µM RA 6.9 ± 1.9 (p=3.5E-10) 85.9 ± 7.1 (p=8.3E-07) 7.1 ± 5.5
E14.5 + 10d B-cells (%) I-cells (%) S-cells (%) 
DMSO 24.3 ± 5.2 71.5 ± 7.2 4.2 ± 3.4
1 µM BMS493 22.9 ± 7.9 50.4 ± 4.9 (p=1.9E-06) 26.7 ± 5.3 (p=1.2E-08)
1 µM RA 3.4 ± 2.9 (p=1.3E-08) 89.2 ± 4.3 (p=1.1E-05) 7.4 ± 3.3
E16.5 + 8d B-cells (%) I-cells (%) S-cells (%) 
DMSO 53.1 ± 7.5 44.1 ± 7.0 2.8 ± 1.1
1 µM BMS493 52.3 ± 6.9 45.3 ± 7.0 2.3 ± 0.7
1 µM RA 32.8 ± 6.8 (p=1.8E-05) 65.3 ± 6.7 (p=6.3E-06) 1.9 ± 0.6
E18.5 + 6d B-cells (%) I-cells (%) S-cells (%) 
DMSO 80.4 ± 3.9 14.6 ± 3.8 5.0 ± 1.3
1 µM BMS493 84.5 ± 4.4 9.9 ± 2.8 5.6 ± 2.2
1 µM RA 71.3 ± 2.6 (p=8.4E-04) 22.9 ± 3.0 (p=2.0E-02) 5.8 ± 1.2
Supplemental Table 2: Ratios of urothelial cell types under RA loss- and gain-of-function conditions. 
Values are displayed in % as mean ± sd of basal cells (B-cells), intermediate cells (I-cells) and superficial 
cells (S-cells) with respect to the total cell number. Quantification is based on 6 sections of the proximal 
ureter from 3 individuals of each stage and condition. Student’s t-test was applied to test for significant dif-
ferences between control (DMSO) and test groups (BMS493 or RA). P-values are shown in brackets when p 
≤ 0.01. 
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E11.5 + 1d IM OM E 
DMSO 0.266 ± 0.045 0.073 ± 0.022 0.006 ± 0.021
1 µM BMS493 0.159 ± 0.055 ** 0.081 ± 0.033 0.042 ± 0.04
1 µM RA 0.261 ± 0.082 0.077 ± 0.021 0.032 ± 0.038
E12.5 + 1d IM OM E 
DMSO 0.293 ± 0.034 0.138 ± 0.023 0.234 ± 0.148
1 µM BMS493 0.265 ± 0.063 0.136 ± 0.017 0.166 ± 0.068
1 µM RA 0.261 ± 0.069 0.137 ± 0.018 0.2 ± 0.141
E14.5 + 1d IM OM E 
DMSO 0.263 ± 0.061 0.155 ± 0.020 0.336 ± 0.024
1 µM BMS493 0.218 ± 0.035 0.14 ± 0.012 0.321 ± 0.073
1 µM RA 0.258 ± 0.046 0.169 ± 0.037 0.374 ± 0.052
Supplemental Table 3: Proliferation rates in the developing ureter under RA loss- and gain-of-function 
conditions. Shown are BrdU indices for the inner mesenchymal (IM) and outer mesenchymal compartment (OM) 
and the ureteric epithelium (E) as mean ± sd. Quantification is based on 12 sections of the proximal ureter from 3 
individuals of each stage and condition. Student’s t-test was applied to test for significant differences between 
control (DMSO) and test groups (BMS493 or RA). ** p=3.350E-05. 
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Rank Gene symbol BMS493 FC 1 BMS493 FC 2 BMS493 FC 3 BMS493 Avg FC RA FC 1 RA FC 2 RA FC 3 RA Avg FC
1 Corin 4.4 5.3 3.6 4.4 -2.4 -1.8 -1.3 -1.8
2 Pkp1 5.0 4.0 4.2 4.4 -3.6 -3.4 -6.3 -4.4
3 3830417A13Rik 3.8 4.2 4.7 4.2 -5.8 -3.1 -2.9 -4.0
4 S100a4 4.0 4.5 4.0 4.2 -3.7 -2.8 -5.0 -3.8
5 Krt6b 4.4 5.0 2.6 4.0 -2.4 -3.2 -7.8 -4.4
6 Serpinb5 4.4 4.6 2.2 3.7 -1.2 -1.8 -9.5 -4.2
7 Col17a1 3.1 4.7 2.9 3.6 -2.1 -1.6 -5.8 -3.2
8 Krt6a 4.0 4.2 2.1 3.4 -2.9 -2.8 -4.9 -3.6
9 Rgcc 3.1 3.5 3.3 3.3 -2.6 -3.9 -6.1 -4.2
10 AK008770 2.6 4.0 3.0 3.2 -1.5 -1.6 -2.0 -1.7
11 Krt14 3.3 3.7 2.3 3.1 -1.7 -2.5 -4.4 -2.8
12 Ly6d 3.2 2.6 2.8 2.9 -1.8 -1.4 -2.7 -2.0
13 Serpine1 3.3 2.9 2.6 2.9 -2.8 -2.5 -7.3 -4.2
14 Nr0b1 2.2 2.8 3.5 2.8 -1.3 -1.8 -2.1 -1.7
15 Crlf1 2.7 2.8 2.7 2.7 -1.0 -1.2 -2.7 -1.7
16 Dkk1 2.3 2.6 3.1 2.7 -4.3 -3.5 -4.4 -4.1
17 Gm5476 2.4 3.5 2.1 2.7 -2.0 -2.3 -4.1 -2.8
18 Kcnc2 2.5 2.9 2.5 2.7 -3.0 -2.0 -1.7 -2.2
19 Osr2 3.4 2.6 2.0 2.7 -2.1 -1.4 -2.2 -1.9
20 Ugt2b34 2.3 2.7 3.2 2.7 -4.3 -4.8 -5.0 -4.7
21 Efcab6 2.6 2.9 2.1 2.6 -2.4 -2.4 -2.4 -2.4
22 Ryr3 2.8 2.5 2.5 2.6 -1.6 -1.9 -2.3 -1.9
23 Glis1 2.2 2.4 2.8 2.5 -2.1 -2.0 -1.7 -1.9
24 Mc4r 3.0 2.3 2.2 2.5 -2.6 -2.5 -3.0 -2.7
25 Pcp4l1 2.3 2.4 2.8 2.5 -1.4 -1.2 -1.4 -1.3
26 Penk 2.4 2.2 2.9 2.5 -2.6 -3.2 -3.2 -3.0
27 Rasgrf1 3.4 2.2 2.0 2.5 -8.4 -4.6 -4.9 -5.9
28 Serpina3f 2.2 2.8 2.6 2.5 -1.9 -2.0 -4.5 -2.8
29 Wif1 2.5 2.8 2.3 2.5 -2.4 -2.4 -2.3 -2.4
30 Aard 2.7 2.1 2.3 2.4 -2.2 -2.1 -2.6 -2.3
31 Cbr2 2.8 2.4 2 2.4 -2.3 -2.4 -2.9 -2.5
32 AK137313 2.2 2.4 2.3 2.3 -1.9 -2.2 -1.6 -1.9
33 Col8a1 2.1 2.1 2.8 2.3 -2.7 -5.3 -5.7 -4.6
34 Gm10639 1.8 2.3 2.8 2.3 -2.9 -2.6 -2.7 -2.7
35 Grm7 2 2.7 2.1 2.3 -4.4 -3.7 -4.2 -4.1
36 Higd1c 2.9 2.6 1.4 2.3 -4.9 -4.6 -8.7 -6
37 Lypd3 2.6 2.3 2 2.3 -1.6 -1.4 -2.3 -1.8
38 Serpina3i 2.4 2.7 1.9 2.3 -1.7 -1.7 -5.2 -2.8
39 Slc26a7 2.4 1.9 2.5 2.3 -2.6 -1.7 -2 -2.1
40 8430436N08Rik 2.1 1.9 2.7 2.2 -3.3 -1.4 -7 -3.9
41 C1qtnf7 2.2 2.3 2 2.2 -1.9 -1.6 -1.8 -1.8
42 Cxcl5 1.9 2.4 2.2 2.2 -2.4 -2.1 -4.3 -2.9
43 Gabra1 2.1 1.9 2.5 2.2 -5.3 -5.8 -5.9 -5.7
44 Npy 2.9 2 1.6 2.2 -5.4 -4.9 -5.4 -5.2
45 Nts 2 2.8 1.8 2.2 -3.4 -4 -9.5 -5.6
46 Pde4d 2 2 2.6 2.2 -2.9 -4 -2.2 -3
47 Trim29 2.8 2.2 1.7 2.2 -2.2 -1.4 -3.1 -2.2
48 Vgf 1.9 2.9 1.8 2.2 1 -1.1 -4.6 -1.5
49 Cd55 1.8 2 2.4 2.1 -1.7 -2.1 -1.4 -1.7
50 Dmkn 1.8 2.1 2.3 2.1 -1.6 -1.5 -1.6 -1.6
Supplemental Table 4: Transcripts identified by microarray analysis that were negatively regulated by RA in the early 
ureter. Shown is a list of transcripts that were negatively regulated by RA, i.e. upregulated after BMS493 treatment and down-
regulated after RA treatment of E12.5 ureter explants. Three groups for each condition were compared to untreated controls 
and the resulting fold changes (FC) in expression are displayed. Intensity thresholds were >100 for the BMS493 treated ex-
plants; fold changes were larger than 1.2. 
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Rank Gene symbol BMS493 FC 1 BMS493 FC 2 BMS493 FC 3 BMS493 Avg FC RA FC 1 RA FC 2 RA FC 3 RA Avg FC
51 Fbp1 2.4 2.4 1.5 2.1 -2.2 -1.7 -2 -2
52 Gsdma 1.9 2 2.3 2.1 -1.5 -1.3 -1.6 -1.5
53 Kcnip4 2.2 2 1.9 2.1 -1.8 -2.7 -3.1 -2.5
54 Krt17 2.3 2.7 1.3 2.1 1.2 -2.1 -6.1 -2.3
55 Krt5 2.4 2.2 1.7 2.1 -2.1 -1.9 -3.7 -2.5
56 Rasd2 1.9 2.6 1.7 2.1 -3.1 -2.5 -2.5 -2.7
57 Rasl10a 2.1 2.1 2 2.1 -1.1 -1.4 -1.5 -1.4
58 Vcam1 2.1 2.2 2 2.1 -2.8 -3 -3.1 -3
59 5031415H12Rik 1.6 2.3 2 2 -2 -1.5 -1.7 -1.7
60 Anxa8 2.1 2.1 1.7 2 -2.4 -2.2 -3.7 -2.8
61 Artn 1.9 2.1 2 2 -1.8 -1.5 -1.8 -1.7
62 Dmrta2 1.7 2 2.2 2 -1.6 -1.5 -1.3 -1.5
63 Daf2 2 1.9 2 2 -1.8 -1.9 -1.7 -1.8
64 Dlx5 1.8 1.7 2.5 2 -2.1 -1.8 -2.1 -2
65 Emp2 1.5 2.8 1.8 2 -1.5 -1.3 -1.4 -1.4
66 Fam65c 2.3 2.1 1.5 2 -2.3 -1.8 -2.9 -2.3
67 Gem 2 2.1 2 2 -1.8 -1.5 -2 -1.8
68 Guca2a 2.2 2.2 1.5 2 -1.6 -1.7 -2.4 -1.9
69 Kcnab1 2 1.9 2.1 2 -2.3 -1.8 -2.8 -2.3
70 Krt16 2 1.6 2.4 2 -1.1 -1.2 -1.5 -1.3
71 Ltbp2 2 2.3 1.8 2 -2.4 -2.2 -4.6 -3.1
72 Meox2 1.5 1.5 3 2 -1.2 -1.2 -1.3 -1.3
73 Mt2 1.9 2 2.1 2 -1.8 -1.9 -1.6 -1.7
74 Pgam2 2 1.9 2 2 -1.5 -1.5 -1.8 -1.6
75 Bfsp2 2.1 1.9 1.8 1.9 -1.8 -1.9 -2.3 -2
76 Cx3cl1 1.8 1.8 1.9 1.9 -1.5 -1.3 -3.1 -1.9
77 Hmcn1 2.1 2 1.7 1.9 -1.9 -1.6 -1.7 -1.8
78 Ifi202b 2 2.2 1.5 1.9 -1.2 -1.3 -3.4 -2
79 Isl2 1.7 1.7 2.4 1.9 -1.4 -1.2 -1.3 -1.3
80 Krtdap 2.1 2 1.6 1.9 -1.1 -1.2 -2.1 -1.5
81 Nfatc2 1.6 2.1 1.9 1.9 -1.5 -1.3 -1.3 -1.4
82 Tcea3 1.9 2.3 1.5 1.9 -1.4 -1.4 -1.4 -1.4
83 Rasgef1a 1.4 2.2 2 1.9 -2.4 -1.9 -2.1 -2.1
84 S100a6 2.1 2 1.5 1.9 -1.7 -1.7 -3 -2.1
85 Svep1 1.8 2.1 1.8 1.9 -2 -1.4 -1.7 -1.7
86 Tfap2a 1.8 2.6 1.3 1.9 -1.7 -1.2 -1.4 -1.4
87 Tfap2c 1.7 1.6 2.4 1.9 -1.4 -1.4 -1.1 -1.3
88 Tox 1.9 1.9 1.9 1.9 -3.1 -2.4 -3.1 -2.9
89 Adamtsl5 2.1 1.6 1.7 1.8 -1.4 -1.4 -2.3 -1.7
90 Aqp3 1.7 1.6 2.2 1.8 -2.8 -2.7 -1.9 -2.5
91 Arc 1.9 2 1.6 1.8 -1.7 -1.4 -3.8 -2.3
92 Ctgf 1.7 1.9 1.8 1.8 -3 -3.1 -5.1 -3.7
93 Dlk1 2.3 1.9 1.3 1.8 -1.7 -1.4 -2.7 -1.9
94 Egr4 1.5 2.3 1.7 1.8 -3 -2.5 -5.7 -3.7
95 ENSMUST00000064591 2 1.9 1.6 1.8 -1.4 -1.6 -2.5 -1.8
96 Fam81a 1.5 2.4 1.6 1.8 -1.5 -1.8 -1.8 -1.7
97 Figf 1.9 2.1 1.3 1.8 -2.1 -2.1 -2.8 -2.3
98 Gm10387 1.4 2.7 1.2 1.8 -2.5 -2.4 -2 -2.3
99 Gm2115 1.8 1.8 1.8 1.8 -1.5 -1.9 -2 -1.8
100 Gnas 1.8 2.1 1.5 1.8 -2.8 -3.6 -3.5 -3.3
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101 Gpr165 2.2 1.6 1.5 1.8 -3 -1.6 -1.9 -2.2
102 Hspb2 2 2.1 1.5 1.8 -1.9 -2 -3.3 -2.4
103 Lrrc15 2 2.2 1.2 1.8 -1.7 -1.7 -3.5 -2.3
104 Mdga2 1.4 2.2 1.9 1.8 -1.8 -2.6 -2.3 -2.2
105 Nov 1.8 1.8 1.7 1.8 -2.4 -2.1 -2.8 -2.4
106 Perp 1.9 1.8 1.7 1.8 -2 -1.5 -3 -2.2
107 Ptchd4 1.5 2.2 1.7 1.8 -1.7 -1.5 -2 -1.8
108 Rab38 1.7 1.9 1.8 1.8 -1.7 -2.1 -3.1 -2.3
109 Rgs4 1.6 1.8 1.9 1.8 -3.4 -4.3 -4.5 -4.1
110 Rgs5 1.7 1.8 1.9 1.8 -3.3 -5.5 -5.5 -4.8
111 Six2 1.6 1.7 2 1.8 -2.3 -1.4 -1.9 -1.9
112 Robo2 1.7 1.8 1.9 1.8 -2.2 -2.1 -1.5 -1.9
113 Sgk2 1.4 1.9 2.1 1.8 -3.2 -2.3 -2.6 -2.7
114 Tfap2b 2 2 1.3 1.8 -2.4 -2.4 -2.9 -2.6
115 Sytl2 2 1.5 1.8 1.8 -1.9 -1.6 -1.9 -1.8
116 TC1654523 1.6 2.1 1.6 1.8 -2.1 -1.4 -1.6 -1.7
117 Vnn1 1.4 1.9 2.1 1.8 -1.8 -1.8 -1.7 -1.8
118 Zfp365 1.8 1.8 1.9 1.8 -2.6 -2.2 -2.2 -2.3
119 1700038P13Rik 1.6 1.8 1.6 1.7 -1.6 -1.5 -1.2 -1.4
120 4631405K08Rik 1.7 2.3 1.2 1.7 -2.1 -1.5 -2.2 -1.9
121 Aldh1a2 1.8 1.8 1.6 1.7 -2.3 -1.8 -1.8 -2
122 Ascl2 1.9 1.3 1.9 1.7 -1.5 -1.3 -1.2 -1.3
123 Bgn 2 1.6 1.4 1.7 -1.5 -1.5 -2.4 -1.8
124 Trp63 1.3 2.3 1.6 1.7 -3.3 -2.5 -2.7 -2.8
125 Ctsc 1.7 2 1.4 1.7 -1.9 -1.7 -3.2 -2.3
126 Cyr61 1.6 1.8 1.7 1.7 -1.9 -1.7 -2.5 -2
127 D630013G24Rik 1.5 1.8 1.6 1.7 -1.6 -1.4 -1.3 -1.5
128 Dclk2 2 1.7 1.5 1.7 -1.5 -1.4 -1.4 -1.4
129 Ddah1 1.6 1.8 1.6 1.7 -1.3 -1.4 -2.1 -1.6
130 Dkk2 1.5 1.8 1.7 1.7 -3 -3.4 -4.5 -3.6
131 Egr2 1.6 1.7 2 1.7 -2.6 -2.4 -5.3 -3.4
132 Epha3 1.5 1.5 1.9 1.7 -2.4 -2.8 -2.4 -2.5
133 Gabrb2 1.8 2 1.4 1.7 -3 -2.3 -3.1 -2.8
134 Cited1 1.7 2 1.6 1.7 -1.3 -1.4 -1.2 -1.3
135 Itga7 1.9 1.8 1.5 1.7 -1.4 -1.5 -1.4 -1.4
136 Kcnq5 1.9 1.9 1.5 1.7 -2.1 -1.4 -1.8 -1.8
137 Ms4a7 1.9 2.1 1.1 1.7 -1.5 -1.8 -3.9 -2.4
138 Ndrg1 1.9 1.9 1.5 1.7 -1.6 -1.2 -1.7 -1.5
139 Nr4a1 1.8 1.7 1.5 1.7 -1.7 -1.5 -2.5 -1.9
140 Osmr 2 1.8 1.2 1.7 -1.8 -1.4 -3.2 -2.1
141 Pip5k1a 1.6 1.8 1.7 1.7 -1.5 -1.4 -1.5 -1.5
142 Pitx2 1.6 1.8 1.7 1.7 -2 -1.5 -1.8 -1.8
143 Rarres1 1.8 1.5 1.8 1.7 -1.6 -1.6 -2.2 -1.8
144 Serpinb1a 2.1 1.8 1.1 1.7 -1.4 -1.5 -2 -1.6
145 Stc1 1.8 1.6 1.7 1.7 -1.7 -2.2 -1.8 -1.9
146 Tmem132c 1.6 1.8 1.8 1.7 -2 -1.6 -1.5 -1.7
147 Trim47 1.6 1.7 1.7 1.7 -1.8 -1.6 -2.9 -2.1
148 Ttc22 1.8 1.6 1.6 1.7 -1.9 -1.3 -1.8 -1.7
149 Wnt6 1.6 1.6 2 1.7 -1.5 -1.3 -1.3 -1.3
150 Zmat4 1.7 1.9 1.7 1.7 -1.6 -1.3 -2.4 -1.8
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151 1500015O10Rik 1.5 1.7 1.5 1.6 -2.3 -2.6 -3.9 -2.9
152 2900001G08Rik 1.4 2 1.5 1.6 -1.8 -1.3 -1.5 -1.5
153 A4galt 1.4 1.7 1.7 1.6 -1.6 -1.3 -1 -1.3
154 Ace2 1.7 1.7 1.4 1.6 -6.1 -5.1 -4.9 -5.4
155 Actg2 1.6 1.8 1.5 1.6 -2.1 -1.7 -2.9 -2.2
156 Agtr1a 1.6 1.7 1.5 1.6 -1.6 -1.5 -1.6 -1.6
157 Ankrd1 1.6 1.6 1.5 1.6 -1.2 -1.2 -3.8 -2.1
158 Atp6v0a4 1.5 1.6 1.6 1.6 -1.3 -1.3 -1.3 -1.3
159 Btc 1.8 1.6 1.4 1.6 -2 -1.8 -1.9 -1.9
160 Cacna2d3 1.5 1.5 1.6 1.6 -1.3 -1.2 -1.4 -1.3
161 Calcrl 2 1.4 1.4 1.6 -2.7 -2 -2.3 -2.3
162 Cartpt 1.9 1.7 1.2 1.6 -2.4 -4.1 -4.9 -3.8
163 Cd44 1.7 1.7 1.3 1.6 -1.8 -1.3 -2.1 -1.7
164 Hopx 2.1 1.4 1.3 1.6 -1.7 -1.7 -2.2 -1.9
165 Col5a3 1.7 1.6 1.4 1.6 -1.6 -1.3 -2 -1.6
166 D630010B17Rik 1.6 1.7 1.6 1.6 -1.8 -1.9 -2.1 -1.9
167 Dusp2 1.5 1.5 1.6 1.6 -1.2 -1.2 -1.7 -1.3
168 Fam150b 1.7 1.8 1.3 1.6 -2.8 -3.1 -7.8 -4.6
169 Fas 1.4 1.7 1.5 1.6 -1.9 -2.2 -4.2 -2.7
170 Fgf12 1.8 1.7 1.4 1.6 -1.6 -1.8 -1.4 -1.6
171 Gas2 1.4 1.5 1.8 1.6 -1.6 -1.8 -2.1 -1.8
172 Gfra2 1.7 1.6 1.4 1.6 -2.2 -2.3 -1.9 -2.1
173 Hist2h2bb 1.6 1.8 1.4 1.6 -1.7 -1.4 -1.3 -1.5
174 Itga11 1.4 1.7 1.6 1.6 -2.2 -1.3 -2.1 -1.9
175 Kcnn2 1.7 1.7 1.3 1.6 -1.9 -1.6 -1.8 -1.8
176 Lama3 1.6 1.6 1.5 1.6 -1.3 -1.2 -2.6 -1.7
177 Lgi2 1.7 1.5 1.6 1.6 -1.4 -1.9 -1.5 -1.6
178 Lhfpl3 1.9 1.4 1.5 1.6 -1.3 -2.2 -1.9 -1.8
179 Lmo1 1.6 1.6 1.5 1.6 -2.2 -2.8 -3 -2.6
180 Lrrtm1 1.6 1.7 1.4 1.6 -2.1 -2.2 -2.6 -2.3
181 40603 1.5 1.7 1.6 1.6 -1.4 -1.7 -2.2 -1.8
182 Nfkbiz 1.7 2 1.3 1.6 -1.9 -1.5 -2 -1.8
183 Npas4 1.6 1.5 1.5 1.6 -1.5 -1.4 -1.7 -1.5
184 Nrp2 1.6 1.9 1.2 1.6 -1.3 -1.3 -1.7 -1.4
185 Ntrk3 1.7 1.7 1.3 1.6 -1.7 -1.4 -2.2 -1.8
186 Pcdh10 1.7 1.7 1.5 1.6 -1.3 -1.8 -1.7 -1.6
187 Pcdhac2 1.3 2.1 1.4 1.6 -1.4 -1.4 -1.2 -1.3
188 Pdgfrb 1.6 1.6 1.4 1.6 -2.3 -1.8 -1.9 -2
189 Plekha4 1.8 1.6 1.4 1.6 -1.5 -1.4 -2.1 -1.7
190 Ppp1r3d 1.5 1.6 1.7 1.6 -1.4 -1.4 -1.3 -1.4
191 Prrx2 1.5 1.6 1.8 1.6 -1.2 -1.5 -1.5 -1.4
192 Ptchd1 1.6 1.6 1.5 1.6 -2.1 -2.3 -2.2 -2.2
193 Ptgs2 1.6 1.8 1.5 1.6 -1 -2 -4.2 -2.4
194 Rasgrp2 1.7 1.5 1.4 1.6 -1.5 -1.3 -2 -1.6
195 Slc23a3 1.4 1.5 2 1.6 -1.9 -1.9 -1.6 -1.8
196 Hand1 1.9 1.5 1.4 1.6 -1.5 -2 -2.5 -2
197 1500009L16Rik 1.4 1.4 1.6 1.5 -1.3 -1.5 -1.7 -1.5
198 1700040L02Rik 1.3 1.7 1.5 1.5 -1.7 -1.7 -1.5 -1.6
199 1810011O10Rik 1.5 1.4 1.7 1.5 -1.5 -1.7 -2.4 -1.9
200 2010111I01Rik 1.4 1.4 1.7 1.5 -1.4 -1.5 -1.7 -1.5
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201 5330426P16Rik 1.4 1.4 1.6 1.5 -1.5 -1.5 -1.5 -1.5
202 A_55_P1953377 1.5 1.8 1.1 1.5 -1.6 -1.4 -2.8 -1.9
203 A930009L07Rik 1.4 1.8 1.2 1.5 -3.1 -7.2 -4.8 -5
204 Acta1 1.7 1.4 1.4 1.5 -1.2 -1.3 -2.7 -1.8
205 Hr 1.5 1.9 1.1 1.5 -3 -2.6 -2.6 -2.7
206 Ahrr 1.2 1.5 2 1.5 -2.1 -2.1 -1.1 -1.8
207 AK036131 1.3 1.7 1.4 1.5 -1.3 -1.6 -1.1 -1.3
208 Arid5a 1.5 1.6 1.5 1.5 -1.5 -1.4 -1.7 -1.5
209 Aspn 1.6 1.5 1.5 1.5 -1.8 -1.6 -2 -1.8
210 AY512938 1.4 1.4 1.7 1.5 -1.5 -1.6 -1.3 -1.5
211 Bdnf 1.3 1.5 1.6 1.5 -1.3 -1.4 -2.6 -1.8
212 C1qtnf2 1.8 1.2 1.4 1.5 -1.4 -1.6 -1.7 -1.6
213 Calcr 1.5 1.5 1.4 1.5 -2 -1.7 -1.1 -1.6
214 Cap2 1.7 1.3 1.5 1.5 -1.5 -1.3 -1.4 -1.4
215 Ccdc3 1.5 1.7 1.3 1.5 -1.7 -1.5 -1.7 -1.7
216 Cdkn2b 1.5 1.6 1.3 1.5 -1 -1.6 -2.9 -1.9
217 Col12a1 1.5 1.5 1.6 1.5 -1.5 -1.3 -1.4 -1.4
218 Cryab 1.9 1.3 1.3 1.5 -1.4 -1.7 -2.1 -1.7
219 Dgkk 1.4 1.7 1.4 1.5 -1.8 -2.7 -1.6 -2
220 Dmrta1 1.3 1.6 1.5 1.5 -1.8 -1.9 -1.9 -1.9
221 Fam83g 1.4 1.7 1.4 1.5 -1.5 -1.2 -1.5 -1.4
222 Fbn2 1.6 1.7 1.2 1.5 -1.5 -1.6 -1.4 -1.5
223 Fn1 1.5 1.3 1.6 1.5 -1.4 -1.4 -1.4 -1.4
224 Frzb 1.5 1.6 1.5 1.5 -2 -1.7 -2.1 -1.9
225 Fxyd2 1.2 1.4 1.8 1.5 -1.4 -1.7 -1.6 -1.6
226 Gadd45b 1.6 1.5 1.5 1.5 -1.2 -1.6 -2.3 -1.7
227 Gpr17 1.9 1.6 1.1 1.5 -1.7 -2.5 -2.6 -2.3
228 Gsn 1.4 1.5 1.4 1.5 -1.4 -1.2 -1.3 -1.3
229 Fos 1.4 1.5 1.6 1.5 -1.6 -1.8 -2.4 -1.9
230 Hspb1 1.5 1.2 1.6 1.5 -1.2 -1.5 -1.6 -1.4
231 Htra1 1.3 1.6 1.5 1.5 -1.4 -1.2 -1.7 -1.4
232 Inhba 1.5 1.8 1.3 1.5 -1.1 -1.4 -3.5 -2
233 Inhbb 1.6 1.8 1.3 1.5 -2.7 -1.9 -2.3 -2.3
234 Ism1 1.5 1.6 1.4 1.5 -1.9 -1.5 -1.6 -1.7
235 Itga4 1.5 1.6 1.5 1.5 -1.6 -1.5 -1.5 -1.5
236 Jag1 1.5 1.5 1.4 1.5 -1.5 -1.4 -1.6 -1.5
237 Kctd12 1.5 1.4 1.5 1.5 -2 -2.1 -1.3 -1.8
238 Klc3 1.6 1.4 1.4 1.5 -1.2 -1 -1.6 -1.3
239 Loxl1 1.7 1.4 1.2 1.5 -1.5 -1.3 -1.9 -1.6
240 Lum 1.5 1.4 1.6 1.5 -2.7 -3.5 -3.2 -3.1
241 Ly6c1 1.5 1.7 1.2 1.5 -1.8 -1.6 -3.3 -2.2
242 Magel2 1.6 1.3 1.6 1.5 -1.4 -1.2 -1.4 -1.3
243 Mamdc2 1.6 1.3 1.7 1.5 -2.2 -1.8 -2.2 -2.1
244 Maob 1.3 1.5 1.7 1.5 -2.1 -2.2 -2.2 -2.2
245 Mme 1.6 1.5 1.4 1.5 -2.1 -1.5 -1.5 -1.7
246 Mmrn1 1.4 1.6 1.4 1.5 -1.7 -1.3 -1.8 -1.6
247 NAP061760-1 1.8 1.4 1.3 1.5 -1.2 -1.2 -2.4 -1.6
248 Nppb 1.8 1.5 1.1 1.5 1.3 -1.2 -6 -2
249 Pamr1 1.4 1.7 1.5 1.5 -1.5 -1.2 -1.4 -1.4
250 Pappa2 1.6 1.7 1.1 1.5 -2.2 -1.5 -1.9 -1.9
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251 Pcdh8 1.5 1.8 1.3 1.5 -2.2 -2.6 -2.2 -2.3
252 Plec 1.5 1.7 1.4 1.5 -1.4 -1.1 -1.3 -1.3
253 Plk3 1.4 1.5 1.5 1.5 -1.2 -1.2 -1.7 -1.3
254 Pmaip1 1.4 1.6 1.4 1.5 -1.4 -1.4 -2.9 -1.9
255 Rasgef1b 1.4 1.5 1.5 1.5 -1.9 -1.7 -1.7 -1.8
256 Rgs7bp 1.2 1.6 1.7 1.5 -1.1 -1.5 -1.3 -1.3
257 Rgs8 1.3 1.7 1.4 1.5 -1.3 -1.1 -1.4 -1.3
258 Rin1 1.4 1.6 1.4 1.5 -1.1 -1 -2.2 -1.5
259 Runx1 1.7 1.3 1.4 1.5 -1.2 -1.1 -2.1 -1.5
260 S100a13 1.4 1.6 1.6 1.5 -1.4 -1.4 -1.6 -1.5
261 S100a14 2.2 1.2 1 1.5 -1.3 -1.3 -1.3 -1.3
262 Sfn 1.7 1.5 1.3 1.5 -1.2 -1.2 -2.3 -1.5
263 Ssfa2 1.7 1.5 1.3 1.5 -1.7 -1.5 -1.7 -1.6
264 Sytl1 1.4 1.4 1.6 1.5 -1.3 -1.3 -1.4 -1.3
265 Thrb 1.3 1.4 1.6 1.5 -1.2 -1.8 -1.7 -1.5
266 Tiam2 1.5 1.7 1.5 1.5 -1.3 -1.2 -1.3 -1.3
267 Tmem100 1.5 1.5 1.4 1.5 -1.3 -1.4 -1.5 -1.4
268 Tmem26 1.6 1.6 1.5 1.5 -1.6 -1.9 -1.7 -1.7
269 Tmem40 1.6 1.5 1.5 1.5 -1.4 -1.4 -2 -1.6
270 Traf1 1.4 1.6 1.4 1.5 -1.4 -1.3 -1.6 -1.5
271 Wnt10a 1.4 2 1.1 1.5 -1.2 -1 -2.5 -1.6
272 1110032F04Rik 1.3 1.4 1.4 1.4 -2 -1.7 -1.6 -1.7
273 1700011H14Rik 1.2 1.6 1.4 1.4 -1.4 -1.4 -1.6 -1.5
274 2610018G03Rik 1.7 1.2 1.5 1.4 -1.4 -1.9 -1.6 -1.6
275 2610316D01Rik 1.5 1.3 1.4 1.4 -1.3 -1.3 -1.6 -1.4
276 9330159M07Rik 1.2 1.3 1.7 1.4 -1.3 -1.6 -1.5 -1.5
277 A_55_P1970825 1.8 1.3 1.3 1.4 -1.9 -2.4 -1.9 -2.1
278 A_55_P1972975 1.2 1.3 1.7 1.4 -1.3 -1.6 -1.8 -1.5
279 A_55_P2180347 1.4 1.2 1.6 1.4 -1.4 -1.5 -1.4 -1.4
280 Actc1 1.5 1.4 1.5 1.4 -2 -2.2 -2.5 -2.2
281 Adamts14 1.4 1.5 1.4 1.4 -1.4 -1.4 -1.8 -1.5
282 Adamts5 1.8 1.2 1.2 1.4 -2.1 -2 -2.2 -2.1
283 Afm 1.2 1.5 1.4 1.4 -1.5 -1.4 -1.5 -1.4
284 Agpat2 1.6 1.3 1.2 1.4 -1.2 -1.2 -1.5 -1.3
285 Ahnak 1.4 1.2 1.5 1.4 -1.4 -1.4 -1.5 -1.4
286 Akr1b7 1.5 1.6 1 1.4 -5.3 -3 -4.6 -4.3
287 Akr1c19 1.5 1.5 1.3 1.4 -1.3 -1.3 -1.5 -1.3
288 Anxa1 1.4 1.2 1.4 1.4 -1.5 -1.8 -2.6 -2
289 Arid5b 1.3 1.4 1.3 1.4 -1.8 -1.3 -1.4 -1.5
290 B930095G15Rik 1.4 1.4 1.3 1.4 -1.4 -1.3 -1.1 -1.3
291 Bai3 1.4 1.4 1.3 1.4 -1.7 -1.4 -1.5 -1.6
292 Trps1 1.3 1.5 1.3 1.4 -1.5 -1.7 -1.3 -1.5
293 Bmp5 1.3 1.6 1.3 1.4 -1.5 -1.6 -1.5 -1.6
294 Btbd17 1.6 1.5 1 1.4 -1.7 -1.8 -2.3 -1.9
295 C2cd4b 1.5 1.3 1.3 1.4 -1.5 -3.4 -2.5 -2.5
296 Cav1 1.6 1.4 1.2 1.4 -1.7 -1.6 -2.9 -2.1
297 Cav2 1.3 1.3 1.4 1.4 -2 -1.9 -2.7 -2.2
298 Cbr3 1.6 1.4 1.1 1.4 -1.3 -1.3 -2 -1.5
299 Cd99 1.4 1.6 1.2 1.4 -1.2 -1.1 -1.5 -1.3
300 Cdc42ep3 1.2 1.4 1.5 1.4 -1.1 -1.4 -1.4 -1.3
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301 Chmp2b 1.4 1.1 1.7 1.4 -1.4 -1.6 -1.4 -1.5
302 Chst1 1.4 1.5 1.4 1.4 -1.6 -1.5 -1.5 -1.5
303 Ckmt1 1.2 1.4 1.5 1.4 -1.4 -1.2 -1.2 -1.3
304 Clec4n 1.6 1.2 1.3 1.4 -1.2 -1.2 -1.8 -1.4
305 Col2a1 1.5 1.5 1.2 1.4 -1.6 -1.4 -1.5 -1.5
306 Ctla2a 1.2 1.6 1.4 1.4 -1.8 -1.2 -1.9 -1.7
307 Cttnbp2 1.4 1.2 1.7 1.4 -1.7 -1.6 -1.1 -1.4
308 D230018H15Rik 1.1 1.6 1.5 1.4 -1.7 -1.3 -1.4 -1.5
309 D630033O11Rik 1.6 1.4 1.1 1.4 -1.4 -1.4 -1.4 -1.4
310 Dbh 1.5 1.6 1.1 1.4 -2.1 -3.5 -3.5 -3
311 Degs2 1.5 1.3 1.5 1.4 -1.4 -1.5 -1.7 -1.5
312 Dpp4 1.3 1.5 1.5 1.4 -1.4 -1.5 -1.4 -1.4
313 Egr1 1.3 1.5 1.5 1.4 -2 -1.7 -2 -1.9
314 Fbln2 1.4 1.6 1.2 1.4 -1.8 -2 -1.9 -1.9
315 Fbln5 1.3 1.2 1.7 1.4 -2.1 -2.2 -2 -2.1
316 Fgd3 1.4 1.5 1.3 1.4 -1.4 -1.3 -2.2 -1.6
317 Fstl3 1.5 1.3 1.3 1.4 -1 -1.1 -1.7 -1.3
318 Fxyd5 1.5 1.3 1.2 1.4 -1.3 -1.3 -2.2 -1.6
319 Gm10134 1.7 1.5 1 1.4 -1.3 -1.2 -1.4 -1.3
320 Gm17501 1.1 2 1.2 1.4 -1.6 -2.5 -2.6 -2.2
321 Gpc4 1.4 1.5 1.3 1.4 -1.5 -1.2 -2 -1.6
322 Grem2 1.5 1.5 1.4 1.4 -2.3 -2 -1.9 -2.1
323 Grin3a 1.4 1.4 1.5 1.4 -1.3 -1.5 -1.6 -1.5
324 Cited2 1.3 1.2 1.8 1.4 -1.1 -1.7 -1.2 -1.3
325 Foxs1 1.7 1.4 1.2 1.4 -1.5 -1.5 -3 -2
326 Hspa1a 1.4 1.3 1.6 1.4 -1.5 -1.1 -1.2 -1.3
327 Id4 1.5 1.5 1.3 1.4 -1.6 -1.5 -1.7 -1.6
328 Ier3 1.3 1.3 1.7 1.4 -1.6 -1.5 -2.5 -1.9
329 Igfbp2 1.5 1.4 1.3 1.4 -1.1 -1.2 -1.7 -1.4
330 Il1r1 1.5 1.6 1.3 1.4 -1.6 -1.3 -2.1 -1.6
331 Il2rg 1.7 1.4 1.1 1.4 -1.6 -1.1 -1.6 -1.4
332 Junb 1.7 1.3 1.4 1.4 -1.1 -1.1 -2 -1.4
333 Kcnj8 1.6 1.6 1.2 1.4 -1.5 -2.4 -2.3 -2.1
334 Kif21b 1.4 1.6 1.3 1.4 -1.3 -1.2 -1.3 -1.3
335 Klf2 1.2 1.4 1.5 1.4 -1.4 -1.4 -1.4 -1.4
336 Klf8 1.3 1.5 1.6 1.4 -1.4 -1.3 -1.2 -1.3
337 Ldlrad4 1.4 1.5 1.4 1.4 -1.3 -1.2 -2.3 -1.6
338 Ldoc1 1.2 1.4 1.6 1.4 -1.6 -1.3 -1.3 -1.4
339 Lfng 1.6 1.6 1.2 1.4 -1.5 -1.3 -1.9 -1.6
340 Lilrb4 1.5 1.3 1.5 1.4 -1.8 -1.6 -1.7 -1.7
341 Lmna 1.6 1.4 1.2 1.4 -1.4 -1.4 -1.9 -1.6
342 Lox 1.4 1.5 1.4 1.4 -2.5 -1.9 -1.9 -2.1
343 Lrrn3 1.4 1.3 1.6 1.4 -2.1 -2.2 -1.9 -2.1
344 Lxn 1.2 1.6 1.5 1.4 -1.4 -1.4 -1.5 -1.5
345 Ly6a 1.5 1.5 1.2 1.4 -1.6 -1.6 -3.3 -2.2
346 37681 1.6 1.4 1.3 1.4 -1.3 -1.3 -2 -1.5
347 Mef2c 1.5 1.6 1.3 1.4 -1.2 -1.6 -1.7 -1.5
348 Mmd 1.3 1.4 1.4 1.4 -1.4 -1.5 -1.6 -1.5
349 Ms4a6d 1.4 1.2 1.5 1.4 -1.6 -1.4 -2.3 -1.8
350 Myo1g 1.2 1.6 1.5 1.4 -1.6 -1.6 -1.7 -1.6
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351 Nog 1.7 1.3 1.2 1.4 -1.2 -1.1 -1.9 -1.4
352 Npb 1.2 1.5 1.6 1.4 -1.3 -1.4 -1.5 -1.4
353 Nrbp2 1.4 1.4 1.3 1.4 -1.3 -1.5 -1.4 -1.4
354 Nup62cl 1.4 1.4 1.4 1.4 -1.8 -1.3 -2.4 -1.8
355 Nupr1 1.4 1.6 1.1 1.4 -1.2 -1.3 -2.2 -1.6
356 Ogfrl1 1.5 1.4 1.5 1.4 -1.5 -1.2 -1.2 -1.3
357 Olfml2b 1.5 1.4 1.3 1.4 -1.3 -1.1 -1.5 -1.3
358 Palm3 1.3 1.4 1.5 1.4 -1.3 -1.3 -1.2 -1.3
359 Pdlim2 1.7 1.3 1.3 1.4 -1.4 -1.5 -1.7 -1.6
360 Pdzk1ip1 1.3 1.2 1.5 1.4 -1.5 -1.6 -1.7 -1.6
361 Plac1 1.1 1.5 1.6 1.4 -1.7 -1.4 -1.8 -1.7
362 Plcl1 1.4 1.6 1.2 1.4 -1.4 -1.1 -1.4 -1.3
363 Pnma2 1.3 1.5 1.2 1.4 -1.9 -1.6 -1.7 -1.7
364 Prdm6 1.5 1.4 1.5 1.4 -1.3 -1.6 -1.3 -1.4
365 Prr5l 1.3 1.4 1.4 1.4 -1.4 -1.4 -1.5 -1.5
366 Prss12 1.2 1.3 1.5 1.4 -1.6 -1.2 -2.3 -1.7
367 Ptn 1.6 1.4 1.4 1.4 -2.3 -2.3 -2.3 -2.3
368 Ramp2 1.5 1.4 1.3 1.4 -1.5 -1.5 -1.8 -1.6
369 Rdh10 1.4 1.3 1.6 1.4 -1.8 -1.5 -1.7 -1.7
370 Rem2 1.5 1.6 1.3 1.4 -1.3 -1.1 -1.7 -1.4
371 Rhbdf1 1.3 1.5 1.3 1.4 -1.3 -1.2 -1.5 -1.3
372 Rspo3 1.3 1.3 1.5 1.4 -1.8 -1.9 -1.9 -1.9
373 Runx1t1 1.4 1.4 1.5 1.4 -1.6 -1.8 -1.3 -1.6
374 Rxrg 1.4 1.7 1.2 1.4 -1.5 -1.5 -1.5 -1.5
375 S100a10 1.4 1.2 1.5 1.4 -1.1 -1.6 -1.6 -1.4
376 Sema5b 1.7 1.4 1.1 1.4 -1.5 -1.2 -1.9 -1.5
377 Sfmbt2 1.4 1.3 1.5 1.4 -1.6 -1.7 -1.4 -1.6
378 Smoc2 1.6 1.3 1.4 1.4 -1.7 -1.6 -1.8 -1.7
379 Spry2 1.4 1.3 1.4 1.4 -1.3 -1.3 -2 -1.6
380 Sqrdl 1.4 1.6 1.3 1.4 -1.4 -1.5 -2 -1.6
381 Tacstd2 1.5 1.4 1.3 1.4 -1.6 -1.3 -1.7 -1.5
382 Tcerg1l 1.2 1.8 1.2 1.4 -1.5 -1.5 -1.4 -1.5
383 Tep1 1.4 1.5 1.3 1.4 -1.3 -1.4 -1.2 -1.3
384 Tfpi2 1.4 1.5 1.4 1.4 -1.6 -1.5 -1.6 -1.6
385 Insm2 1.6 1.6 1.1 1.4 -4.7 -9.4 -7.5 -7.2
386 Th 1.5 1.5 1.2 1.4 -1.5 -1.9 -2.5 -2
387 Thbs1 1.4 1.4 1.3 1.4 -1.5 -1.4 -2 -1.7
388 Tm4sf1 1.5 1.6 1.1 1.4 -1.7 -1.8 -4.7 -2.7
389 Tmem171 1.5 1.2 1.4 1.4 -1.5 -1.4 -2.9 -1.9
390 Tnfrsf12a 1.7 1.2 1.3 1.4 -1.5 -1.7 -3.5 -2.2
391 Tril 1.4 1.3 1.4 1.4 -1.6 -1.1 -1.1 -1.3
392 Vav3 1.4 1.5 1.4 1.4 -1.8 -1.4 -1.9 -1.7
393 Sox2 1.6 1.4 1.2 1.4 -2.4 -1.6 -2.2 -2.1
394 1110006E14Rik 1.3 1.5 1.2 1.3 -1.9 -1.5 -1.5 -1.6
395 1110046J04Rik 1.4 1.3 1.2 1.3 -1.3 -1.2 -1.5 -1.3
396 5730416F02Rik 1.4 1.2 1.2 1.3 -1.3 -1.3 -1.5 -1.4
397 6430411K18Rik 1.2 1.6 1.2 1.3 -1.5 -1.7 -2 -1.7
398 6430519N07Rik 1.2 1.4 1.4 1.3 -1.9 -1.6 -1.1 -1.5
399 8430408G22Rik 1.3 1.2 1.3 1.3 -1.5 -1.3 -1.7 -1.5
400 9.13002E+15 1.3 1.4 1.3 1.3 -1.7 -1.4 -1.2 -1.4
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401 A_55_P2005672 1.3 1.3 1.4 1.3 -1.2 -1.3 -1.6 -1.4
402 A_55_P2092286 1.2 1.6 1.1 1.3 -1.5 -1.5 -1.5 -1.5
403 A930002H24Rik 1 1.2 1.5 1.3 -1.3 -1.5 -1.5 -1.4
404 Acot11 1.1 1.4 1.4 1.3 -1.6 -1.5 -1.7 -1.6
405 Acot9 1.2 1.4 1.1 1.3 -1.4 -1.2 -1.9 -1.5
406 Adam23 1.2 1.6 1.2 1.3 -1.9 -1.3 -1.7 -1.6
407 Adk 1.3 1.4 1.2 1.3 -1.3 -1.2 -1.5 -1.4
408 Adm 1.4 1.3 1.2 1.3 -1.4 -1.5 -2.1 -1.7
409 Agap2 1.1 1.5 1.1 1.3 -1.4 -1.2 -1.2 -1.3
410 Aldh1a1 1.4 1.4 1.1 1.3 -1.6 -1.5 -1.7 -1.6
411 Ankrd29 1.3 1.3 1.2 1.3 -1.4 -1.3 -1.5 -1.4
412 Arl4a 1.3 1.3 1.4 1.3 -1.3 -1.4 -1.8 -1.5
413 Dmrt2 1.1 1.3 1.6 1.3 -2.1 -2.4 -2.9 -2.4
414 Atp1a2 1.4 1.2 1.2 1.3 -1.4 -1.4 -1.3 -1.4
415 Atp6v0d2 1.2 1.4 1.3 1.3 -1.5 -1.4 -2.1 -1.7
416 Bcl10 1.3 1.3 1.3 1.3 -1.3 -1.1 -1.5 -1.3
417 Blnk 1.1 1.5 1.4 1.3 -1.1 -1.1 -1.6 -1.3
418 Capg 1.3 1.3 1.2 1.3 -1.4 -1.2 -1.4 -1.3
419 Caps2 1.2 1.3 1.3 1.3 -1.5 -1.3 -1.2 -1.3
420 Cd109 1.3 1.4 1.3 1.3 -1.3 -1 -1.5 -1.3
421 Chga 1.4 1.5 1 1.3 -2 -3.3 -3.4 -2.9
422 Ell2 1.4 1.3 1.2 1.3 -1.6 -1.4 -1.7 -1.6
423 Clec4d 1.3 1.2 1.3 1.3 -1.6 -1.5 -2.1 -1.7
424 Clic5 1.3 1.4 1.3 1.3 -1.8 -1 -1.2 -1.4
425 Col14a1 1.4 1.3 1.1 1.3 -2.1 -1.6 -2.2 -2
426 Col16a1 1.1 1.6 1.3 1.3 -1.4 -1.2 -1.3 -1.3
427 Col23a1 1.5 1.4 1 1.3 -1.5 -1.4 -1.3 -1.4
428 Col4a2 1.5 1.4 1.1 1.3 -1.3 -1.1 -1.5 -1.3
429 Crim1 1.1 1.3 1.4 1.3 -1.1 -1.5 -1.2 -1.3
430 Crip1 1.4 1.5 1.1 1.3 -1.2 -1.2 -1.6 -1.3
431 Csf1 1.3 1.3 1.2 1.3 -1.1 -1.2 -1.5 -1.3
432 Ctla2b 1.2 1.4 1.2 1.3 -1.7 -1.2 -2.1 -1.7
433 D9Ertd115e 1.2 1.2 1.4 1.3 -1.2 -1.3 -1.4 -1.3
434 Dgat2 1.2 1.3 1.3 1.3 -1.4 -1.2 -1.3 -1.3
435 Dgkh 1.3 1.3 1.4 1.3 -1.4 -1.4 -1.3 -1.4
436 Zcchc12 1.1 1.2 1.4 1.3 -1.3 -1.5 -1.5 -1.4
437 Eif4e3 1.3 1.2 1.3 1.3 -1.4 -1.2 -1.2 -1.3
438 Emb 1.4 1.3 1.3 1.3 -1.5 -1.5 -1.3 -1.5
439 F2r 1.2 1.2 1.5 1.3 -1.3 -1.3 -1.7 -1.4
440 Fam13c 1.3 1.4 1.3 1.3 -1.8 -1.6 -1.5 -1.6
441 Fbxo17 1.3 1.3 1.2 1.3 -1.2 -1.2 -1.5 -1.3
442 Fgfr4 1.3 1.5 1.1 1.3 -1.8 -1.5 -1.4 -1.6
443 Fibin 1.3 1.5 1.2 1.3 -1.2 -1.3 -1.3 -1.3
444 Filip1l 1.5 1.3 1.3 1.3 -1.8 -1.9 -2.3 -2
445 Frmpd4 1.2 1.3 1.4 1.3 -1.7 -1.3 -1.2 -1.4
446 Fxyd3 1.6 1.4 1.1 1.3 -1.6 -1.7 -1.9 -1.7
447 Gch1 1.4 1.2 1.3 1.3 -1.5 -1.6 -2.7 -1.9
448 Gjb3 1.4 1.3 1.2 1.3 -1.4 -1.1 -2 -1.5
449 Glipr1 1.5 1.3 1.1 1.3 -1.3 -1.3 -2.7 -1.7
450 Glt8d2 1.3 1.1 1.5 1.3 -1.3 -1.4 -1.6 -1.4
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451 Gm13889 1.1 1.6 1.3 1.3 -1.2 -1.2 -1.5 -1.3
452 Gm6403 1.3 1.5 1.2 1.3 -2.4 -2.1 -2.3 -2.3
453 Gm9963 1.6 1.1 1.1 1.3 -1.5 -1.2 -1.4 -1.4
454 Gng11 1.3 1.4 1.2 1.3 -1.3 -1.3 -1.6 -1.4
455 Gp49a 1.6 1.3 1.1 1.3 -2 -1.4 -2.1 -1.9
456 Gpr176 1.3 1.2 1.4 1.3 -1.2 -1.2 -1.6 -1.3
457 Gpr97 1.1 1.6 1.1 1.3 -1.6 -1.5 -1.9 -1.7
458 Grhl3 1.3 1.2 1.4 1.3 -2.3 -1.2 -1.8 -1.8
459 Gsg1l 1.3 1.4 1.3 1.3 -1.5 -1.3 -1.7 -1.5
460 Gxylt2 1.3 1.4 1.3 1.3 -1.3 -1.2 -1.4 -1.3
461 Hmga2 1.2 1.2 1.5 1.3 -1 -1.5 -1.4 -1.3
462 Hmga2-ps1 1.2 1.3 1.3 1.3 -1.2 -1.4 -1.9 -1.5
463 Hs3st5 1.5 1.4 1 1.3 -2.9 -3 -3 -3
464 Hspb7 1.6 1.2 1.2 1.3 -1.2 -1.2 -1.6 -1.3
465 Htra4 1.4 1.3 1.3 1.3 -1.9 -2.3 -2 -2.1
466 Icam1 1.6 1.3 1.1 1.3 -1.5 -1.1 -1.8 -1.5
467 Ifih1 1.3 1.1 1.6 1.3 -1.4 -1.4 -2.1 -1.7
468 Itga6 1.1 1.6 1.1 1.3 -1.3 -1.2 -1.6 -1.4
469 Itga8 1.3 1.3 1.3 1.3 -1.8 -1.4 -1.2 -1.5
470 Kcne1l 1.4 1.2 1.3 1.3 -1.2 -1.3 -1.7 -1.4
471 Kcnma1 1.3 1.1 1.5 1.3 -1.8 -1.5 -1.7 -1.7
472 Kctd11 1.1 1.4 1.3 1.3 -1.3 -1.1 -1.6 -1.3
473 Lamb3 1.2 1.3 1.4 1.3 -1.4 -1.2 -1.9 -1.5
474 Lamc2 1.2 1.4 1.3 1.3 -1.5 -1.1 -1.9 -1.5
475 Lamc3 1.4 1.4 1.1 1.3 -1.6 -1.4 -1.6 -1.5
476 Lgals1 1.2 1.3 1.3 1.3 -1.3 -1.1 -1.5 -1.3
477 Lgals3 1.3 1.4 1.2 1.3 -1.8 -1.5 -1.8 -1.7
478 Lhfpl1 1.4 1.2 1.3 1.3 -1.6 -1.5 -2 -1.7
479 Lifr 1.3 1.2 1.4 1.3 -1.6 -1.4 -1.2 -1.4
480 Lsamp 1.1 1.5 1.3 1.3 -1.2 -1.6 -1 -1.3
481 Maff 1.2 1.3 1.3 1.3 -1.3 -1.3 -2.1 -1.6
482 Man2a1 1.2 1.5 1.3 1.3 -1.5 -1.4 -1.5 -1.4
483 Mcam 1.5 1.2 1.2 1.3 -1.4 -1.3 -2.5 -1.8
484 Meg3 1.4 1.3 1.1 1.3 -1.1 -1.3 -1.5 -1.3
485 Mfap3l 1.1 1 1.6 1.3 -1.3 -1.4 -1.1 -1.3
486 Mir22hg 1.4 1.3 1.4 1.3 -1.1 -1.4 -1.4 -1.3
487 Mirg 1 1.4 1.3 1.3 -1.4 -1.8 -1.5 -1.6
488 Msn 1.2 1.3 1.2 1.3 -1.5 -1.1 -1.3 -1.3
489 Mt1 1.3 1.3 1.4 1.3 -1.6 -1.5 -1.2 -1.4
490 Myadm 1.4 1.4 1.2 1.3 -1.4 -1.1 -1.4 -1.3
491 Ncf4 1.5 1.2 1.2 1.3 -1.4 -1.2 -1.5 -1.4
492 Nfkb2 1.5 1.4 1.1 1.3 -1.3 -1 -1.5 -1.3
493 Nuak1 1.4 1.2 1.2 1.3 -1.2 -1.1 -1.6 -1.3
494 Oas1f 1.4 1.3 1.4 1.3 -1.1 -1.2 -2 -1.4
495 Ovol1 1.1 1.3 1.7 1.3 -1.4 -1.4 -1.1 -1.3
496 Paqr5 1.1 1.3 1.4 1.3 -1.7 -1.7 -1.6 -1.7
497 Pcdh19 1.3 1.3 1.4 1.3 -1.7 -1.6 -1.4 -1.6
498 Pfkp 1.6 1.3 1 1.3 -2 -2 -3.3 -2.5
499 Phactr1 1.3 1.3 1.3 1.3 -1.6 -1.6 -1.6 -1.6
500 Tfcp2l1 1.3 1.3 1.4 1.3 -1.5 -1.4 -1.2 -1.4
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501 Plac9a 1.7 1.1 1.1 1.3 -1.2 -1.4 -2.1 -1.6
502 Plau 1.3 1.3 1.2 1.3 -2.1 -2.4 -2.9 -2.5
503 Plcxd2 1 1.3 1.5 1.3 -1.3 -1.4 -1.5 -1.4
504 Plcxd3 1.2 1.3 1.3 1.3 -1.7 -2.6 -2.1 -2.1
505 Plp2 1.1 1.3 1.4 1.3 -1.3 -1.2 -1.3 -1.3
506 Postn 1.2 1.2 1.5 1.3 -1.7 -2.3 -2.1 -2
507 Ppap2c 1.2 1.3 1.3 1.3 -1.3 -1.3 -1.2 -1.3
508 Prkcdbp 1.3 1.4 1.2 1.3 -1.2 -1.2 -1.9 -1.4
509 Prss35 1.1 1 1.9 1.3 -1.1 -1.4 -1.4 -1.3
510 Ptger4 1.5 1.2 1.1 1.3 -1.4 -1.3 -1.5 -1.4
511 Rgs16 1.4 1.4 1.2 1.3 -1.2 -1.1 -2.1 -1.5
512 Rnd3 1.2 1.3 1.5 1.3 -2.1 -1.5 -1.5 -1.7
513 Rxfp1 1.2 1.3 1.3 1.3 -1.6 -1.3 -1.9 -1.6
514 Schip1 1.5 1.3 1.2 1.3 -1.2 -1.3 -2 -1.5
515 38231 1.4 1.3 1.1 1.3 -1.3 -1.4 -1.4 -1.3
516 Serpine2 1.3 1.3 1.2 1.3 -1.4 -1.5 -1.9 -1.6
517 Sertad1 1.4 1.2 1.3 1.3 -1.2 -1.2 -1.6 -1.3
518 Sgpp2 1.3 1.4 1.2 1.3 -1.5 -1.1 -1.2 -1.3
519 Sh3gl2 1.4 1.2 1.2 1.3 -1.8 -1.7 -1.4 -1.6
520 Sh3tc2 1.4 1.4 1.2 1.3 -1.5 -1.4 -1.6 -1.5
521 Slamf9 1.3 1.5 1.2 1.3 -1.4 -1.4 -2.2 -1.6
522 Slc16a14 1.3 1.3 1.4 1.3 -1.3 -1.8 -1.1 -1.4
523 Slc29a1 1.2 1.3 1.3 1.3 -1.4 -1.3 -1.3 -1.4
524 Slc41a2 1.4 1.3 1.2 1.3 -1.7 -1.5 -1.6 -1.6
525 Slc4a11 1.3 1.3 1.2 1.3 -1.2 -1.2 -1.7 -1.4
526 Slit3 1.5 1.3 1 1.3 -1.3 -1.1 -1.5 -1.3
527 Snai2 1.4 1.1 1.4 1.3 -1.2 -1.8 -1.2 -1.4
528 Heyl 1.3 1.5 1.2 1.3 -1.4 -1.2 -2.2 -1.6
529 Srpx 1.2 1.3 1.3 1.3 -1.3 -1.6 -1.7 -1.5
530 Stx11 1.2 1.3 1.3 1.3 -1.2 -1 -2.6 -1.6
531 Tagln 1.3 1.3 1.4 1.3 -1.7 -1.6 -2.7 -2
532 TC1598269 1.3 1.3 1.2 1.3 -1.5 -1.9 -1.6 -1.7
533 Tgfa 1.4 1.4 1 1.3 -1.6 -1.1 -1.1 -1.3
534 Timp1 1.3 1.4 1.2 1.3 -1.3 -1.2 -2.4 -1.6
535 Timp3 1.2 1.4 1.3 1.3 -1.7 -2 -2.1 -1.9
536 Tle4 1.3 1.3 1.3 1.3 -1.4 -1.2 -1.2 -1.3
537 Tmem173 1.2 1.3 1.3 1.3 -1.2 -1.1 -1.5 -1.3
538 Tmem213 1.4 1.5 1.1 1.3 -1.3 -1.3 -1.6 -1.4
539 Tph1 1.3 1.3 1.2 1.3 -1.7 -1.3 -1.8 -1.6
540 Tspan4 1.3 1.4 1.1 1.3 -1.4 -1.2 -1.6 -1.4
541 Vim 1.4 1 1.4 1.3 -1.3 -1.5 -1.5 -1.4
542 Vstm2l 1.3 1.6 1.1 1.3 -1.4 -1.5 -1.8 -1.6
543 Wisp1 1.4 1.3 1.2 1.3 -1.4 -1.3 -2.2 -1.6
544 Zfp608 1.3 1.3 1.4 1.3 -1.4 -1.4 -1.2 -1.3
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1 Tgm5 -15.4 -16.3 -14.4 -15.4 1.6 1.9 2.1 1.9
2 Tnfsf13b -10.1 -7.4 -11.1 -9.5 4.5 5.0 5.3 4.9
3 Dhrs3 -6.5 -7.4 -5.7 -6.5 2.7 2.8 3.6 3.0
4 Pnliprp1 -6.3 -5.7 -6.6 -6.2 1.9 2.7 3.1 2.6
5 Il33 -7.6 -5.6 -4.8 -6.0 3.7 2.8 3.6 3.4
6 Sst -5.1 -4.7 -4.9 -4.9 5.1 5.2 5.1 5.1
7 Elf5 -5.1 -4.7 -4.6 -4.8 1.4 1.4 1.8 1.5
8 Ntsr1 -4.7 -3.4 -4.8 -4.3 2.5 3.1 4.4 3.3
9 Hic1 -4.5 -3.5 -4.3 -4.1 3.0 3.2 3.5 3.2
10 Colq -4.1 -3.3 -4.9 -4.1 2.2 2.8 2.7 2.6
11 Ecm1 -3.7 -4.1 -4.0 -3.9 5.8 6.0 5.6 5.8
12 Angptl7 -3.5 -3.5 -3.4 -3.5 2.8 2.7 2.4 2.7
13 Ednrb -4.0 -2.9 -3.5 -3.5 1.4 1.7 1.8 1.6
14 Shisa3 -3.4 -3.5 -3.2 -3.4 2.3 2.1 2.6 2.3
15 Tgm2 -3.0 -3.2 -3.6 -3.3 2.0 2.1 1.9 2.0
16 Slc38a5 -3.6 -2.5 -3.4 -3.2 1.8 1.7 2.1 1.9
17 Slitrk1 -3.7 -2.5 -2.5 -2.9 2.8 2.3 2.5 2.5
18 Akap12 -2.7 -2.7 -3.2 -2.9 1.7 2.2 2.0 2.0
19 Tmem62 -3.1 -2.9 -2.6 -2.9 2.0 2.0 2.2 2.1
20 Gna14 -3.0 -2.4 -3.1 -2.8 2.8 3.1 2.8 2.9
21 Kcnk2 -2.8 -2.7 -3.0 -2.8 2.1 2.5 3.5 2.7
22 Fut9 -3.1 -2.7 -2.6 -2.8 1.6 1.5 2.7 1.9
23 Rbm46 -2.6 -3.2 -2.4 -2.7 1.8 1.6 1.7 1.7
24 Spon2 -2.4 -2.8 -2.8 -2.7 2.0 2.0 1.8 1.9
25 Cntn1 -3.0 -2.8 -2.2 -2.7 1.9 1.6 3.0 2.2
26 Adamtsl4 -3.2 -2.3 -2.5 -2.6 3.9 4.0 4.2 4.1
27 Gdf10 -2.7 -2.2 -3.0 -2.6 1.4 1.5 1.6 1.5
28 Slitrk5 -3.1 -2.2 -2.5 -2.6 1.2 1.3 1.9 1.5
29 Flrt1 -3.0 -2.1 -2.6 -2.6 2.4 1.8 3.0 2.4
30 AI593442 -2.4 -2.2 -2.9 -2.5 1.5 2.3 2.4 2.1
31 Npy1r -2.5 -2.4 -2.6 -2.5 1.5 1.4 1.5 1.4
32 AK141540 -2.6 -2.5 -2.4 -2.5 3.3 3.4 3.1 3.2
33 Rarb -2.4 -2.8 -2.4 -2.5 1.8 1.8 2.0 1.9
34 A_55_P1960936 -2.6 -2.5 -2.4 -2.5 1.9 2.0 2.2 2.1
35 Hoxc4 -2.7 -2.4 -2.3 -2.5 3.0 3.2 4.6 3.6
36 Hs3st6 -3.2 -2.3 -1.9 -2.5 2.1 2.3 1.8 2.1
37 BB713741 -2.5 -2.6 -2.3 -2.5 1.7 1.9 2.2 1.9
38 AK046833 -2.8 -2.5 -2.0 -2.5 1.7 1.5 2.5 1.9
39 Cyp7b1 -2.7 -2.2 -2.4 -2.4 2.5 2.7 2.8 2.6
40 Sp5 -3.1 -2.2 -2.1 -2.4 1.5 1.6 2.1 1.8
41 Esrrg -2.6 -2.2 -2.5 -2.4 1.8 1.8 2.2 2.0
42 Adh1 -2.7 -2.3 -2.1 -2.4 2.0 2.6 2.6 2.4
43 Mbd1 -2.5 -2.5 -2.2 -2.4 1.8 1.8 2.2 1.9
44 Crispld2 -2.7 -2.1 -2.3 -2.4 1.7 1.9 1.7 1.8
45 Hapln1 -2.3 -2.0 -2.7 -2.4 1.4 1.5 1.5 1.5
46 Wdr92 -2.6 -2.4 -2.1 -2.3 2.4 2.6 2.5 2.5
47 Gdf5 -2.0 -2.9 -2.1 -2.3 1.8 1.7 2.1 1.8
48 A_55_P1978866 -2.3 -2.5 -2.1 -2.3 1.7 1.6 2.1 1.8
49 Enpp1 -2.4 -2.0 -2.5 -2.3 1.5 1.7 1.3 1.5
50 Fam155a -2.6 -2.2 -2.1 -2.3 1.7 1.7 1.8 1.8
Supplemental Table 5: Transcripts identified by microarray analysis that were positively regulated by RA in the early 
ureter. Shown is a list of transcripts that were positively regulated by RA, i.e. downregulated after BMS493 treatment and 
upregulated after RA treatment of E12.5 ureter explants. Three groups were for each condition were compared to untreated 
controls and the resulting fold changes (FC) in expression are displayed. Intensity thresholds were >100 for the control; fold 
changes were larger than 1.2. 
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51 Sprr1a -2.1 -2.4 -2.3 -2.3 1.7 1.7 1.4 1.6
52 Vipr1 -2.4 -2.1 -2.3 -2.3 3.7 4.2 5.5 4.5
53 Fabp4 -1.9 -2.1 -2.7 -2.2 1.9 1.8 1.7 1.8
54 Nsg2 -2.2 -2.0 -2.4 -2.2 1.5 1.4 1.6 1.5
55 Fap -2.2 -2.0 -2.4 -2.2 1.3 1.4 1.4 1.4
56 Cd83 -2.3 -2.1 -2.2 -2.2 1.8 1.9 2.0 1.9
57 Anxa9 -2.5 -2.2 -1.9 -2.2 1.5 1.5 1.4 1.5
58 AK035396 -2.4 -2.2 -1.9 -2.2 3.2 2.8 2.8 2.9
59 A_55_P1998811 -2.6 -2.3 -1.6 -2.2 1.6 1.7 2.0 1.7
60 Gfra1 -1.9 -1.9 -2.5 -2.1 1.7 2.1 2.1 2.0
61 3930401B19Rik -2.4 -2.1 -1.9 -2.1 3.0 2.9 3.0 3.0
62 Sstr1 -2.4 -1.9 -2.0 -2.1 2.3 2.1 1.6 2.0
63 Tspan1 -1.8 -2.4 -2.2 -2.1 1.9 2.2 2.8 2.3
64 A_55_P2051596 -2.5 -2.1 -1.7 -2.1 1.4 1.5 1.8 1.6
65 Pdgfd -2.2 -2.0 -2.0 -2.1 1.3 1.3 1.3 1.3
66 AK132033 -2.2 -2.1 -1.9 -2.1 3.0 2.9 3.0 2.9
67 Cd38 -2.1 -1.8 -2.3 -2.1 1.6 2.3 1.9 1.9
68 Ephb1 -2.9 -1.8 -1.4 -2.1 1.5 1.5 1.6 1.5
69 Gm4951 -2.3 -2.5 -1.4 -2.0 2.0 1.3 1.6 1.6
70 Synpr -2.0 -2.0 -2.1 -2.0 2.1 1.5 1.7 1.8
71 Rbp1 -2.1 -1.8 -2.2 -2.0 1.6 1.6 1.9 1.7
72 BC057675 -2.4 -2.1 -1.6 -2.0 2.8 1.8 2.5 2.4
73 TC1616199 -2.4 -2.0 -1.7 -2.0 3.6 3.6 3.1 3.4
74 A_55_P2107785 -1.9 -1.9 -2.3 -2.0 1.5 1.7 1.4 1.5
75 Iigp1 -2.2 -2.2 -1.5 -2.0 1.8 1.5 1.9 1.7
76 TC1703733 -2.1 -2.4 -1.3 -2.0 1.9 1.2 1.9 1.7
77 Mab21l1 -1.8 -1.8 -2.3 -1.9 1.8 1.6 1.5 1.6
78 5730446D14Rik -1.9 -2.0 -2.0 -1.9 1.9 1.5 1.6 1.7
79 Adamts18 -2.1 -2.1 -1.6 -1.9 3.5 1.4 1.9 2.3
80 Insc -2.0 -1.4 -2.3 -1.9 1.3 1.5 1.4 1.4
81 Hspa12a -1.8 -2.1 -1.6 -1.9 2.4 2.0 3.8 2.7
82 Grik4 -1.9 -1.8 -1.9 -1.9 1.9 1.8 2.0 1.9
83 Anxa11 -2.2 -1.8 -1.7 -1.9 1.5 1.8 1.9 1.7
84 Lhfpl2 -2.0 -1.8 -1.8 -1.9 1.7 2.0 2.1 2.0
85 Enpp3 -1.9 -1.8 -1.9 -1.9 2.0 2.0 2.2 2.1
86 Syt6 -1.7 -1.5 -2.3 -1.8 1.4 2.1 1.9 1.8
87 Cmbl -2.1 -1.5 -1.9 -1.8 1.6 1.5 1.5 1.5
88 AI427809 -2.0 -1.7 -1.8 -1.8 1.7 1.7 1.9 1.8
89 Stra6 -1.9 -1.5 -2.1 -1.8 2.3 2.6 3.2 2.7
90 Slc18a3 -1.6 -1.3 -2.6 -1.8 1.9 2.5 2.6 2.3
91 Ptprb -2.0 -1.5 -1.9 -1.8 1.5 1.3 1.8 1.6
92 6030408B16Rik -1.8 -1.9 -1.8 -1.8 1.7 1.6 1.4 1.6
93 Igf1 -1.8 -1.7 -2.0 -1.8 2.1 2.4 2.0 2.2
94 Cplx2 -1.8 -1.7 -2.0 -1.8 1.5 1.5 2.0 1.6
95 Stmn2 -1.8 -1.5 -2.1 -1.8 1.6 1.3 1.2 1.4
96 Lrrc3b -2.3 -1.7 -1.3 -1.8 1.6 1.3 1.2 1.4
97 Oprl1 -1.8 -1.6 -1.9 -1.8 1.3 1.5 1.3 1.3
98 AI596198 -2.0 -1.8 -1.5 -1.7 2.1 1.8 2.3 2.1
99 Erc2 -2.0 -1.6 -1.6 -1.7 2.2 2.4 2.3 2.3
100 Hdhd3 -1.6 -1.9 -1.7 -1.7 1.8 1.6 1.5 1.6
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101 Neurl3 -1.6 -1.6 -1.9 -1.7 1.3 1.6 1.4 1.4
102 Zfp958 -1.5 -2.3 -1.3 -1.7 1.6 1.5 2.4 1.8
103 Hoxc9 -1.9 -1.7 -1.5 -1.7 2.5 2.2 2.4 2.4
104 Adamts8 -1.9 -1.4 -1.8 -1.7 1.4 1.6 1.9 1.6
105 Scd1 -1.7 -1.5 -1.9 -1.7 1.4 1.9 1.3 1.5
106 Scnn1b -1.8 -1.5 -1.8 -1.7 1.3 1.4 1.4 1.3
107 Hoxc6 -1.8 -1.5 -1.7 -1.7 1.3 1.7 1.9 1.6
108 A_55_P2007495 -1.7 -1.7 -1.6 -1.7 1.3 1.5 1.6 1.5
109 Plekhb1 -1.5 -1.6 -1.9 -1.7 1.5 1.5 1.3 1.4
110 Adra2a -1.8 -1.3 -1.9 -1.7 1.3 1.7 1.9 1.6
111 Aifm2 -1.5 -1.8 -1.7 -1.7 1.3 1.4 1.4 1.4
112 2010300C02Rik -1.6 -1.7 -1.7 -1.7 1.6 1.6 1.6 1.6
113 Smim3 -1.8 -1.7 -1.4 -1.6 1.8 1.4 1.3 1.5
114 A_55_P2114318 -1.7 -1.7 -1.6 -1.6 1.3 1.5 1.6 1.5
115 Ihh -1.6 -1.9 -1.5 -1.6 2.0 2.1 2.5 2.2
116 A_55_P2090505 -1.8 -1.6 -1.5 -1.6 2.3 2.2 2.5 2.3
117 Oxnad1 -1.6 -1.7 -1.6 -1.6 1.5 1.4 1.4 1.4
118 Calca -1.7 -1.4 -1.7 -1.6 1.6 1.5 1.3 1.5
119 Usp53 -1.7 -1.8 -1.4 -1.6 1.7 2.0 2.5 2.1
120 Asic4 -1.6 -1.5 -1.6 -1.6 1.8 1.8 2.4 2.0
121 Fam78b -1.6 -1.4 -1.8 -1.6 1.3 1.4 1.8 1.5
122 Trim9 -1.7 -1.4 -1.6 -1.6 1.4 1.5 1.6 1.5
123 Fndc5 -1.6 -1.4 -1.8 -1.6 1.5 1.8 1.9 1.8
124 Agtpbp1 -1.8 -1.6 -1.4 -1.6 1.4 1.4 1.4 1.4
125 Masp1 -1.8 -1.5 -1.5 -1.6 1.4 1.8 2.1 1.8
126 Ncoa3 -1.7 -1.3 -1.7 -1.6 1.2 1.5 1.3 1.3
127 Foxd1 -1.4 -1.8 -1.5 -1.6 1.6 1.3 1.9 1.6
128 Mrvi1 -1.5 -1.4 -1.8 -1.6 1.2 1.5 1.3 1.3
129 Gata2 -1.3 -1.5 -1.9 -1.6 1.3 1.8 1.9 1.7
130 Gstt3 -1.5 -1.7 -1.5 -1.6 1.3 1.5 1.4 1.4
131 Ano1 -1.5 -1.4 -1.7 -1.6 1.6 1.5 1.4 1.5
132 Coro2a -1.4 -1.5 -1.7 -1.6 1.5 1.8 1.6 1.7
133 Foxf1 -1.5 -1.5 -1.7 -1.6 1.2 1.3 1.6 1.4
134 Eva1c -1.5 -1.3 -1.8 -1.5 1.7 2.2 1.5 1.8
135 Pbx1 -1.7 -1.6 -1.3 -1.5 1.5 1.7 2.2 1.8
136 Hoxa3 -1.5 -1.5 -1.6 -1.5 1.7 1.6 2.4 1.9
137 Dzank1 -1.5 -1.4 -1.7 -1.5 1.4 1.3 1.5 1.4
138 Itpka -1.4 -1.4 -1.8 -1.5 2.1 2.1 2.3 2.2
139 Arg1 -1.6 -1.7 -1.3 -1.5 1.4 1.5 1.2 1.4
140 Ubash3b -1.9 -1.3 -1.4 -1.5 2.3 1.6 1.8 1.9
141 BB237529 -1.6 -1.7 -1.3 -1.5 1.3 1.3 1.4 1.3
142 Pparg -1.7 -1.5 -1.3 -1.5 1.2 1.5 1.6 1.4
143 Trim24 -1.5 -1.6 -1.4 -1.5 1.2 1.2 1.5 1.3
144 Clec7a -1.5 -1.4 -1.7 -1.5 1.5 1.8 2.6 2.0
145 Hoxc10 -1.4 -1.4 -1.8 -1.5 1.6 1.6 1.7 1.7
146 Pde2a -1.4 -1.5 -1.6 -1.5 1.3 1.8 1.4 1.5
147 Cfl2 -1.6 -1.6 -1.4 -1.5 1.3 1.5 1.7 1.5
148 AK149472 -1.7 -1.6 -1.3 -1.5 2.2 1.7 2.1 2.0
149 Map3k5 -1.5 -1.4 -1.6 -1.5 1.3 1.3 1.3 1.3
150 Mpzl1 -1.7 -1.4 -1.4 -1.5 1.6 1.6 1.6 1.6
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151 Fmo5 -1.7 -1.5 -1.4 -1.5 1.6 1.7 2.1 1.8
152 Bace2 -1.4 -1.5 -1.6 -1.5 1.6 1.3 1.4 1.5
153 Gbp2 -1.4 -1.6 -1.5 -1.5 4.7 3.8 2.3 3.6
154 Tmem27 -1.6 -1.4 -1.5 -1.5 1.3 1.4 1.2 1.3
155 Efemp1 -1.6 -1.6 -1.3 -1.5 2.5 2.0 1.9 2.1
156 Plat -1.3 -1.7 -1.5 -1.5 1.3 1.4 1.5 1.4
157 Ncoa4 -1.5 -1.6 -1.4 -1.5 1.5 1.6 2.0 1.7
158 Gm6557 -1.3 -1.5 -1.6 -1.5 1.4 1.7 1.6 1.5
159 Nrip1 -1.6 -1.5 -1.3 -1.5 1.3 1.6 1.9 1.6
160 Egfr -1.4 -1.4 -1.6 -1.5 1.2 1.3 1.2 1.2
161 Clmn -1.5 -1.3 -1.6 -1.5 1.7 1.8 2.0 1.8
162 Ephx2 -1.5 -1.6 -1.3 -1.5 1.9 1.8 2.4 2.0
163 Pitx1 -1.7 -1.3 -1.4 -1.5 1.5 1.9 2.0 1.8
164 Gpr116 -1.8 -1.2 -1.4 -1.5 1.3 1.5 1.6 1.4
165 Pou3f1 -1.4 -1.3 -1.6 -1.5 1.3 1.8 1.7 1.6
166 Tshz2 -1.3 -1.4 -1.6 -1.5 1.3 1.4 1.7 1.5
167 Spata33 -1.5 -1.4 -1.5 -1.5 1.6 1.3 1.4 1.4
168 Kbtbd11 -1.2 -1.4 -1.7 -1.5 1.5 1.8 1.5 1.6
169 1700017B05Rik -1.4 -1.4 -1.6 -1.4 1.3 1.7 1.6 1.5
170 Add3 -1.4 -1.5 -1.5 -1.4 1.3 1.5 1.9 1.6
171 Rtn4rl1 -1.4 -1.2 -1.7 -1.4 1.2 1.6 1.6 1.5
172 Fam101a -1.4 -1.5 -1.4 -1.4 1.6 1.2 1.4 1.4
173 Adam12 -1.4 -1.3 -1.6 -1.4 1.3 1.6 1.2 1.4
174 Larp6 -1.5 -1.3 -1.4 -1.4 1.4 1.5 1.3 1.4
175 S1pr3 -1.3 -1.4 -1.5 -1.4 1.3 1.6 1.6 1.5
176 St8sia2 -1.4 -1.3 -1.6 -1.4 1.4 1.8 1.8 1.7
177 Egfl6 -1.5 -1.3 -1.4 -1.4 1.4 1.7 1.9 1.6
178 Acsl1 -1.6 -1.4 -1.2 -1.4 1.5 1.4 1.5 1.5
179 Ptp4a3 -1.2 -1.4 -1.7 -1.4 1.4 1.7 1.3 1.5
180 Kcnj10 -1.8 -1.3 -1.2 -1.4 1.2 1.4 1.5 1.4
181 Clip4 -1.5 -1.4 -1.3 -1.4 1.8 1.3 1.4 1.5
182 Isoc1 -1.4 -1.3 -1.5 -1.4 1.3 1.4 1.3 1.4
183 Hoxa5 -1.6 -1.4 -1.2 -1.4 2.4 1.7 2.1 2.1
184 Rasl10b -1.2 -1.3 -1.6 -1.4 1.3 1.5 1.5 1.4
185 Hey2 -1.4 -1.4 -1.5 -1.4 1.6 2.0 1.4 1.7
186 Cntnap2 -1.6 -1.3 -1.3 -1.4 1.3 1.3 1.4 1.3
187 Ccndbp1 -1.4 -1.4 -1.3 -1.4 1.4 1.3 1.4 1.3
188 Hoxa2 -1.4 -1.4 -1.4 -1.4 2.1 1.6 1.9 1.9
189 Sfxn1 -1.6 -1.3 -1.2 -1.4 1.6 1.2 1.5 1.4
190 Stard5 -1.3 -1.3 -1.6 -1.4 1.5 1.9 1.6 1.6
191 Rec8 -1.4 -1.4 -1.3 -1.4 1.2 1.6 1.4 1.4
192 Dna2 -1.4 -1.4 -1.4 -1.4 1.2 1.3 1.2 1.2
193 Abca1 -1.4 -1.5 -1.3 -1.4 1.4 1.3 2.0 1.6
194 Clhc1 -1.4 -1.5 -1.3 -1.4 1.8 1.6 1.4 1.6
195 Syndig1 -1.4 -1.4 -1.3 -1.4 1.3 1.6 1.8 1.6
196 Cdc25b -1.3 -1.3 -1.6 -1.4 1.4 1.7 1.5 1.6
197 Bmp7 -1.6 -1.2 -1.3 -1.4 1.3 1.5 1.5 1.4
198 Ropn1l -1.4 -1.4 -1.3 -1.4 1.3 1.3 1.4 1.3
199 Stac -1.3 -1.5 -1.3 -1.4 1.2 1.2 1.4 1.3
200 Kank4 -1.3 -1.3 -1.4 -1.4 1.8 2.4 2.4 2.2
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201 Tm7sf2 -1.4 -1.3 -1.3 -1.3 1.5 1.5 1.3 1.4
202 Celf2 -1.5 -1.2 -1.3 -1.3 1.3 1.3 1.2 1.3
203 Flrt3 -1.6 -1.3 -1.2 -1.3 1.4 1.3 1.5 1.4
204 Olfm1 -1.5 -1.3 -1.2 -1.3 3.1 3.4 2.9 3.2
205 Xkr5 -1.4 -1.2 -1.4 -1.3 1.3 1.8 1.4 1.5
206 Neto2 -1.4 -1.2 -1.4 -1.3 1.6 1.7 1.5 1.6
207 Hoxb2 -1.4 -1.3 -1.3 -1.3 1.7 1.8 1.8 1.8
208 Zfp937 -1.5 -1.2 -1.2 -1.3 1.4 1.3 1.6 1.4
209 Gse1 -1.3 -1.2 -1.4 -1.3 1.6 1.5 1.9 1.7
210 A_55_P2024391 -1.3 -1.4 -1.3 -1.3 1.4 1.3 1.2 1.3
211 Fblim1 -1.4 -1.3 -1.3 -1.3 1.4 1.3 1.7 1.5
212 Dcaf6 -1.3 -1.3 -1.4 -1.3 1.5 1.6 1.7 1.6
213 AK140216 -1.5 -1.2 -1.2 -1.3 1.6 1.8 2.1 1.9
214 Pbk -1.3 -1.3 -1.3 -1.3 1.3 1.3 1.2 1.3
215 Rbpms -1.3 -1.2 -1.3 -1.3 1.2 1.6 1.5 1.4
216 Fanca -1.2 -1.3 -1.3 -1.3 1.3 1.2 1.4 1.3
217 Fry -1.4 -1.3 -1.2 -1.3 1.5 1.8 1.7 1.7
218 Fads2 -1.3 -1.2 -1.4 -1.3 1.3 1.5 1.5 1.4
219 Gpa33 -1.4 -1.2 -1.2 -1.3 1.5 1.7 1.3 1.5
220 Qk -1.3 -1.3 -1.2 -1.3 1.4 1.2 1.7 1.4
221 Gmnn -1.3 -1.2 -1.2 -1.3 1.4 1.4 1.4 1.4
222 Uaca -1.3 -1.3 -1.2 -1.3 1.3 1.4 1.5 1.4
223 Vps13d -1.2 -1.2 -1.4 -1.3 1.4 1.5 1.8 1.6
224 Ptpru -1.3 -1.3 -1.2 -1.3 1.4 1.4 1.6 1.4
225 Mex3b -1.3 -1.2 -1.2 -1.3 1.7 1.2 1.5 1.5
226 Chd1l -1.2 -1.2 -1.3 -1.3 1.3 1.2 1.2 1.2
227 Mreg -1.2 -1.2 -1.3 -1.2 1.5 1.9 1.6 1.7
228 Nxnl2 -1.2 -1.3 -1.2 -1.2 2.2 2.1 2.2 2.1
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ABSTRACT
Congenital anomalies of the kidney and urinary tract (CAKUT) are the most common cause of CKD in the first
three decades of life. However, for most patients with CAKUT, the causative mutation remains unknown.We
identifieda kindredwithanautosomaldominant formofCAKUT.Bywhole-exomesequencing,we identifieda
heterozygous truncatingmutation (c.279delG, p.Trp93fs*) of the nuclear receptor interacting protein 1 gene
(NRIP1) in all seven affectedmembers.NRIP1 encodes a nuclear receptor transcriptional cofactor that directly
interacts with the retinoic acid receptors (RARs) to modulate retinoic acid transcriptional activity. Unlike wild-
typeNRIP1, thealteredNRIP1proteindidnot translocate to thenucleus, didnot interactwithRARa, and failed
to inhibit retinoic acid–dependent transcriptional activity upon expression in HEK293 cells. Notably, we also
showed that treatment with retinoic acid enhanced NRIP1 binding to RARa. RNA in situ hybridization con-
firmedNrip1 expression in the developing urogenital system of the mouse. In explant cultures of embryonic
kidney rudiments, retinoic acid stimulatedNrip1 expression, whereas a pan-RAR antagonist strongly reduced
it. Furthermore, mice heterozygous for a null allele ofNrip1 showed a CAKUT-spectrum phenotype. Finally,
expression and knockdown experiments in Xenopus laevis confirmed an evolutionarily conserved role for
NRIP1 in renal development. These data indicate that dominantNRIP1mutations can cause CAKUT by inter-
ference with retinoic acid transcriptional signaling, shedding light on the well documented association
between abnormal vitamin A levels and renal malformations in humans, and suggest a possible gene-
environment pathomechanism in this disease.
J Am Soc Nephrol 28: ccc–ccc, 2017. doi: https://doi.org/10.1681/ASN.2016060694
Congenital anomalies of the kidney and urinary
tract (CAKUT) constitute the most frequent cause
of CKD in the first three decades of life, accounting
for approximately 50% of all patients.1,2 CAKUT
comprises awide range of structural malformations
that result from defects in themorphogenesis of the
kidneys and/or the urinary tract.3–6 The pathologic
basis of CAKUT lies in the disturbance of normal kid-
ney development, primarily resulting from mutations
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in genes that direct this process. Most gene products that
cause CAKUT in humans or mice if altered are transcription
factors involved in protein-protein interactions that form
large transcription complexes.7–13 These monogenic forms of
CAKUTare often inherited in an autosomal dominant manner
and exhibit the clinical features of incomplete penetrance and
variable expressivity. Loose genotype/phenotype correlations,
as well as extensive genetic locus heterogeneity, have rendered
gene discovery in CAKUT very difficult. Although approxi-
mately 30 CAKUT genes have been identified,1,2,14–16 approxi-
mately 85% of patients with CAKUT do not have mutations in
any known genes.17,18Hence, the remaining challenge is to iden-
tify the missing components of the pathogenesis of CAKUT, in
order to better understand how these proteins and transcription
factor complexes exert their developmental and tissue-specific
functions.
In addition to the regulatory roles of genetic factors for the
properdevelopment of the kidney andurinary tract, numerous
studies also support the influence of environmental factors on
normal and abnormal kidney development.4,19 This suggests
that the pathogenesis of CAKUT can be multifactorial, likely
due to a complex interplay between genes and the environ-
ment. The most prominent example of this is the effect of
retinoic acid (RA), the active form of vitamin A, on the kid-
neys and urinary tract during development. During fetal life,
nephrogenesis is influenced by RA levels, such that even mod-
est fluctuations inmaternal vitamin A levels in either direction
can cause CAKUT in humans and rodents.20,21 In addition,
elegant studies of murine kidney development byMendelsohn
et al. have shown that inactivation of genes in the RA pathway
causes CAKUT in mice.22–24
To gain further insight into the pathogenesis of CAKUT, we
investigated a three-generation family with renal malforma-
tions by using whole-exome sequencing (WES). Here we iden-
tify a dominantmutation in the transcriptional cofactorNRIP1
(nuclear receptor interacting protein 1) gene as causing human
autosomal dominant CAKUT by interference with RA tran-
scriptional signaling, thereby shedding light on the well docu-
mented association between RA and renal malformations.
RESULTS
Mutations in NRIP1 Can Cause CAKUT
To identify a causativemutatedgene forCAKUT,we investigateda
three-generation Yemenite Jewish family with seven individuals
who have CAKUT. Renal hypo/dysplasia was the predominant
phenotype (six individuals), together with vesicoureteral reflux
(VUR) (four individuals) and/or ectopia (two individuals)
(Figure 1, A and B, Supplemental Figure 1, Table 1). The
age at diagnosis ranged from the prenatal period to late adult-
hood (Table 1). Two of the seven affected individuals under-
went unilateral nephrectomy for their malformations. None
of the affected individuals had extrarenal malformations or
syndromic features. The pedigree structure was compatible
with an autosomal dominant mode of inheritance with vari-
able expressivity and incomplete penetrance (Figure 1A). In-
dividual II:1 had a renal ultrasound showing bilateral small
renal cysts (Supplemental Figure 1), which can be a common
finding in his age group and is not necessarily related to the
CAKUT phenotype in this family. Therefore, individual II:1
was not included in the initialWES analysis, which considered
only affected family members.
Under the hypothesis that amutationof an autosomal dom-
inant gene causesCAKUT in this family,we selected six affected
family members (individuals III:3, III:4, III:5, IV:7, IV:8, and
IV:9) forWES.Given the pedigree structure (Figure 1A), the six
affected individuals are expected to share about 3.125% of all
alleles by descent, allowing a 32-fold reduction in the thou-
sands of variants from the normal reference sequence that are
expected to result from WES (Supplemental Table 1). We
identified a novel heterozygous truncating mutation
(c.279delG, p.Trp93fs*) in the gene encoding NRIP1 (MIM
602490, RefSeq accession number NM_003489.3) (Figure 1, C
and D, Table 1). Segregation analysis revealed that this muta-
tion was shared by all seven available affected family members
as well as by individual II:1, who, as expected from the pedi-
gree structure, is an obligatory mutation carrier given that his
brother (individual II:8) was found to have CAKUTon renal
ultrasound and to harbor the NRIP1 mutation (Figure 1A,
Supplemental Figure 1, Table 1). In addition, the mutation
was absent from seven unaffected family members, from all
available databases of healthy controls including approxi-
mately 100,000 alleles in the ExAC database (Table 1), as
well as from two in-house control cohorts of 200 individuals
with nephronophthisis and 429 individuals with nephrotic
syndrome. Finally, we showed by copy number variant
(CNV) analysis that the affected index patient (IV:8) lacked
any heterozygous deletions or duplications that have previ-
ously been associated with CAKUT, including the HNF1B
locus and the DiGeorge/velocardiofacial syndrome locus.25
Because Yemenite Jews are a genetically distinct Jewish sub-
cluster,26 we aimed to determine the frequency of the NRIP1
mutation in 236 anonymized samples of ethnically matched
Yemenite Jews whose disease status is unknown. The NRIP1
c.279delG mutation was found in two individuals out of 236
screened (472 alleles) yielding a minor allele frequency (MAF)
of 0.004. We next performed highly parallel exon sequencing
of NRIP1 in 155 sporadic cases and 253 familial cases of
CAKUT (total of 724 affected individuals), but did not identify
additional families with CAKUTand novel NRIP1 variants.
The NRIP1 Mutation Interferes with Nuclear
Translocation, Transcriptional Repression, and NRIP1
Interaction with Retinoic Acid Receptor a
NRIP1 is a nuclear receptor transcriptional cofactor.27 Previous
biochemical analyses showed that themurineNRIP1 protein har-
bors two putative nuclear localization signals and four repression
domains thatmediate its transcriptional repression27 (Figure 1C).
In addition, NRIP1 has been shown to directly interact with RA
2 Journal of the American Society of Nephrology J Am Soc Nephrol 28: ccc–ccc, 2017
BASIC RESEARCH www.jasn.org
Part 5 - NRIP1 mutation causes CAKUT
!149
Figure 1. Identification of a heterozygous NRIP1 truncating mutation in index family H with CAKUT. (A) Shows the pedigree of index
family H. Squares represent males, circles females, black symbols affected persons, white symbols unaffected persons, and white
symbol with black dot denotes an obligatory mutation carrier. White symbols with a black question mark indicate individuals with an
unknown phenotype. Pedigree is compatible with an autosomal dominant mode of inheritance with incomplete penetrance and
variable expressivity. Roman numerals denote generations. Individuals are numbered with Arabic numerals if DNA was tested in the
study. The arrow points to the proband IV:8. WT denotes the wild-type allele. p.Trp93* indicates the mutation c.279 deletion of
G in NRIP1, leading to a frame-shift mutation and introducing a premature stop codon. The mutation fully segregated heterozygously
(WT/p.Trp93*) across all seven affected individuals examined and was absent from seven unaffected family members (WT/WT). In-
dividual II:1 is an obligatory mutation carrier given the pedigree structure and segregation analysis. This patient was considered as
having an inconclusive phenotype with only two renal cysts. Red circles indicate the persons selected for WES analysis. (B) Shows
voiding cystourethrogram (left panel) and renal ultrasound (right panel) of the index individual IV:8, revealing severe grade five left
VUR and hydroureter (white arrows, respectively). He presented during infancy after positive prenatal ultrasound screening. He is
managed expectantly and has no extrarenal manifestations. (C) Shows exon structure of human NRIP1 cDNA and domain structure of
the NRIP1 protein. NRIP1 contains two putative nuclear localization signals (blue), four transcriptional repression domains (RD, yellow),
and 10 interaction motifs LxxLL/LxxML (red and orange). Start codon (ATG) and stop codon (TAA) are indicated. (D) Shows
chromatograms of the heterozygous mutation and WT sequence detected in NRIP1 (in relation to exons and protein domains in [C]
in index family H [red] with CAKUT). The index family’s heterozygous NRIP1 mutation c.279delG leads to a frameshift and pre-
mature stop codon resulting in p.Trp93fs*.
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receptors (RARs) and retinoid receptors (RXRs) to suppress
their RA-mediated transcriptional activity.28 The NRIP1 pro-
tein contains nine nuclear receptor interacting motifs
(LxxLL) spread throughout the molecule (Figure 1C).27 In-
terestingly, the binding of NRIP1 to RARs and RXRs was
suggested to also require a slightly different sequence, an
LxxML motif, located at the protein’s C-terminus.29
To determine how the c.279delG (p.Trp93fs*) mutation,
which segregated with the CAKUT phenotype in the large
family H, conveys NRIP1 loss of function, we evaluated
NRIP1 for its known functional features. These include: (1)
nuclear localization, (2) transcriptional repression, and (3)
interactionwith retinoic acid receptora (RARa). Transfection
of expression constructs in HEK293 cells revealed that,
whereas the wild-type NRIP1 protein translocated into the
nucleus, the NRIP1-altered protein (p.Trp93fs*) remained lo-
calized in the cytoplasm (Figure 2, A and B). In target cells, RA,
the active form of vitamin A, acts as a ligand for nuclear RARs
and RXRs. The complex binds to a regulatory DNA segment,
the RA response element (RARE), to control transcription of
RA target genes.30 Accordingly, we next determined whether
the NRIP1mutation affects RA-dependent transcriptional ac-
tivity usingNRIP1 expression plasmids and a reporter plasmid
harboring an RARE. Although the wild-type NRIP1 expres-
sion construct acted as a transcriptional repressor, and com-
pletely suppressed RA-mediated transcriptional activity, the
mutant construct (p.Trp93fs*) showed lack of transcriptional
repressor activity (Figure 2C).
We previously showed that monogenic CAKUT can be sec-
ondary to a dominant-negative pathomechanism.14To test this
possibility, we cotransfected the NRIP1 wild-type construct
with increasing amounts of mutant NRIP1, and subsequently
performed luciferase reporter assays. This did not yield a
dose-dependent lack of repression, suggesting that the loss
of function caused by the mutation is not mediated via a
dominant-negative mechanism (Supplemental Figure 2A).
To further support this, we showed that wild-type andmutant
NRIP1 proteins did not colocalize when cotransfected, sug-
gesting that they do not dimerize (Supplemental Figure 2B).
Furthermore, because proteins that hetero-dimerize are par-
ticularly prone, when altered, to exerting dominant-negative
effects by sequestering functioning molecules into inactive
dimers, we tested the interaction between the altered NRIP1
protein and RARa. Notably, the altered NRIP1 protein still
contains one intact interaction motif (Figure 1C), which may
theoretically be sufficient to interact with the nuclear receptor
ligand–binding domain of RARa. We performed overexpres-
sion experiments of RARa with either wild-type or altered
NRIP1 protein. Interestingly, RARa, when overexpressed
with the wild-type NRIP1 protein, colocalized in a speckled
nuclear pattern. When overexpressed with the altered NRIP1
protein (p.Trp93fs*), however, RARa localized diffusely in
the nucleus whereas the altered NRIP1 remained in the cyto-
plasm (Figure 2D). Furthermore, coimmunoprecipitation
experiments showed that the NRIP1 mutation abrogates
NRIP1-RARa interaction and that binding of NRIP1 to
RARa is enhanced by RA treatment (Figure 3, A and B). Taken
together, these data argue against a dominant-negative
pathomechanism and render a dominant mechanism of
haploinsufficiency more likely.
Nrip1 mRNA Expression in the Nephric Duct and
Ureteric Epithelium Depends on RA
Formationof theureter andkidneybeginswithureter budding,
during which the epithelial tube sprouts from the base of the
Wolffian ducts immediately above the urogenital sinus—an
embryonic structure that eventually gives rise to the urinary
bladder. Distally, the ureteric bud invades the renal metaneph-
ric mesenchyme and, after successive branching, gives rise to
the renal collecting-duct system. The ureteric bud stalk differ-
entiates into the ureter, and its proximal part is transposed to
the primitive bladder via the common nephric duct. Elegant
studies have shown that the common nephric duct undergoes
apoptosis, thereby severing connections with the Wolffian duct
as the ureter orifice is transposed to its final insertion site in the
bladder ureter.24 This crucial step is controlled by RA-induced
signals, which govern ureter maturation and formation of
proper connections between the bladder and ureter.24
To further characterize the role of NRIP1 in RA signaling, we
determined whether the mouse ortholog Nrip1 is expressed in
RA-dependent tissues in the development of the murine urogen-
ital system. For this, we performed RNA in situ hybridization on
whole-mount preparations of urogenital systems of E11.5–E18.5
mouse embryos and on sections of the urogenital system at the
same stages (Figure 4A). Elevated levels of Nrip1 transcripts were
found in the nephric duct and ureter from E11.5 to E14.5, as well
as in the collecting ducts at E14.5 (Figure 4A). Expression in the
kidney andureter was abolished at E18.5 (Supplemental Figure 3).
To test whether Nrip1 expression in the nephric duct and its de-
rivatives depends on RA, we explanted E11.5 kidney rudiments
and cultured them in the presence of 1 mM RA or 1 mM of the
pan-RAR antagonist BMS493. Although BMS493 treatment
strongly reducedNrip1 expression in the nephric duct and ureter
epithelium, RA increasedNrip1 expression in these tissues slightly
(Figure 4B). Thus,Nrip1 represents a novel RA-responsive gene in
the genitourinary system.
Functional In Vivo Studies in Xenopus laevis Show a
Major Role for NRIP1 during Renal Development
Which Is Abolished with the Mutant NRIP1
Expression and knockdown experiments in X. laevis further
confirmed a role for NRIP1 in renal development. Because
unilateral injections allow a tissue-restricted knockdown and
analysis of organ-specific phenotypes, we turned to the Xen-
opus model to analyze the developmental events in renal for-
mation in further detail.31 Nrip1 is expressed during Xenopus
development at neurula and tadpole stages. Strong expression
was detected in the condensing pronephric tubules and so-
mites (Figure 5, A–C9). Neither overexpression of the wild
type NRIP1 nor the altered protein significantly interfered
4 Journal of the American Society of Nephrology J Am Soc Nephrol 28: ccc–ccc, 2017
BASIC RESEARCH www.jasn.org
Part 5 - NRIP1 mutation causes CAKUT
!151
with pronephric development, again arguing against a a dom-
inant-negative effect of the mutant construct (Figure 5, E, F,
and K). Knockdown with a translation-blocking nrip1 MO
inhibited renal development and resulted in distorted pro-
nephric structures (Figure 5, H and K; P,0.001). This could
partially be rescued with the wild-typeNRIP1mRNA (Figure 5,
I and K; P=0.01) but not with the mutant (NRIP1 279delG)
mRNA (Figure 5, J and K; P=0.43).
Further analysis of early pronephros markers after nrip1
MO injection resulted in significantly reduced expression of
transcription factors implicated in pronephros specification
and patterning, such as wt1, lhx1, tfap2b, sall1, and evi1 (Figure
6). No significant difference was observed for gata3 or pax8. We
conclude that nrip1 is necessary for early specification events in
pronephros formation in Xenopus. Taken together, these data
support a role for nrip1 during early tubular morphogenesis,
and are consistent with the human CAKUT phenotype.
CAKUT Phenotype in Nrip1+/2 Mice
Previous work reported that mice homozygous for a null allele
of Nrip1 exhibit defective ovulation in females as well as re-
duced body weight and body fat content.32 The genitourinary
system was not yet analyzed for defects. To uncover a possible
involvement of Nrip1 in the development of the murine uri-
nary tract, we analyzed mice heterozygous for a null allele of
Nrip1 at E18.5 for phenotypic changes. In all three specimens
analyzed we detected dysplastic kidneys with cystic dilations.
One of the specimens exhibited severe hydoureter with hy-
dronephrosis and ureterocele (Figure 7). Hence, heterozygous
loss of Nrip1 results in a spectrum of CAKUT phenotypes in
mice similar to the human situation.
DISCUSSION
We identified a truncating mutation of NRIP1 as a novel au-
tosomal dominant cause of human CAKUT. By studying
NRIP1 cellular localization, transcriptional activation, and
protein-protein interaction, we demonstrate loss of function
for a truncating NRIP1mutation (c.279delG; p.Trp93fs*) that
segregated in a large CAKUT pedigree. We show that this mu-
tation acts via haploinsufficiency rather than in a dominant-
negative manner. By expression and knockdown experiments
in X. laevis, as well as by analyzing the genitourinary system in
mice with Nrip1 heterozygous deletions, we generated addi-
tional data that suggest that dysregulation of NRIP1-depen-
dent RA signaling during kidney and ureter morphogenesis
causes CAKUT.
NRIP1, also known as receptor-interacting protein 140
(RIP140), is a transcriptional coregulator that plays an integral
role in fine-tuning the activity of a large number of transcrip-
tion factors during development.27 NRIP1 has been mainly
implicated in transcriptional repression by interacting with
different nuclear receptors, including the RARs.28,29,33,34
Nonetheless, the role of NRIP1 during kidney and ureter de-
velopment, as well as its relation to RA signaling, has re-
mained unclear. In this study, our finding of a germline
NRIP1 mutation as a novel cause of human CAKUT
Table 1. Dominant NRIP1 mutation detected in individuals with CAKUTa
Family – Individuala,b,c
Presenting
Symptoms or
Diagnostic
Test (at Age in yr)
Kidney Phenotype Treatment
Serum Creatinine,
mg/dl (at Age in yr)
H
II:8 Renal US (69) R small pelvic kidney with
hydronephrosis
Conservative 0.93 (69)
III:3 Abdominal mass
(newborn)
L MCDK; R VUR, dilated ureter,
and dysplasia
L nephrectomy 1.5 (35)
R nephrostomy
III:4 Abdominal pain (7) L dysplastic kidney and VUR L nephrectomy 0.75 (27)
III:5 Renal US and
VCUG (3)
Bilateral grade 2 VUR Conservative 0.64 (28)
IV:7 Renal US (2) Small right kidney Conservative 0.23 (5)
IV:8 Hydronephrosis on
renal US (prenatal)
L VUR grade 5 and dysplasia;
R VUR grade 2
Conservative 0.45 (8)
IV:9 Renal US (prenatal) L ectopic dysplastic kidney Conservative 0.23 (3)
Co-IP, coimmunoprecipitation; k.d., knock-down; US, ultrasound; R, right; L, left; MCDK, multicystic dysplastic kidney; VCUG, voiding cystourethrogram.
aAll individuals were found to harbor a c.279delG mutation in NRIP1. The cDNA mutation is numbered according to human cDNA reference sequence
NM_003489.3, isoform (NRIP1), where +1 corresponds to the A of ATG start translation.
bThe c.279delGNRIP1mutation corresponds to the following alteration in the coding sequence: p.Trp93fs*. Thismutation was absent from200 control individuals with
renal ciliopathies, 429 individualswith steroid-resistantnephrotic syndrome, fromapproximately 13,000healthy control alleles of theEVS (http://evs.gs.washington.edu/
EVS), from2577 control individuals of the“1000genomesproject” (http://www.1000genomes.org), and fromapproximately 100,000control chromosomesof theExAC
server (http://exac.broadinstitute.org). In addition,NRIP1 had an ExAC: pLI (probability of being loss-of-function intolerant) score of 0.99. The closer the pLI is to 1, the
more loss-of-function-intolerant the gene appears to be. Genes with pLI$0.9 are considered as an extremely loss-of-function-intolerant set of genes.
cLoss of function of the NRIP1 c.279delG allele was demonstrated in four assays: nuclear localization (Figures 2A and 2B), luciferase assay (Figure 2C), co-IP with
RARa (Figure 3A), or Xenopus knockdown and rescue experiments (Figure 5, D–K).
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provides a link between the well documented
association of vitamin A/RA and renal
malformations.20,21,24
RA is a signaling molecule that is crucial
in the development of many organs.35 In
human21,36 and rodent20,37 embryos, both
excess or deficiency (which was shown
mainly in animal models) of RA can cause
CAKUT. Classic mouse-model studies
have highlighted the importance of RA sig-
naling for proper ureter maturation and
ureter-bladder connectivity.22–24 Pertur-
bation of this process in mice can result
in hypo/dysplastic kidneys as well as in
backflow of urine to the ureters, clinically
known as VUR. Interestingly, renal dyspla-
sia and VUR were both the predominant
phenotypes in the kindred we have studied
(Figure 1, Supplemental Figure 1, Table 1).
Furthermore, we detected a ureterocele in
one Nrip1+/2 embryo, pointing to a role of
NRIP1 in regulating RA signaling during
ureter maturation. Our results indicate that
NRIP1 inhibits RA-induced transcription.
Because Nrip1 is a target of RA signaling in
the nephric duct and ureter, NRIP1 most
likely serves as a feedback inhibitor for this
pathway in ureter development. We postu-
late that loss of this feedback inhibition re-
sults in an excess of RA and RA signaling,
leading to congenital renal and urinary tract
malformations. A negative-feedback regula-
torymechanism forNRIP1 is also supported
by previous reports.38
NRIP1 mutations have never been im-
plicated before in human disease. Further-
more, early NRIP1 truncating mutations
are absent from all available WES data-
bases, supporting intolerance for this gene
for loss of function (see ExAC: pLI score of
0.99 [i.e., probability of being loss-of-function
intolerant]). This is consistent with our
finding that the early truncatingNRIP1mu-
tation, which we identified, results in a
pathomechanism of haploinsufficiency
rather than a dominant-negative effect.
The fact that we did not find a second
CAKUT family with NRIP1 mutations sup-
ports the general notion that CAKUT is prob-
ably caused by a very large number of different
Figure 2. NRIP1 p.Trp93fs* fails to translocate to the nucleus, does not suppress RA-
induced transcriptional activation, and fails to interact with RARa. (A) Immunofluorescence
staining of HEK293 cells transfected with Myc-tagged wild-type (WT) NRIP1 cDNA and
Myc-tagged NRIP1 c.279delG cDNA. WT NRIP1 localizes to the nucleus, whereas the
altered NRIP1 protein (p.Trp93fs*) predominantly localizes to the cytoplasm. (B) Western
blot of cytoplasmic (C) and nuclear (N) extracts from transfected HEK293 cells shows
localization of WT NRIP1 predominantly in the nucleus and of NRIP1 p.Trp93fs* in the
cytoplasm. Sp1 and GAPDH were used as nuclear and cytoplasmic markers, respectively.
(C) Luciferase assay of HEK293 cells transfected with Mock GFP, GFP-tagged WT NRIP1
cDNA, and GFP-tagged NRIP1 c.279delG mutant cDNA and subsequently treated with
RA. WT NRIP1 suppresses RA-induced transcriptional activity, whereas the mutant form
fails to do so. (D) Immunofluorescence staining of HEK293 cells cotransfected with
GFP-tagged RARa and either Mock Myc, Myc-tagged WT NRIP1, or Myc-tagged NRIP1
c.279delG. RARa and WT NRIP1 colocalize in the nucleus (speckled pattern), whereas the
Trp93fs* altered protein remains in the cyto-
plasm and fails to produce a speckled nuclear
pattern together with RARa. **P,0.01.
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and extremely rare disease-causing mutations in large numbers of
different genes.1,17
Our study provides several insights into the complex genetic
basis of CAKUT.4 In addition to the genetic heterogeneity, low
penetrance mutations, and variable expressivity already de-
scribed in monogenic CAKUT, our results emphasize possible
gene-environment interactions as an additional level of com-
plexity in the pathogenesis of human CAKUT and provide
insight into potential therapeutic targets.
The loss-of-function mutation we identified in the NRIP1
genemay cause developmental renal abnormalities in humans
and could indicate that NRIP1 is an important player in
the development of the kidneys and urinary tract. Any gen-
eralizations regarding its direct causal role, however, must
await the description and characterization of mutations in
additional patients.
CONCISE METHODS
Study Participants
After informed consent, we obtained clinical data, pedigree data,
and blood samples from individuals with CAKUT from worldwide
sources using a standardized questionnaire. Approval for human
subjects’ research was obtained from the In-
stitutional Review Boards of the University of
Michigan, Boston Children’s Hospital, Sheba
Medical Center, and from other relevant local
Ethics Review Boards. Informed consent was
obtained from the individuals and/or parents,
as appropriate. The diagnosis of CAKUT was
made by (pediatric) nephrologists and/or
urologists on the basis of relevant imaging.
WES
To identify a causative mutated gene for CAKUT,
we investigated family members from a three-
generation Yemenite Jewish family (Figure 1)
with an autosomal dominant form of CAKUT
characterized predominantly by lower urinary
tract involvement, renal hypodysplasia, and/or
ectopia (Table 1). DNA samples from six affected
individuals (Figure 1) were subjected to WES us-
ing Agilent SureSelect human exome capture ar-
rays (Life Technologies) with next-generation
sequencing on an Illumina sequencing platform.
Sequence reads were mapped against the human
reference genome (NCBI build 37/hg19) using
CLC Genomics Workbench (version 6.5.1) soft-
ware (CLC bio). Mutation calling under an au-
tosomal dominant model was performed by
geneticists and cell biologists, who had knowl-
edge regarding clinical phenotypes, pedigree
structure, genetic mapping, andWES evaluation
(Supplemental Table 1), and in linewith proposed
guidelines.39,40 Sequence variants that remained after the WES evalua-
tion process were examined for segregation.
WES Analysis
After WES, genetic variants were first filtered to retain only hetero-
zygous, nonsynonymous variants that were shared between the six
affected relatives of family H subjected to WES (Supplemental
Table 1). Second, filtering was performed to retain only alleles
with a MAF,0.1%, a widely accepted cutoff for autosomal dominant
disorders.41,42MAF was estimated using combined datasets incorpo-
rating all available data from the 1000 Genomes Project, the Exome
Variant Server (EVS) project, dbSNP138, and the Exome Aggregation
Consortium (ExAC). Third, observed sequence variants were ana-
lyzed using the UCSC Human Genome Bioinformatics Browser for
the presence of paralogous genes, pseudogenes, or misalignments.
Fourth, we scrutinized all variants with MAF,0.1% within the se-
quence alignments of the CLC Genomic Workbench software
program for poor sequence quality and for the presence of mis-
matches that indicate potential false alignments. Fifth, we employed
web-based programs to assess variants for evolutionary conserva-
tion, to predict the effect of disease candidate variants on the
encoded protein, and to predict whether these variants represen-
ted known disease-causing mutations. Finally, Sanger sequencing
was performed to confirm the remaining variants in original DNA
Figure 3. RA increases NRIP1 binding to RARa in vitro. (A) Coimmunoprecipitation of
protein lysates of wild type (WT) NRIP1 and RARa overexpressed in HEK293 cells.
Note that the Trp93fs* mutation abrogates binding to RARa. Treatment with RA in-
creases WT NRIP1 binding to RARa (orange boxes). (B) Quantification of data shown
in (A). RARa coimmunoprecipitation band intensity was normalized to WT NRIP1
immunoprecipitation band intensity in the absence and presence of RA. *P,0.05,
average of three separate experiments.
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samples and to test for familial segregation of phenotype with
genotype. Variants were also tested for absence from in-house
control populations of 200 individuals with nephronophthisis
and 429 individuals with steroid-resistant nephrotic syndrome
(Supplemental Table 1).
CNV Analysis
One individual fromthe index family (familyH individual IV:8; Figure
1A, Table 1) was analyzed for copy number variations. CNVanalysis
was performed on a 180K genome-wide array, using array compar-
ative genomic hybridization with approximately 180,000 oligonucle-
otides covering the whole genome at an average resolution of 30 kb,
with denser coverage at disease loci. The array was designed by Baylor
Medical Genetics Laboratories andmanufactured by Agilent. The CNV
calls were determined with generalized copy number variation al-
gorithms. CNVs were mapped to the human reference genome
hg19, and annotated with UCSC RefGene. Polymorphic variants
were excluded on the basis of the database of genomic variants
(http://projects.tcag.ca/variation/).
High-Throughput NRIP1 Mutation Analysis
Massively parallel sequencing of all NRIP1 exons was performed in 155
sporadic cases and 253 familial cases of CAKUT (total of 724 affected
individuals) from different pediatric nephrology centers worldwide using
microfluidic PCR (Fluidigm) and next-generation sequencing (MiSeq;
Illumina), as described previously.43,44Variants were filtered against public
variant databases (http://evs.gs.washington.edu/EVS) and only novel
heterozygous variants were considered, confirmed by Sanger sequenc-
ing, and tested for segregation with the CAKUT phenotype.
cDNA Cloning
Full-length human NRIP1 cDNA (cDNA clone MGC:9257
IMAGE:3918685) and RARa cDNA (cDNA clone MGC:1651
IMAGE:3163891) were subcloned by PCR from full-length cDNAclones.
Expression vectors were generated using LR Clonase (Thermo Fisher)
according to the manufacturer’s instructions. The following expression
vectors were used in this study: pRK5-N-Myc, pcDNA6.2-N-GFP, and
pDest69-FLAG.Mutagenesis was performed using theQuikChange II XL
site-directed mutagenesis kit (Agilent Technologies) to generate a clone
with the NRIP1mutation identified in family H.
Cell Culture, Transient Transfections, and RA
Treatment
The experiments describedwereperformed inHEK293cellspurchased
from the American Type Culture Collection biologic resource center.
For transient transfections, HEK293 cells were seeded at 60%–70%
confluency in DMEM, supplemented with 10% fetal calf serum and 1%
penicillin/streptomycin, and grown overnight. Transfections were carried
out using Lipofectamine2000 (Thermo Fisher) and OptiMEM (Thermo
Fisher) following the manufacturer’s instructions. For experiments involv-
ing treatment with RA, HEK293 cells were treated with 500 nM RA 24
hours after transfection. Experiments were then carried out 24 hours
after continuous treatment with RA.
NRIP1 Reporter Gene Assays
Reporter assays (Dual luciferase reporter assay system; Promega)
were carried out using HEK293 cells seeded in 24-well dishes and
transfected with constant amounts of reporter plasmids and 100 ng of
Figure 4. Nrip1 is a target of RA in the nephric duct and ureter
epithelium. (A) In situ hybridization analysis of expression of Nrip1 in
whole urogenital systems (first row), on coronal kidney sections (second
row), on transverse ureter sections (third row), and on cloaca/bladder
sections (fourth row) of wild-type embryos at E11.5, E12.5, and E14.5.
Nrip1 is expressed in the epithelium of the cloaca, the nephric duct,
and the ureter from E11.5 to E14.5. a, adrenal gland; bl, bladder; cl,
cloaca; k, kidney; nd, nephric duct; t, testis; u, ureter; ue, ureteric ep-
ithelium; ur, urethra; ut, ureteric tip. (B) In situ hybridization analysis of
Nrip1 expression in kidney rudiments dissected from E11.5 wild-type
embryos and cultured for 24 hours in the presence of 1mMof BMS493
or 1 mM RA. Nrip1 mRNA expression in the nephric duct and the
ureteric tree is downregulated after treatment with the pan-RAR
antagonist BMS493, and upregulated after treatment with RA.
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pRL-TK Renilla luciferase for normalization. The total amount of expres-
sion plasmid was kept constant by adding empty pcDNA6.2-N-GFP. Per
transfection, 500 ng of pGL3-RARE (RAREs) luciferase (https://www.
addgene.org, plasmid, 13458; Addgene, Cambridge,
MA) and 500 ng of pcDNA6.2-N-GFP.NRIP1 ex-
pression plasmidwere used. For competition exper-
iments, the amount of pcDNA6.2-N-GFP.
NRIP1_WT was held constant and increasing
amounts of pcDNA6.2-N-GFP.NRIP1_p.Trp93fs*
were added. Firefly luciferase and Renilla luciferase
activities weremeasured 24 hours after transfection.
All transfections were performed in triplicate, and
individual experiments were repeated at least three
times. In addition, all experiments were repeated
with a different RARE reporter plasmid (RARE-tk-
luciferase, kind gift from Li-Na Wei). After normal-
ization, the mean luciferase activities and standard
deviations were plotted as “fold activation” when
compared with the empty expression plasmid. P
values were determined using the paired t test.
Immunofluorescence and Confocal
Microscopy in Cell Lines
For immunostaining,HEK293 cellswere seededon
fibronectin-coated coverslips in 6-well plates. After
16–24 hours, cells were transiently transfected us-
ing Lipofectamine2000 (ThermoFisher) according
to the manufacturer’s instructions. Experiments
were performed 24–48 hours after transfection.
Cells were fixed for 15 minutes using 4% parafor-
maldehyde andpermeabilized for 15minutes using
0.5% Triton X-100. After blocking with 10% don-
key serum + BSA, cells were incubated with pri-
mary antibodyovernight at 4°C. The following day,
cells were incubated in secondary antibody for
60minutes at room temperature, and subsequently
stained for 5 minutes with 4’,6-diamidino-2-
phenylindole (DAPI) in PBS. Confocal imaging
was performed using the Leica SP5 3 system with
an upright DM6000 microscope, and images were
processed with the Leica AF software suite. Immu-
nofluorescence experiments were repeated at least
two times in independent experiments. The follow-
ing antibodies were used for immunostaining:
mouse anti-Myc (sc-40; Santa Cruz Biotechnology)
and rabbit anti-NRIP1 (ab42125; Abcam), both di-
luted 1:100. Donkey anti-mouse secondary anti-
bodies conjugated to Alexa Fluor 488 or 594 and
donkey anti-rabbit secondary antibody conjugated
to Alexa Fluor 594 were purchased from Thermo
Fisher Scientific.
Coimmunoprecipitation Assays
Coimmunoprecipitation experiments were
performed using protein lysates from transfected
HEK293 cells. Cell lysates were precleared with Recombinant
Protein G Sepharose beads (Thermo Fisher) at 4°C overnight in IP
lysis buffer (Thermo Fisher) containing Halt Protease Inhibitor
Figure 5. Nrip1 deficiency affects pronephros development in Xenopus. (A–C) WM-ISH of
nrip1 expression in X. laevis shows its occurrence in the pronephros during development.
Expression starts in the pronephric anlage at stage 22 (A, A’) (black arrows) and is present in
the tubules of stage 26 (B, B’) and stage 33 tadpoles (C, C’) (black arrow head). (D–K)
Functional analysis of nrip1 in X. laevis. Embryos were unilaterally injected with nrip1 MO
and/or NRIP1-encoding mRNA at the four-cell stage. Stage 39 tadpoles were stained with
fluorescein-conjugated lectin to visualize the pronephros (D–J). The size of the pronephros
was measured and the proportion between the injected (right) and uninjected (left) side
calculated (K). The structure of the pronephros was not changed by microinjections of the
NRIP1wt (E/K) mRNA or its truncated variant (NRIP1 279delG; [F]) compared with the controls
(D’/K). Knockdown with a translation-blocking nrip1 MO inhibited pronephros development
(H/K; P,0.001) and could be partially rescued withNRIP1 wt (I/K; P=0.01) but not with NRIP1
G279 del (J/K; P=0.43). Error bars represent SEM. **P,0.01, ***P,0.001 (MWU-test). coMO,
control morpholino oligonucleotide; del, deletion; MO, antisense morpholino oligonucleo-
tide; st., stage according to Nieuwkoop and Faber50; wt, wild-type.
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Cocktail (Thermo Fisher) and EDTA (Thermo Fisher). Coimmuno-
precipitation of Myc-tagged proteins was performed using Myc aga-
rose beads (Sigma). The beadswerewashed four timeswith lysis buffer
and proteins were eluted from the beads by incubating in loading
buffer for 30 minutes at 30°C, shaking at 300 rpm. Samples were
analyzed by western blot with anti-Myc (sc-40; Santa Cruz Biotech-
nology) and anti-FLAG (F3165; Sigma) antibodies at 1:1000 dilutions.
Horseradish peroxidase–labeled secondary antibodies were purchased
fromSantaCruz Biotechnology. Tenpercent of the inputwas loaded as a
control. Experiments were repeated at least
three times in independent experiments and
quantification of band intensity was performed
using ImageJ (https://imagej.nih.gov/ij/).
Organ Cultures
E11.5 kidney rudiments were dissected from the
embryo, explanted on 0.4-mm polyester mem-
brane Transwell supports (Corning), and cul-
tured at the air-liquid interface for 24 hours
with DMEM/F12 (Gibco) supplemented with
10% FCS (Biochrom), 13 penicillin/streptomycin
(Gibco), 13 pyruvate (Gibco), and 13 glutamax
(Gibco). The pan-RA receptor antagonist
BMS493 (Tocris) or RA (Tocris) was dissolved
in DMSO and used at a final concentration of
1 mM in the culture medium.
In Situ Hybridization Analysis
Whole-mount in situ hybridization (WM-ISH)
was performed with a digoxigenin-labeled anti-
sense riboprobe corresponding to position 3102–
4030 of the Nrip1 mRNA (NM_173440.2)
following a standard procedure.45 Stained spec-
imens were cleared in 80% glycerol before doc-
umentation. In situ hybridization on 10-mm
paraffin sections was done essentially as de-
scribed.46 For each stage, at least three indepen-
dent specimens were analyzed.
Xenopus Embryo Manipulations
Xenopus embryos were cultured and their stages
determined as described before.47 Microinjec-
tions were performed in the ventrolateral re-
gion of 4- and 8-cell stage Xenopus embryos
targeting the pronephros anlagen. Five-hundred
picograms of RNA and/or 10 ng MO in a
volume of 10 nl were injected. A standard
control MO was used as negative control.
GFP-mRNA or RFP-mRNA were coinjected
as lineage tracers and embryos showing fluo-
rescence in the pronephros were sorted for
further analysis.
Staining and Imaging of Xenopus
Embryos
Xenopus embryos were fixed withMEMFA (0.1mol/LMops, 2mmol/
L EGTA, 1 mmol/L MgSO4, 3.7% formaldehyde, pH 7.4) for 2 hours
at room temperature. For WM-ISH, nrip1 in pBS II KS (2) was
linearized with NotI. The digoxigenin-labeled antisense probe was
transcribed with SP6 (Roche) and bound probes detected with an
alkaline phosphatase–conjungated secondary antibody (Roche).
WM-ISH was performed as described before.48 For immunofluores-
cence, embryos were fixed at stage 39 and their pronephros stained
with fluorescein or Texas Red–labeled Lycopersicon esculentum
Figure 6. Nrip1 deficiency affects early pronephros marker gene expression in Xenopus
embryos. (A–H) Pronephros marker gene analysis of Nrip1-depleted embryos at stage
22. Embryos were injected with nrip1 MO (+) or control MO (2) at the four-cell stage
targeting their right sided pronephros. An in situ hybridization was performed for
early pronephros markers (gata3, pax8, sall1, emx1, evi1, lhx1, tfap2b, and wt1) followed
by the examination of their expression intensity on the injected (right) side compared
with the uninjected side and quantified as shown in (I) (R, right side, injected; L, left side,
uninjected). The expression of gata3 was not affected (P=0.16 z-test). The expression of
pax8 (P=0.09) was slightly, but not significantly, reduced. Significant differences were
observed for sall1 ([C]; P50.035 z-test), evi1 ([D]; P=0.004), lhx1, tfap2b, and wt1 ([E–H];
P,0.001). n, number of embryos analyzed. *p,0.05; **p,0.01; ***p,0.001. coMO, control
morpholino oligonucleotide; MO, antisense morpholino oligonucleotide; n.s., not significant.
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lectin (1:100 dilution; Vector Laboratories). Embryos were imaged
with SteREO Discovery.V8 from Zeiss and Zen 2011 Blue Edition.
The pronephros size was measured with ImageJ and the ratio of the
injected and uninjected side calculated.47 SigmaStat was used to
show statistical significance with the Wilcoxon–Mann–Whitney
test. Significances are quoted in the figure legend and above the
bars with ***P,0.001, **P,0.01, and *P,0.05.
Xenopus Plasmids, MOs, and mRNA Synthesis
Full-length human NRIP1 CDS was obtained from BIOCAT and
subcloned into VF1049 for overexpression in Xenopus after addition
of a stop-codon. The deletion construct NRIP1 279delG was gener-
ated by site-directed mutagenesis (New England BioLabs). mRNAs
for microinjections were synthesized by in vitro transcription of lin-
earized plasmids using the mMessage Machine kit (Ambion, Kassel,
Germany). For WM-ISH full-length CDS of X. laevis nrip1
(NM_001090238.1) was cloned with MluI/NotI restriction enzyme
sites in pBS II KS (2). The nrip1 translation-blocking morpholino
oligonucleotide (59-AGCTCTTCTCCATAAGTCATGTTCA-39) was
designed by and ordered from GeneTools.
Analysis of Nrip1-Deficient Mice
Mice with a null allele of Nrip1 (RIPKO mice) were generated in
Professor MG Parker’s laboratory (Imperial College London, Lon-
don, UK).32 They were maintained at the ICRMunder standard con-
ditions, on a 12:12-hour light/dark schedule and fed a chow diet ad
libitum, according to EuropeanUnion guidelines for use of laboratory
animals. In compliancewith the French guidelines for experimental animal
studies (agreement B34–172–27), heterozygous mice were mated to wild-
type C57BL/6J mice. At E18.5, females were euthanized to obtain hetero-
zygous Nrip1 embryos which were fixed in 4% PFA and processed into
methanolbeforeparaffin-embeddingand sectioning to5mm.Hematoxylin
and eosin staining was performed according to standard procedures. Three
embryos of each genotype were used for each analysis.
Web Resources
http://www.renalgenes.org
UCSC Genome Browser, http://genome.ucsc.edu/cgi-bin/hgGateway
1000 Genomes Browser, http://browser.1000genomes.org
Ensembl Genome Browser, http://www.ensembl.org
Exome Variant Server, http://evs.gs.washington.edu/EVS
Polyphen2, http://genetics.bwh.harvard.edu/pph2/
Sorting Intolerant From Tolerant (SIFT), http://sift.jcvi.org
Online Mendelian Inheritance in Man (OMIM), http://www.omim.
org/
ExAC Browser Beta, http://exac.broadinstitute.org
Gudmap (GenitoUrinary Molecular Anatomy Project), http://www.
gudmap.org
Mutation Taster, http://www.mutationtaster.org/
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Concluding remarks 
Specification and diversification of the ureteric lineages 
The different components of the urinary system, the kidneys, the ureters, the urinary bladder 
and the urethra, arise in development from diverse mesenchymal and epithelial progenitor pools 
within the intermediate mesoderm. How these lineages are established and diversify in time and 
space, has been most intensively studied for the kidney. All renal cell types derive from com-
mon Osr1+ progenitors in the intermediate mesoderm. These progenitors segregate into the 
Pax2+ nephric duct lineage that gives rise to the ureteric epithelium and the collecting duct 
system, the Six2+ cap mesenchymal lineage that comprises all nephron progenitors and the 
Foxd1+ stromal lineage that contributes to interstitial cells of the kidney.15, 29, 48-50 The differ-
entiated cell types of the ureter arise from uncommitted precursor cells in the distal ureteric bud 
and its surrounding mesenchyme, respectively. How the ureteric lineages are specified and how 
they segregate from the other renal lineages has remained poorly understood. Moreover, it is 
unclear how the distinct ureteric sub-lineages diversify to achieve tissue complexity. 
Pulse labeling and lineage tracing of Osr1 expressing intermediate mesoderm cells previously 
suggested that the ureteric mesenchymal lineage segregates early from that giving rise to neph-
rons.29 Indeed, our comparative expression analysis indicated that Tbx18 expression demarcates 
a mesenchymal cell population surrounding the ureteric bud stalk that is clearly separated from 
Six2+Uncx+ nephron progenitors. Genetic fate mapping and lineage tracing of Tbx18+ revealed 
that cells from this expression domain do not intermingle with the nephron lineage but give rise 
to the complete mesenchymal wall of the ureter, a subset of bladder smooth muscle cells and 
also contribute to interstitial cells of the kidney. These observations suggest that Tbx18+ cells 
are not yet specified towards a ureteric mesenchymal fate but represent a multipotent progenitor 
population. Tbx18 expression at E10.5 is not yet confined to cells adjacent to the distal ureteric 
stalk but comprises a band of mesenchymal cells in between the nephric duct and the meta-
nephric mesenchyme, suggesting that it encompassed stromal and bladder smooth muscle pro-
genitors as well. Because Tbx18 expression at E11.5 does not overlap with the stromal marker 
Foxd1, we propose that the lineage segregation is completed shortly before. From E12.5 on, 
Tbx18 expression is restricted to the mesenchymal cells of the ureter. Our tissue recombination 
experiments indicated that signals from the ureteric epithelium are required to maintain Tbx18 
expression in the adjacent cell population and to impose a ureteric mesenchymal fate. Tbx18 is 
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exclusively required in these cells to render them responsive for epithelial SHH and WNT sig-
nals. This suggests a function of Tbx18 in the pre-patterning of the ureteric mesenchyme prior 
to the action of specifying signals from the ureteric epithelium.  
Cells from the ureteric mesenchyme subsequently diversify into adventitial fibrocytes, smooth 
muscle and lamina propria cells. Adventitial fibrocytes are the first cell type to differentiate and 
express POSTN in the periphery of the ureteric mesenchyme at E13.5. They are succeeded by 
TAGLN+ACTA2+ smooth muscle cells which differentiate in a proximal to distal gradient start-
ing from E15.5. By E16.5, subepithelial TAGLN-ACTA2- lamina propria cells are established. 
While smooth muscle cells and lamina propria cells subsequently expand, adventitial fibrocytes 
decrease in number and are only present at low abundancy in the mature ureter. The early dif-
ferentiation of adventitial fibrocytes in the periphery of the ureteric mesenchyme, out of reach 
of inductive epithelial signals, may indicate that these cells represent the default fate of the 
ureteric mesenchyme. The expansion of adventitial fibrocytes at the expense of smooth muscle 
cells under WNT loss-of-function conditions suggest that WNT signals specify smooth muscle 
progenitors via a spatial inhibition of the adventitial program.20 Our genetic lineage tracing 
experiments further supported this hypothesis and revealed that adventitial fibrocytes segregate 
early from WNT-responsive cells that preferentially contribute to the smooth muscle and lam-
ina propria layers. It has been speculated that lamina propria cells arise from smooth muscle 
precursors by spatial inhibition of the smooth muscle gene program.23 This thesis clearly de-
fined their common origin from WNT-responsive progenitor cells in the inner compartment of 
the ureteric mesenchyme. Interestingly, lamina propria cells establish or maintain characteris-
tics of the undifferentiated progenitors like the expression of components and target genes of 
the SHH, WNT and RA signaling pathways.20, 23 It is conceivable that lamina propria cells 
retain a progenitor character and are able to contribute to the smooth muscle layer in homeo-
stasis or regeneration which should be addressed in future experiments. The mechanisms of 
mesenchymal specification, radial patterning and differentiation are likely to be conserved in 
the development of visceral smooth muscle organs of the urinary and gastrointestinal tract. A 
similar requirement for reciprocal epithelial-mesenchymal signaling has been reported in both 
systems.23, 51, 52 
The genetic fate mapping experiments in the urothelium confirmed the common origin of basal, 
intermediate and superficial cells from the Pax2+Shh+ ureteric bud lineage. The uncommitted 
ureteric bud cells start to stratify and differentiate into ∆NP63+UPK1B+[low] intermediate cells 
between E13.5 and E14.5. At E15.5, single luminal cells downregulate ∆NP63 expression and 
become ∆NP63-UPK1B+[high] superficial cells. At E16.5, the urothelium is stratified into three 
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layers and single cells in the basal layer start to co-express KRT5 and ∆NP63. These 
KRT5+∆NP63+UPK1B- basal cells subsequently increase in number and constitute the main 
cell type of the mature urothelium. In the adult a single layer of binucleate superficial cells seal 
the urothelium and intermediate cells are maintained at low abundancy. Our genetic tracing of 
the urothelial sub-lineages of the ureter and a recent report in the developing and regenerating 
urinary bladder44 indicated that the sequence of differentiation and the nature of progenitor cells 
in the urothelium are fundamentally different compared to other stratified epithelia. While api-
cal cell types arise in a sequential fashion from basal cells for example in the epidermis53 or the 
bronchial epithelium54, we clearly defined intermediate cells as urothelial progenitors that give 
rise to basal and superficial cells in development and homeostasis. However, a conflicting re-
port described a subpopulation of KRT14+ basal cells as progenitors in the regenerating bladder 
urothelium.55 KRT14 is expressed in a minor fraction of basal cells in the ureter only in adults, 
so it can be excluded that these cells constitute a progenitor population in development. Never-
theless, it remains to be solved whether basal cells can be reprogrammed to a progenitor status 
under injury conditions. Future studies should establish injury and regeneration models for the 
ureter to test the significance of the different cell populations in urothelial repair. In general, it 
has to be remarked that the set of urothelial differentiation markers is very limited. So far, no 
unique marker for intermediate cells is established and only a combination of several differen-
tiation markers allows the labeling of the urothelial cell layers. Moreover, the presence of dif-
ferent subpopulations of basal cells indicates that large heterogeneity within the urothelial lay-
ers exists.25, 55 Cell type specific and single-cell transcriptome analyses should help to identify 
new differentiation markers and to elucidate the cellular heterogeneity within the urothelial 
populations. 
Molecular control of growth and differentiation in the developing ureter 
The importance of morphogenetic interactions of epithelial and mesenchymal tissues in the 
growth and differentiation of the ureters and the kidneys was discovered more than 50 years 
ago, but the molecular nature of these reciprocal signals has remained elusive for a long time.26, 
27
 Lately, the analysis of genetically modified mouse models revealed SHH and WNT signals 
from the ureteric epithelium to be involved in the growth and differentiation of the ureteric 
mesenchyme.20, 23, 30 Still it is unclear how these signaling activities are balanced to initiate the 
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ureteric differentiation programs in a precise temporal and spatial fashion. Moreover, it is un-
known how the growth and differentiation of the mesenchymal and epithelial components of 
the ureter are coordinated between the two tissue compartments. 
This thesis gave significant new insight into the molecular function of SHH signaling in the 
developing ureter. Genetic deletion of the SHH signal transducer smoothened (SMO) from the 
ureteric mesenchyme resulted in hypoplastic hydroureter formation at birth. Conditional SMO 
mutants failed to initiate the smooth muscle differentiation program and showed reduced pro-
liferation and survival of ureteric mesenchymal cells. In a complementary approach, misexpres-
sion of a constitutive active form of SMO in the ureteric mesenchyme resulted in mesenchymal 
hyperplasia due to increased proliferation and cell survival but did not affect patterning or dif-
ferentiation. As it was previously reported, ureteric smooth muscle differentiation also depends 
on epithelial WNT signals.20 It seems plausible, that the initiation of the smooth muscle gene 
program requires the combinatorial activity of both SHH and WNT signaling and potentially 
other inductive signals. In contrast to previous studies23, 30, we also addressed the consequences 
of defective mesenchymal SHH signaling on urothelial growth and differentiation. Excitingly, 
proliferation was significantly reduced and the stratification and differentiation of the urothe-
lium was not initiated. Our genetic approach specifically targeted SHH signaling only in the 
ureteric mesenchyme, suggesting that urothelial growth and differentiation are regulated by a 
paracrine relay signal downstream of mesenchymal SHH signaling. Pharmacological inhibition 
of SHH signaling and transcriptional profiling by microarray analysis revealed that expression 
of the forkhead transcription factor gene Foxf1 was SHH dependent in the ureteric mesen-
chyme. The dependency of Foxf1 on SHH signaling has previously been reported in the intes-
tine, where Foxf1 controls visceral smooth muscle differentiation as a direct target gene of the 
pathway.56-58 To address a potential function of Foxf1 in the ureter, two transgenic alleles were 
generated that allowed a conditional misexpression of a dominant negative or wildtype version 
of Foxf1 in the ureteric mesenchyme. While misexpression of the dominant negative allele re-
capitulated the growth and differentiation defects in the epithelial and mesenchymal compart-
ments of the ureter that were observed under SHH loss-of-function conditions, re-expression of 
wildtype Foxf1 rescued smooth muscle and urothelial differentiation when SHH signaling was 
inhibited. Further molecular analyses revealed that expression of Bmp4 in the ureteric mesen-
chyme depends on both SHH signaling and FOXF1 function. Administration of exogenous 
BMP4 protein to ureter explant cultures with impaired SHH signaling or FOXF1 function was 
not able to rescue smooth muscle differentiation defects but partially restored tissue growth and 
completely rescued urothelial differentiation. Together these findings imply that epithelial SHH 
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is a crucial signal that couples the growth and differentiation of mesenchymal and epithelial 
tissues of the ureter via a FOXF1-BMP4 regulatory module. While this work clearly deciphered 
the epistatic relations of SHH signaling, FOXF1 and BMP4 in the developing ureter, some open 
questions remain. Our molecular analysis indicated SHH signaling alone is not sufficient to 
induce Foxf1 expression. It is conceivable that Foxf1 integrates multiple signaling inputs that 
culminate in the ureteric smooth muscle differentiation program and it remains to be tested 
whether a combinatorial activation of SHH and WNT signaling is sufficient to drive Foxf1 
expression and smooth muscle differentiation or if additional inductive signals are required. 
While BMP4 is a partial mediator of FOXF1 function in the ureter and an epistatic relation of 
the two factor has been implied in vasculogenesis59 and development of the lateral plate meso-
derm60, it remains to be analyzed whether Bmp4 is a direct target gene and which other factors 
are regulated by FOXF1. A genome wide analysis of DNA binding sites by chromatin immuno-
precipitation combined with assays to detect the FOXF1 dependent transcriptome might help 
to unravel this open question in the future. Furthermore, our rescue experiments provided clear 
evidence that BMP signaling acts downstream of SHH and FOXF1 activity to induce urothelial 
differentiation. Although genetic ablation of Bmp4 from the ureteric mesenchyme has been 
shown to impair superficial cell differentiation39, the precise function of BMP4 signaling and 
its molecular mediators in the urothelium remain elusive. 
While a gradual build-up and a combinatorial input of inductive signals seems to be a plausible 
explanation for the tight temporal and spatial sequence of ureteric differentiation, inhibitory or 
restrictive activities in the undifferentiated progenitors could represent an alternative scenario. 
We analyzed a potential function RA signaling in the ureter since it has been implicated in 
progenitor maintenance in other contexts. For example, RA is required to maintain skeletal 
muscle progenitors in an immature state and to control olfactory stem cell self-renewal and 
progenitor commitment.61, 62 A comprehensive expression analysis of components and target 
genes of RA signaling revealed pathway activity in the undifferentiated mesenchymal and epi-
thelial progenitors of the ureter. Pharmacological inhibition of the early RA signaling activity 
resulted in an expansion of smooth muscle cells at the expense of lamina propria fibrocytes in 
the ureteric mesenchyme, and an increase of superficial cells at the expense of intermediate 
cells in the urothelium. In contrast, activation of the pathway expanded the mesenchymal lam-
ina propria compartment and blocked basal cell differentiation in the urothelium. A precocious 
differentiation of the mesenchymal and epithelial cell types under RA loss-of-function condi-
tions implied a critical requirement of the pathway in the maintenance of ureteric progenitors. 
The identification of the RA-responsive expression of WNT antagonist genes Hic1 and Shisa3 
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in the ureteric mesenchyme suggested that a negative regulation of inductive signaling activities 
may represent a potential mechanism for the temporal-spatial control of smooth muscle differ-
entiation which should be further tested. In the undifferentiated ureteric epithelium, expression 
of the E74 like ETS transcription factor gene Elf5 was detected to be RA dependent. Interest-
ingly, an enrichment of ELF5 motifs in the regulatory regions of urothelial differentiation genes 
has been reported.63 While the paralogous gene Elf3 is an activator of urothelial differentia-
tion64, misexpression of Elf5 in the lung epithelium prevents terminal differentiation65. It re-
mains to be tested whether Elf5 also negatively regulates urothelial differentiation. 
This thesis and previous reports suggest that a combination of positive signaling inputs of the 
SHH23, 30, WNT20 and BMP33-35 pathway families and a negative input of RA are required to 
control the ureteric differentiation programs. If these factors are really sufficient to explain the 
strict temporal and spatial sequence of differentiation in the ureter remains to be solved. Further 
temporal characterization of signaling and transcription factor activities in the course of ureter 
development could provide us with additional factors that specifically act in the mesenchymal 
and epithelial progenitor populations and help to refine our current model of differentiation 
control. 
Developmental basis of congenital ureter anomalies 
Congenital anomalies of the kidney and urinary tract (CAKUT) are a leading cause of early-
onset end-stage renal disease and are among the most common human birth defects.10, 11 Alt-
hough more than 20 CAKUT-causing genes have been identified to date, the disease etiology 
as well as the underlying mutations have remained elusive for the majority of cases.13 Hy-
droureter and hydronephrosis represent frequent manifestations in CAKUT that are character-
ized by structural or functional defects of the ureteric tissues and their junctions to the renal 
pelvis and the urinary bladder. These anomalies arise from alterations of the morphogenesis or 
cellular differentiation programs during ureter development.12, 13 The novel insights into the 
cellular and molecular mechanisms of ureter development achieved in this thesis provide us 
with a better understanding of the disease etiology. 
The proper investment of the ureter with a functional smooth muscle layer is a prerequisite for 
efficient urine drainage. Thus, defects in the differentiation of smooth muscle cells represent a 
potential cellular mechanism for hydroureter and hydronephrosis formation. Here, it was shown 
that a SHH-FOXF1-BMP4 regulatory axis is essential for the ureteric smooth muscle differen-
tiation program. A complete or partial loss of components of this axis is not only associated 
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with urinary tract defects in the mouse, but heterozygous loss-of-function mutations in BMP4 
and GLI3 genes have been identified in human patients with ureter and kidney defects.66, 67 
Urinary tract anomalies may appear as isolated features but often encompass malformations in 
multiple organs.68-70 The requirement of SHH signaling in the development of numerous em-
bryonic tissues renders components of this pathway as promising disease candidates. The 
VACTERL association represents a group of birth defects that include vertebral anomalies, 
anorectal malformations, cardiac anomalies, tracheoesophageal fistula, esophageal atresia, re-
nal malformations, and limb defects. Mutations in the FOXF1 gene or genomic imbalances 
around the FOX gene cluster have been associated with VACTERL phenotypes.71-73 Moreover, 
disease-causing FOXF1 mutations were identified in patients with component features of 
VACTERL that display alveolar capillary dysplasia and misalignment of the pulmonary veins 
(ACDMPV) but also develop hydroureter and hydronephrosis phenotypes.74, 75 Developmental 
expression of Foxf1 in the mouse was detected in most VACTERL associated organs except 
the urinary system.72, 73 Given our finding that Foxf1 is expressed and functionally required for 
ureteric smooth muscle differentiation, the renal manifestations of VACTERL and ACDMPV 
can now be explained. 
The newly identified requirement of the SHH-FOXF1-BMP4 signaling axis for urothelial dif-
ferentiation points to another potential cellular mechanism for hydroureter and hydronephrosis 
formation. An efficient sealing of the urothelium is required to protect the underlying mesen-
chyme from the hypertonic urine. Leakage of the urothelium could lead to damage of the ure-
teric smooth muscle layer and impede efficient urine transport. Interestingly, Upk1b deficiency 
disturbs urothelial plaque formation and results in progressive hydronephrosis in mice.76 In 
contrast to functional or physical ureteric obstructions, urothelial defects should not necessarily 
result in a phenotype at birth but should display a delayed disease progression. If urothelial 
defects may also account for late-onset CAKUT in humans remains to be investigated. 
A requirement for RA signaling has previously been described for multiple aspects of urogenital 
system development and is highlighted by urogenital defects that are caused by reduced or in-
creased maternal Vitamin A levels in humans and rodents.77, 78 The insertion of the distal ureter 
into the bladder is a complex tissue remodeling process that requires RA signaling activity.17 
The patency of the ureterovesical junction is a prerequisite for proper urine drainage and defects 
in the insertion of the ureters into the bladder can lead to physical obstruction or urine reflux. 
Defects in the RA-mediated maintenance of ureteric progenitors that was reported in this thesis 
could represent an additional disease mechanism. This work contributed to the functional char-
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acterization of a heterozygous truncating mutation in the Nrip1 gene in a kindred with autoso-
mal dominant CAKUT. Biochemical analysis of NRIP1 revealed that the protein negatively 
regulates the RA-mediated transcriptional response via direct physical interaction with RA re-
ceptors. The finding that Nrip1 expression in the nephric duct and ureteric bud depends on RA 
signaling suggests that the gene represents a negative feedback regulator and exemplifies the 
importance of a tight control of RA signaling activity in the developing urinary system. If the 
phenotypic manifestations of the NRIP1 mutation in human CAKUT patients are caused by 
anomalies in the ureter-bladder connectivity or by RA-mediated differentiation defects remains 
to be investigated. Further analysis of Nrip1 deficient mice should elucidate whether this gene 
really represents a negative feedback regulator and if ectopic RA signaling and associated dif-
ferentiation defects like a loss of urothelial basal cells are detectable.  
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